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Abstract 
Periodontal disease is associated with an inflammatory response to a pathogenic 
biofilm. The host response may cause gingival inflammation, which can progress 
to irreversible gingival recession, alveolar bone destruction and tooth loss. 
Enhanced understanding of the host-biofilm relationship may inform novel 
therapeutic approaches. A key molecule involved in inducing and mediating pro-
inflammatory responses are the IL-17 cytokine family. An in vitro model system 
potentially provides a platform to investigate biofilm interaction with epithelial 
cells. The aim of this study was to develop in vitro mono-species and multi-
species biofilms and investigate the survival of biofilms in cell culture 
conditions, and simultaneously assess the epithelial response to the bacterial 
biofilms and planktonic cells with respect to viablility, apoptosis and 
inflammatory mediators. This study also looked to determine whether IL-17A is 
expressed within and released from periodontal tissues and to investigate its 
role in the regulation of epithelial cell cytokine and chemokine production.  
 
Mono- and multi-species biofilms of P. gingivalis, F. nucleatum, A. 
actinomycetemcomitans and S. mitis were developed, which were assessed for 
survival in cell culture conditions, recovery from biofilms and morphology. 
Gingival tissue from patients with chronic periodontitis or healthy controls were 
analysed for IL-17A gene expression by qPCR. Protein expression and cellular 
localization was determined by immunofluorescence. Single cell suspensions of 
gingival tissue were stimulated in vitro and IL-17A release assessed. Epithelial 
response after bacterial and IL-17A co-culture was assessed. 
 
The individual bacteria survived preferentially in multi-species biofilm compared 
with mono-species biofilm in cell culture conditions. The viability, apoptosis and 
inflammatory mediator response depended on the type (pathogen or commensal) 
and form (planktonic or biofilm) of bacteria. Diseased gingival tissues expressed 
significantly higher levels of IL-17A mRNA than healthy samples. IL-17A localised 
to mast cells in the inflamed gingival tissue, and was released in cell culture 
supernatants following stimulation. Stimulation of epithelial cells with IL-17A 
resulted in the transcriptional regulation and release of numerous cytokines and 
chemokines.  
 
 v
The initial component of the entire investigation has provided a quantitative and 
qualitative assessment of both mono- and multi-species biofilms that can be 
used to investigate how oral biofilms interact with the host epithelium. The 
epithelial-biofilm co-culture model has demonstrated clear differences between 
(i) planktonic and biofilms, (ii) pathogens and commensals, and (iii) live and 
dead bacterial challenge. These observations and the utility of the model will 
provide a platform to investigate key questions relating to pathogen and host 
within the oral cavity and beyond. From this study, it appears that IL-17A plays 
an important role in the protective periodontal immune response to bacterial 
pathogens. The upregulation of acute inflammatory mediators (such as IL-8) will 
promote neutrophil recruitment and potentiate the removal of any invading 
microbial threat. Therefore it is important to understand the benefits of this 
cytokine, before systemic therapeutic agents are used to antagonise its actions. 
The hope for the future is to unravel the details of the mechanisms involved and 
thereby identify novel therapeutic targets for inflammatory and infectious 
disease. 
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CHAPTER 1:  
INTRODUCTION 
  2
1.1 Periodontal disease 
1.1.1 Clinical classification 
Periodontal diseases include a long list of conditions involving the supporting 
structures of the tooth. Of these diseases, the most prevalent are dental-plaque 
induced gingivitis and chronic periodontitis. Gingivitis is defined as gingival 
inflammation without any loss of attachment and may be purely plaque related 
or may be exacerbated by local or systemic factors. Gingivitis may be associated 
with a slight increase in clinical probing depth as a result of erythema and 
swelling of the gingivae. This condition is entirely reversible with removal of the 
aetiological agent (dental plaque) with no permanent loss of periodontal 
attachment (Tatakis and Kumar, 2005).  Periodontitis is defined as “an infectious 
disease resulting in inflammation within the supporting tissues of the teeth, 
progressive attachment loss and bone loss” (Flemmig, 1999). Periodontitis, 
classified as either chronic or aggressive, may present either as clinical probing 
depths greater than the depth of the physiological sulcus or as gingival recession 
or a combination of both (Novak et al., 2008). Chronic periodontitis, the most 
common, may be further described as mild moderate or severe (Lindhe et al., 
2008). Aggressive periodontitis is a severe and widespread form, which is 
characterised by rapid attachment loss and bone destruction. Both chronic and 
aggressive periodontitis can occur in a localised form affecting a small number 
of teeth or a generalised form affecting the majority of the teeth.   
The primary aetiological factor in periodontal disease is dental plaque 
(Socransky et al., 1998). It is a multi-factorial disease, which affects a 
significant proportion of the general population (60%) to some degree or 
another. Severe disease is, however, affects approximately 8% of the dentate 
adult population in Britain (Morris et al., 2001). There are a number of suggested 
reasons for an increase in susceptibility to periodontitis. The differences 
between patients have been suggested to be due to the amount of plaque, the 
microbial composition of the plaque or the host response to the presence of 
dental plaque. In fact, it is well recognised that the bacteria in dental plaque 
are responsible for the initiation of periodontal disease. This is supported by 
studies that confirm the association between the accumulation of dental plaque 
and periodontal disease and the absence of plaque in health (Löe et al., 1986).  
There is also clear evidence that removal of plaque will result in clinical 
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improvement and that when plaque control is poor the disease will recur (Becker 
et al., 1984, Axelsson et al., 2004). 
The bacterial accumulation on teeth induces an inflammatory response in 
associated gingival tissues. The vast majority of patients who experience an 
accumulation of plaque will develop non-destructive periodontal inflammation 
(gingivitis) (Löe et al., 1978).  Removal and disaggregation of the plaque leads to 
resolution of the classical signs of this inflammation (Löe et al., 1965, Theilade 
et al., 1966). Existing evidence indicates that gingivitis precedes the onset of 
periodontitis; however, not all gingivitis cases develop into periodontitis. This is 
because for the development of periodontitis, accumulation of plaque bacteria 
alone is not sufficient but a susceptible host as well (Listgarten et al., 1985, 
Lindhe et al., 1973, Löe et al., 1986, Page, 1999). Periodontitis is a disease that 
involves complex interactions of the biofilm with the host immune response and 
subsequent changes in bone and connective tissue homeostasis (Offenbacher et 
al., 2007, Tatakis and Kumar, 2005, Taubman et al., 2007). 
 
This chapter will detail the microbiological and host factors associated with 
periodontal disease.  
 
1.2 Microbiology of periodontal disease 
Dental plaque has been defined as the diverse community of microorganisms, 
found on the tooth surface as a biofilm embedded in an extracellular matrix of 
polymers of host and microbial origin (Marsh, 2004). Essentially this is the basic 
definition of a biofilm, i.e. matrix enclosed microbial populations adherent to a 
surface and/or to one another (Ramage et al., 2010).  
 
1.2.1 Biofilms 
Historically microbiologists have focused upon free-living (planktonic) cells in 
pure-culture, resulting in the common perception that microorganisms are 
unicellular life forms. However, literature has emerged within the past 3 
decades demonstrating a link between the surface attached growth state to 
microbial pathogenesis and human infection (Costerton et al., 1981a, 
Costerton et al., 1981b). Extensive research efforts since then have now 
revealed that a wide range of bacteria and fungi alternate between planktonic 
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and surface attached (sessile) multicellular communities, or biofilms, which is 
illustrated in Figure 1.1 (Ramage et al., 2010). Within their natural ecosystems 
most microbes have been shown to exist as attached communities of cells 
within an organized biofilm and not as planktonic organisms. Biofilms can form 
in the natural environment as well as inside the human host, and can be 
considered as complex cities of microbes that cooperatively interact in an 
altruistic manner (Coghlan, 1996). The advantages to an organism of forming a 
biofilm include protection from the environment, resistance of physical and 
chemical removal of cells, metabolic cooperation and a community based 
regulation of gene expression (Stoodley et al., 2002, Donlan and Costerton, 
2002). In recent years there has been an increased appreciation of the role 
that microbial biofilms play in human medicine, particularly because microbes 
growing within biofilms exhibit unique phenotypic characteristics compared to 
their planktonic counterpart cells, including increased resistance to 
antimicrobial agents and protection from host defences (Donlan and 
Costerton, 2002, Ramage et al., 2010). Therefore, they pose a major problem 
to clinicians as they are difficult to treat, none more so than those associated 
with the oral cavity, specifically periodontitis.  
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Figure 1.1: Scanning electron micrographs of clinically important biofilms 
formed in vitro. (a) Biofilm representative of subgingival periodontal plaque. 
The biofilm consists of Streptococcus mitis (Sm), Fusobacterium nucleatum (Fn), 
Aggregatibacter actinomycetemcomitams (Aa) and Porphyromonas gingivalis 
(Pg). (b) Streptococcus mutans biofilm. Note the polymeric matrix material 
(arrow) surrounding the coccoid cells because it was grown in media 
supplemented by 1% glucose. (c) Candida albicans biofilm. Note the combination 
of yeasts (Y) and hyphae (H) that form a lattice network to support the dense 
structure. The scale bar represents 10 μm. Taken from (Ramage et al., 2010).  
 
 
1.2.2 Plaque biofilms 
The microflora of the oral cavity is diverse and more than 700 bacterial species 
have been detected (Aas et al., 2005, Paster et al., 2006, Faveri et al., 2008). 
Nonetheless, in the maintenance of oral health and in the aetiology of oral 
diseases in humans, a relatively small number of bacterial species are thought to 
play an important role (Socransky et al., 2002, Kumar et al., 2005). The 
bacterial composition often changes from a sparse Gram-positive bacteria 
biofilm, usually found in healthy individuals, to more Gram-negative anaerobic 
rod bacterial biofilm, usually observed in diseased individuals. The biofilm 
communities are complex and dynamic structures that accumulate through 
sequential and ordered colonization of multiple oral bacteria (Kolenbrander et 
al., 2002). Phenotypical differences are observed in the oral bacteria growing in 
the biofilms and planktonic bacteria like increased tolerance to antibiotics, pH 
and oxygen (Bradshaw et al., 1998, Welin-Neilands and Svensater, 2007, 
Sedlacek and Walker, 2007). Bacterial species in dental biofilm communities 
interact with other bacteria in the biofilm either cooperatively or competitively 
through physiological and metabolic routes. Planktonic bacterial cells attach 
directly to the oral tissue surfaces or bind indirectly to other bacterial cells that 
have already been colonized (Kolenbrander et al., 2002). The communication 
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within the dental biofilms can occur through metabolic communication, genetic 
exchange and importantly, quorum-sensing (Chalmers et al., 2008, Sedgley et 
al., 2008). The defined and sequentially ordered steps in the formation of oral 
biofilms are outlined in Figure 1.2. 
 
 
 
Figure 1.2: Oral biofilm formation. This diagram represents each step of oral 
biofilm formation. (A) Pellicle formation. The pellicle is a thin film derived from 
salivary glycoproteins attached to a clean tooth surface. (B) Initial adhesion. 
Pioneer bacteria in saliva recognize the binding proteins in acquired pellicle and 
attach to them. This adhesion is reversible. (C) Maturation. Different bacterial 
species coaggregate and mature biofilm forms. (D) Dispersion. Bacteria disperse 
from the biofilm surface and spread to colonize a new site. Taken from Huang 
and colleagues (Huang et al., 2011). 
 
 
1.2.2.1 Adhesion to tooth surfaces 
Bacterial adhesion to and subsequent colonization of the surfaces of teeth and 
tissues are the first steps towards the formation of dental biofilms. Oral bacteria 
such as streptococci can colonize the tooth surface by binding to the complex 
proteinaceous pellicle (Rogers et al., 2001, Kolenbrander et al., 2002). Many oral 
streptococci have that ability to bind to proteins such as alpha-amylase, proline-
rich proteins, and proline-rich glycoproteins, and are recognized as early 
colonizers. This capability may present an advantage on the streptococci in 
establishing early dental plaque (Kolenbrander et al., 2002).  
 
1.2.2.2 Co-aggregation among oral bacteria 
Planktonic bacteria that cannot directly colonize the tooth surface may bind via 
receptors to the cell surfaces of early colonizers that adhere to the tooth 
surface. Co-aggregation is a specific cell-to-cell reaction that occurs between 
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distinct bacterial cells and is one of the most important mechanisms underlying 
oral bacterial colonization and dental biofilm formation (Kolenbrander et al., 
2002). Early colonizers bind via adhesins to the complementary pellicle 
receptors on the tooth surface followed by secondary colonizers binding to early 
colonizers that are previously bound to the teeth. The process of bridging 
between a co-aggregation of cells consisting of more than 3 bacterial species is 
very important, because it connects a few species that are not co-aggregation 
partners. F. nucleatum can co-aggregate with many oral bacteria, including 
streptococci and obligate anaerobes like P. gingivalis. Therefore, F. nucleatum 
is a key component of dental biofilms and serves as a coordinator that bridges 
the late and early colonizers making it an “intermediate colonizer” 
(Kolenbrander et al., 2002).  This is illustrated clearly through the schematic 
diagram in Figure 1.3.  
 
1.2.2.3 Metabolic communication among oral bacteria 
Oral bacteria use nutrients which are available from saliva, gingival crevicular 
fluid, food containing sugars, food debris, and metabolic products of other 
bacteria (Hojo et al., 2009). Metabolic communication among oral bacteria may 
occur through the excretion of a metabolite by one organism that can be used as 
a nutrient by a different organism. This can also occur through the breakdown of 
a substrate by the extracellular enzymatic activity of one organism that creates 
biologically available substrates for different organisms (Kolenbrander et al., 
2002). For example, the hydrolysis of host glycoproteins by S. oralis and the 
subsequent utilization of released monosaccharides are important in the survival 
of this and other oral species (Byers et al., 1999).  
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Figure 1.3: Bacterial colonization of a tooth surface. This shows the 
colonisation of bacteria through various adhesion molecules. The diagram shows 
the acquired pellicle on the tooth surface. Early colonisers mainly consisting of 
various streptococcal species bind the acquired pellicle. Actinomyces and 
Veillonella species associate closely with the streptococcus species and start 
forming the primary layer of the biofilm. Intermediate colonisers such as F. 
nucleatum adhere to members of the primary complex. Lastly, pathogenic 
bacteria such A. actinomycetemcomitans and P. gingivalis bind to the 
intermediate colonisers, thus forming a multi- species biofilm (Bakaletz, 2004). 
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1.2.2.4 Quorum-sensing 
Quorum-sensing is a process of chemical communication among bacteria. It is 
defined as gene regulation in response to cell density, which influences various 
functions like virulence, acid tolerance and biofilm formation {Li, 2001 #40}. 
Quorum-sensing is considered an important bacterial function because bacteria 
within biofilms reach a high cell density (Hojo et al., 2009). Auto-inducer 2 (AI-
2) is one of the most well-known signalling molecules associated with quorum-
sensing for cross kingdom communication (Bassler et al., 1994). The synthesis of 
AI-2 is catalyzed by LuxS, an enzyme encoded by the luxS gene, which is 
conserved in the genome of a wide range of Gram-positive and Gram-negative 
bacteria. Many studies suggest that oral bacteria have a quorum-sensing system 
that depends on LuxS/AI-2 (Hojo et al., 2009). For example, LuxS-deficient P. 
gingivalis mutant was found to produce low levels of protease (Burgess et al., 
2002) and an inability to form a mixed-species biofilm with S. gordonii (Lamont 
et al., 2002). 
 
1.2.3 Dental plaque composition 
A variety of Gram-positive (e.g., Streptococcus spp, Actinomyces viscosus) and 
Gram-negative species (e.g., Campylobacter gracilis, Fusobacterium nucleatum, 
Prevotella intermedia) have been implicated in gingivitis (Theilade et al., 1966, 
Macuch and Tanner, 2000, Kremer et al., 2000). The distinct role of the dental 
plaque in periodontitis has been established by various investigators in the field 
over many years. Historical studies indicate that periodontal diseases occur in 
response to the quantity of plaque (non-specific plaque hypothesis), whereas 
others implicate specific microbial species in the aetiology of the disease 
(specific plaque hypothesis) (Loesche, 1976, Loesche and Grossman, 2001). This 
concept is illustrated in Figure 1.4, where the acquisition of a ‘foreign’ bacteria 
can alter the balance of the microbial consortia, resulting a change from health 
to disease (Marsh, 2006).  
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Figure 1.4: Schematic representation of the relationship between the 
microbial composition of dental plaque in health and disease. Potential 
pathogens (grey) may be present in low numbers in plaque, or transmitted in low 
numbers to plaque; both situations may be compatible with health. A major 
ecological pressure will be necessary for such pathogens to outcompete other 
members of the resident microflora (white) and achieve the levels (numerical 
dominance) needed for disease to occur. Possible ecological pressures for caries 
include a sugar-rich diet, conditions of low pH, or low saliva flow. Disease could 
be prevented not only by targeting the pathogen directly (e.g. with 
antimicrobial or anti-adhesion agents) but also indirectly by interfering with the 
ecological pressure responsible for the selection of the pathogen (Marsh, 2006). 
 
 
Seminal studies of sub-gingival plaque by Socransky demonstrate that certain 
species frequently occur in complexes (Socransky and Haffajee, 2005). For 
example, the red complex of species, which includes P. gingivalis, Tannerella 
forsythia and Treponema denticola, is strongly associated with the clinical signs 
of periodontitis. A. actinomycetemcomitansis also strongly associated with 
certain forms of periodontal disease, specifically aggressive periodontitis 
(Berthold et al., 1986, Slots and Ting, 1999, Cortelli et al., 2005). A further 
group are classified as the amber species and these are less strongly associated 
with periodontal destruction. These include Prevotella intermedia, Prevotella 
nigrescens, Peptostreptococcus micros, Fusobacterium nuc. vincentii, 
Fusobacterium nuc. nucleatum, Fusobacterium nuc. polymorphum and 
Fusobacterium periodonticum.  Eiknella nodatum, Campylobacter gracilis, 
Streptococcus constellatus and Capnocytophaga rectus (Socransky et al., 1998, 
Socransky and Haffajee, 2002, Zambon, 1985). Figure 1.5 illustrates the 
different complexes described by Socransky and colleagues (review (Socransky 
and Haffajee, 2005)). All of these species are commonly present at sites of 
periodontal destruction at the time of initial diagnosis and their elimination or 
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persistence is associated with prognosis after treatment. Each bacterium has 
specific virulence factors, which confer biological feasibility on their proposal as 
putative periodontal pathogens. The following section will focus on some of 
these key organisms in more detail, particularly those used in subsequent 
studies. 
 
 
 
Figure 1.5: Diagrammatic representation of the relationships of species 
within microbial complexes and between the microbial complexes (Socransky 
and Haffajee, 2005).  
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1.2.3.1 Porphyromonas gingivalis 
Porphyromonas gingivalis is a Gram-negative, anaerobic, non-motile, 
asaccharolytic coccobacilli associated with periodontal disease. This bacteria 
initially grows as white to cream coloured raised colonies on agar surfaces which 
starts to darken from the edge to the centre to a deep red to black colour with 
time (4-8 days) (Holt et al., 1999). P. gingivalis appears to colonise the inflamed 
gingival sulcus. In healthy subjects this is a 0.5 mm deep crevice between the 
tooth and the gum, the portal of entry and recess for periodontal biofilms. The 
subgingival sites of the oral cavity are the main areas colonized by P. gingivalis 
but has also been recovered from saliva, tongue, tonsils and supragingival plaque 
samples (Socransky and Haffajee, 1992). P. gingivalis makes up less than 5% of 
the cultivable subgingival flora of individuals with gingivitis but increases with 
advanced periodontal disease (Forng et al., 2000). For P. gingivalis to be 
associated with the disease, they have to accumulate in the subgingival dental 
plaque and start to proliferate in high numbers, as P. gingivalis can only be 
found in low numbers in a healthy mouth (Haffajee et al., 1998, Papapanou et 
al., 1997).  
 
The microbial aetiology of periodontitis is inconclusive, but only a few specific 
bacteria, including P. gingivalis have been implicated as major pathogens of 
chronic periodontitis (Socransky et al., 1998), and has recently been assigned as 
a ‘keystone pathogen’ of periodontal disease, capable of causing a shift in 
microbial diversity even thought present in low numbers in the final microbial 
community (Hajishengallis et al., 2012). P. gingivalis produces a variety of 
virulence factors, including bioactive metabolic products, fimbriae and an array 
of proteolytic enzymes (Lamont and Jenkinson, 1998). Among the proteolytic 
enzymes, cysteine proteases (gingipains) have been implicated in at least 85% of 
the total proteolytic activity exerted by various strains of P. gingivalis and are 
considered major contributors to the pathogenic potential of P. gingivalis 
(Potempa et al., 1997). Gingipains, categorized into arginine-specific gingipains 
[Arg-gingipain-A (RgpA) and Arg-gingipain-B (RgpB0] and the lysine-specific 
gingipain [Lys-gingipain(Kgp)], are encoded by three different genes, referred to 
as rgpA, rgpB and kgp, which are conserved among laboratory and clinical strains 
of P. gingivalis (Curtis et al., 1999). P. gingivalis participate in the disease 
process sequentially by (i) adherence and colonization, (ii) nutrient acquisition, 
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(iii) neutralization of host defences, (iv) manipulation of inflammatory response 
and (v) tissue destruction, invasion and dissemination to tissue sites (Guo et al., 
2010), which are now discussed. 
 
(i) Adherence and colonization 
Initial colonization of P. gingivalis is facilitated by its ability to adhere to a wide 
variety of biotic host surfaces, including epithelial cells, extracellular matrix 
(ECM) and other bacteria. Gingipains are involved directly or indirectly in this 
process and are therefore crucial in the initial stages of periodontal infection by 
P. gingivalis (Guo et al., 2010). Dental plaque is formed by the specific 
coaggregation of different species of oral bacteria (Kolenbrander et al., 2006, 
Rickard et al., 2003) and this leads to formation and maturation of a biofilm that 
facilitates the adherence and colonization by periodontal pathogens. P. 
gingivalis, which is a late colonizer of the bacterial biofilm on the tooth surface 
of sub-gingival sites, promotes co-aggregation by a variety of surface 
components, including lipopolysaccharides, carbohydrates, gingipain complexes 
and fimbriae, with the latter two being the best characterized (Guo et al., 
2010). Discrete hemagglutinin-adhesin domains of RgpA, Kgp and hemagglutuinin 
A (HagA) have shown evidence in a direct role in coaggregation (Abe et al., 
2004, Kamaguchi et al., 2003, Yamada et al., 2005). Therefore, P. gingivalis 
triple-knockout mutants devoid of gingipains (rgpA rgpB kgp-), or devoid of 
proteins bearing hemagglutinin-adhesin domains (hagA rgpA kgp-), exhibit no 
coaggregative activity (Abe et al., 2004).  
 
The initial step of P. gingivalis attachment to the oral cavity is fimbriae-
mediated [Long fimbriae (FimA) and short fimbriae (Mfa)] which are involved in 
cell invasion and induction of inflammatory responses (Amano, 2010). The 
maturation of the long fimbriae requires RgP activity (Nakayama et al., 1996). 
FimA, which is secreted onto the P. gingivalis surface in a precursor form 
requires Rgp to process it into the filamentous structure of the mature fimbriae 
(Shoji et al., 2004). The precursor form of FimA on the cell surface of Rgp 
devoid gingipain-null mutant can be converted into biologically active polymeric 
fimbriae by exogenous gingipains (Kato et al., 2007b).  
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Gingipains are potent non-fimbrial adhesions that actively bind several 
extracellular proteins (Pathirana et al., 2010) and also mediate tight adherence 
to epithelial cells and gingival fibroblasts (Chen and Duncan, 2004, Chen et al., 
2001a), most of the binding provided by Kgp (Pathirana et al., 2007, Pathirana et 
al., 2008). Gingipains are also involved in P. gingivalis adherence through 
generation of cryptic ligands, by the degradation of extracellular matrix proteins 
by Rgps, which exposes the peptides with C-terminal arginine, for which FimA 
has specific affinity (Kato et al., 2007a, Kontani et al., 1997).  
 
To summarise, gingipains are essential for P. gingivalis adherence to different 
sites within the oral cavity; either directly by acting as non-fimbrial adhesins or 
indirectly by arranging the assembly of fimbriae. The next step in the disease 
process for the pathogen is to acquire nutrients for growth and neutralize host 
defenses. 
 
(ii) Nutrient acquisition 
P. gingivalis, is a fastidious asaccharolytic bacteria which acquires energy by 
fermentation of both carbon and amino acid residues.  The iron and porphyrin 
essential for the growth of P. gingivalis is provided by heme. Gingipains are 
responsible to a large extent to satisfy the nutritional needs of P. gingivalis by 
exploiting different sources of heme and iron in the human host (Guo et al., 
2010). 
 
Red blood cells are the largest reserves of heme and iron in the human hosts. P. 
gingivalis initially clumps the erythrocytes together and slowly lyses them to 
release the haemoglobin and the hemagglutinin activity is related to the 
hemagglutinin-adhesin domains of RgpA, Kgp and HgA (Shi et al., 1999).  The 
slow hemolysis by P. gingivalis is not fully understood, although proteolytic 
activity has been implicated in this process (Chu et al., 1991). The study showed 
that the hemolysin was concentrated on the outer membrane of the bacteria 
with significant haemolytic activity concentrated on the outer membrane 
vesicles. The expression of haemolytic activity was increased by Ca2+ and Mg2+ 
ions while the activity was inhibited by proteinases K, trypsin, the proteinase 
inhibitors Na-P-tosyl-L-lysine chloromethyl ketone and benzamidine, the 
metabolic inhibitor M-chlorophenyl hydrazone, and iodoacetate. The effect of 
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heme limitation on increased haemolytic activity was also studied. Purified 
gingipains do not seem to have a direct involvement in hemolysis but a Kgp-null 
mutants show about half of the hemolytic activity of the wild-type strains or 
complemented mutants suggests a role for Kgp in hemolysis (Lewis et al., 1999).  
 
Transferrin and lactoferrin act as stores of extracellular iron within mucosal 
surfaces. Hemoglobin leaking out from erythrocytes is taken up by haptoglobin, 
while the heme released from the erythrocytes are taken up by hemopexin and 
albumin. Because of these scavenging proteins, there is low concentration of 
free iron and heme in the physiological human fluids. Pathogenic bacteria uses 
siderophores, which are scavenger molecules, to get iron out from carriers of 
iron in the host (Raymond et al., 2003). As P. gingivalis lacks the siderophore 
action it uses gingipains to degrade haptoglobin, transferrin and hemopexin to 
grow on minimal media with serum human serum as the source of heme or iron 
(Sroka et al., 2001). The study showed that the lysine-specific gingipains Kgp can 
cleave haemoglobin, transferrin, haptoglobin and hemopexin. Degradation of 
hemopexin and transferrin in the human serum was also detected. However, the 
degradation of haemoglobin in serum by Kgp was not detected. The arginine-
specific gingipains (RgpA and RgpB) also degraded hemopexin and transferrin in 
serum but only at high concentrations of the enzymes (Sroka et al., 2001).  
 
P. gingivalis depends on peptides for its source of carbon and nitrogen for its 
growth, as it does not utilize free amino acids (Milner et al., 1996). Milner and 
colleagues developed a chemically defined media that used bovine serum 
albumin as the source of carbon and nitrogen, and alpha-ketoglutarate to 
prevent the blackening of the cells due to the deposition of metal sulphides.  P. 
gingivalis uses its extensive proteolytic system, which is composed of 
endopeptidases (gingipains), oligopeptidase and di- and tripeptidylpeptidases, in 
a cascade-like manner, to fulfil this nutritional need (Potempa et al., 2000).  
 
(iii) Neutralization of host defenses 
After successful colonization of the oral mucosa by P. gingivalis, it has to 
confront the host defense system. The innate immune system presents the first 
obstacle, comprising of antimicrobial peptides and peptides, the complement 
system, neutrophils and tissue-resident macrophages. As P. gingivalis is 
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embedded deep in the biofilm, they resist the acute inflammatory reaction 
induced by neutrophil influx and complement activation. Hence, the second line 
of defense is activated, composed of antibodies, activated macrophages and T-
cells. Even the concerted effects of both the systems (synchronized by the 
cytokine network) does not eliminate P. gingivalis, which makes the innate 
immune system cause extensive collateral damage to the surrounding gingival 
and periodontal tissues, with the pathologic changes associated with 
periodontitis (Guo et al., 2010). 
 
The first line of mucosal defense against the invading bacteria is cationic 
antimicrobial peptides. Antimicrobial peptides, which are secreted from cells of 
the gingival tissues, include human beta-defensins, the cathelicidin-type peptide 
LL-37 and neutrophil-derived alpha-defensins, which maintain homoestasis in 
spite of constant exposure from a variety of invading bacteria (Diamond et al., 
2008). This review states that antimicrobial peptides are secreted in the gingival 
epithelium in response to a small subset of bacteria and TLR ligands, via 
different pathways. The environments into which these peptides are secreted in 
the saliva and gingival crevicular fluid differ greatly and can affect their 
respective activities in host defense. Significantly increased levels of alpha-
defensins and LL-37 were reported in the gingival crevicular fluid from chronic 
periodontitis patients in comparison with healthy controls (Puklo et al., 2008, 
Turkoglu et al., 2009). The Turkoglu study included 59 subjects who had their 
GCF levels of LL-37 and IL-18 measured using ELISA. Probing depth (PD), clinical 
attachment level (CAL), plaque index (PI), bleeding on probing, and papilla 
bleeding index (PBI) were also assessed for the chronic periodontitis and 
gingivitis patients and healthy controls. Elevated levels of LL-37 in GCF of 
chronic periodontitis patients were reported in comparison to other groups. 
There was also a positive relationship between the levels of LL-37 and PD, CAL, 
PI and PBI at the sites sampled. Puklo and colleagues (2008) collected GCF 
samples from 14 aggressive periodontitis patients, 17 chronic periodontitis 
patients and 9 healthy subjects. Samples were analysed for periodontopathogen 
load by real time PCR. The levels of methyloperoxidase and alpha-defensins 
(HNP 1-3) were determined by ELISA, and the level of cathelicidin (hCAP18/LL-
37) assayed by Western blot. There was no correlation between myeloperoxidase 
concentration and the levels of LL-37 and HNP 1-3 in patient samples compared 
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to control. Aggressive periodontitis and chronic periodontitis patients showed 
elevated amounts of HNP 1-3 and those with chronic periodontitis had elevated 
levels of mature LL-37. The increased levels of both the peptides in chronic 
periodontitis correlated with the P. gingivalis load.  
 
Chronic periodontitis does not resolve by itself unless there is therapeutic 
intervention due to the resistance of the bacterial biofilm to killing by the 
antimicrobial peptides (Guo et al., 2010). The sensitivity of P. gingivalis killing 
by LL-37 and human beta-defensins are strain dependent: ATCC 33277 is more 
susceptible than W50, W83 and ATCC 49417 (Ji et al., 2007, Joly et al., 2004, 
Ouhara et al., 2005). In the Ji study, 20 strains of 13 oral bacteria were tested 
for their susceptibility to LL-37 and human beta-defensin 3 by liquid dilution 
assay to determine the minimum inhibitory concentration (MIC). It reported that 
the MICs varied greatly depending on the strains and species. The study by Joly 
and colleagues (2004) tested the effectiveness of HBD-2 and HBD-3 against an 
array of oral microbes, including P. gingivalis by radial dilution assays on at least 
three strains of each species. The variability in MIC was strain specific rather 
than species specific. Ouhara and colleagues (2005) tested the antimicrobial 
activity of synthetic antimicrobial peptides human beta-defensin 1 (hBD-1), hBD-
2, hBD-3 and LL-37 (CAP18) against oral bacteria, including six strains of P. 
gingivalis. Beta-defensin resistance was induced in P. gingivalis by pre-treating 
with 1 ng/mL of defensins, heat stress, oxidative stress and peroxide stress 
(Shelburne et al., 2005a), which in turn enhances the expression of rgpA and 
rgpB genes (Shelburne et al., 2005b). A study by Carlisle and co-workers (2009) 
used cell culture supernatants which fully or partially degraded human alpha-
defensins and human beta-defensins after 30 minutes (Carlisle et al., 2009). 
Another study by Gutner and colleagues showed that P. gingivalis was capable of 
degrading LL-37 by utilizing its RgpA and RgpB (Gutner et al., 2009).  
 
P. gingivalis has the ability to survive in the inflamed tissue environment from 
the attacks of phagocytic cells, neutrophils and macrophages. The interplay 
between phagocytic oxidative burst of the host and the oxidative stress response 
of P. gingivalis was investigated; here the oxidative burst by the neutrophils 
enhanced the survival of P. gingivalis (Mydel et al., 2006). P. gingivalis  can also 
survive phagocytosis by macrophages by inducing cross-talk between CXCR4 and 
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TLR2 (Hajishengallis et al., 2008).The gingipains’ role in evading the neutrophil 
and macrophage phagocytosis is either directly by degrading the receptors and 
cytokines essential for phagocyte functions or indirectly by C5a, which is used by 
P. gingivalis to weaken TLR2-dependent immunity (Wang et al., 2010). 
 
(iv) Manipulation of the inflammatory response 
Inflammation is a complex interaction between the cytokines and their receptors 
expressed by the host tissues and immune cells, in response to a foreign agent. 
The immune response is disrupted by the invading bacteria by targeting the 
cytokine mediators (Guo et al., 2010). P. gingivalis uses gingipains to disrupt the 
cytokines and cytokine receptor networks of the host, including interleukin-1 
beta (IL-1 beta) (Sharp et al., 1998), interleukin-6 (IL-6) and its receptors 
(Banbula et al., 1999, Oleksy et al., 2002), interleukin-8 (IL-8) (Mikolajczyk-
Pawlinska et al., 1998), interleukin 12 (IL-12) (Yun et al., 2001, Yun et al., 
2002), interleukin-4 (IL-4) (Yun et al., 2003), interferon-gamma (Yun et al., 
1999), tumor necrosis factor-alpha (Calkins et al., 1998), CD4/CD8 (Kitamura et 
al., 2002), CD14 (Sugawara et al., 2000) and intercellular adhesion molecule-1 
(CD54) (Tada et al., 2003). P. gingivalis is able to manipulate the cytokine 
network through many factors in order to evade the host defence. 
 
(v) Tissue destruction 
Morphological changes associated with advanced periodontal disease include 
alveolar bone resorption and periodontal ligament destruction, which lead to 
attachment loss and periodontal pocket formation. Gingipains play an important 
role, directly and indirectly, in the remodelling of the pathologic tissue 
associated with the development and progression of periodontal disease by 
excessive expression of MMPs over their inhibitors (tissue inhibitors of 
metalloproteinases [TIMPs]), release of proteases from necrotic cells and 
activated neutrophils, inactivation of endogenous protease inhibitors and 
uncontrolled conversion of zymogenic MMPs into their proteolytically active 
forms (Guo et al., 2010). The broad consensus is that P. gingivalis cells, cell 
extracts, spent media or LPS can stimulate the secretion of MMPs at a higher 
level than TIMPs in dendritic cells (Jotwani et al., 2010), human periodontal 
ligament cells (Sato et al., 2009), human gingival fibroblasts (Zhou and Windsor, 
2006) and an engineered human oral mucosa (Andrian et al., 2007). The latent 
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MMPs can be directly activated by gingipains (DeCarlo et al., 1997, Grayson et 
al., 2003). Inflammatory neutrophils are the main source of serine proteases and 
metalloproteases, which are released into the environment and usually 
neutralized by endogenous serine proteinase inhibitors. It has been shown that 
serine proteinase inhibitors are proteolytically inactivated by P. gingivalis-
derived proteases (Nelson et al., 1999, Potempa et al., 1998, Into et al., 2006, 
Kantyka et al., 2009). If this occurs, the host proteases could attack various 
targets in the periodontium. This shows that P. gingivalis can be directly or 
indirectly involved in causing damage to periodontal tissues. 
 
From this it can be concluded that the virulence factors of P. gingivalis are 
essential at every step of the infection: from attachment and colonisation, to 
nutrient acquisition, to evasion of host defences and to tissue invasion. 
 
1.2.3.2 Fusobacterium nucleatum 
Fusobacterium nucleatum are Gram-negative, anaerobic, non-motile, non-spore 
forming, spindle-shaped bacilli associated with periodontal disease. Colony 
morphology is not a consistent parameter of the Fusobacteria and is not 
sufficient for species identification (Tuner et al., 1992). It is one of the first 
Gram-negative species to become established in dental plaque and is considered 
as an intermediate colonizer, which helps in bridging the attachment of non-
pathogens (commensals) and true pathogens (Kolenbrander, 2000, Kolenbrander 
et al., 2002). It is one of the most common species in both supragingival and 
subgingival plaque in both healthy individuals and patients with periodontal 
disease (Kononen et al., 1994, Moore and Moore, 1994, Ximenez-Fyvie et al., 
2000). It is also one of the most common oral species isolated from extra-oral 
infections, including blood, brain, chest, lung, liver, joint, abdominal, 
obstetrical and gynaecological infections and abscesses (Signat et al., 2011). The 
ability of F. nucleatum to co-aggregate with many plaque bacteria suggests that 
it acts as a microbial bridge. 
 
(i) Adhesion and co-aggregation 
F. nucleatum is involved in both adhesion and co-aggregation reactions and 
seems to play a key role in the multi-species co-aggregation network found in 
the periodontal pocket (Bolstad et al., 1996). It is proposed that fusobacteria 
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act as a bridge between early and late colonisers. The early colonizers adhere to 
the tooth pellicle and co-aggregate with other early colonizers and also with F. 
nucleatum. Late colonizers such as P. gingivalis, A. actinomycetemcomitans and 
T. denticola co-aggregate almost exclusively with F. nucleatum, which seems to 
play an important role by bridging these co-aggregations with early colonizers 
(Kolenbrander et al., 1989, Kolenbrander et al., 1993, Kolenbrander and London, 
1993). The adhesins in F. nucleatum are outer membrane proteins (OMPs) which 
are essential for their attachment to specific substrates as a first step of 
colonization. OMP is a receptor polypeptide involved in fusobacterial corncob 
coaggregations (Kaufman and DiRienzo, 1989). Attachment of early colonizers 
streptococci to fusobacteria is mediated through fimbriae on the surface of the 
cocci (Handley et al., 1985, Hasty et al., 1992) by at least two types of corncob 
receptors, one which binds to lipoteichoic acid and which that does not 
(DiRienzo and Rosan, 1984, Kaufman and DiRienzo, 1988, Kaufman and DiRienzo, 
1989). F. nucleatum coaggregates with the late colonizer P. gingivalis through 
an OMP from F. nucleatum and a galactose-containing carbohydrate on P. 
gingivalis (Kinder and Holt, 1989, Kinder and Holt, 1993, Kolenbrander, 1988).  
 
(ii) Immune response induction 
F. nucleatum cell wall extracts have been shown to induce significant changes in 
the expression of genes associated with immune and defence responses which 
were mainly chemokines and cytokines, innate immune or inflammatory 
markers, antimicrobials, or protease inhibitors. The genes of defence responses 
include chemokines IL-8 and CXCL1, 3, 5 and 10, which attract neutrophils, 
monocytes, macrophages, lymphocytes and CSF2 and -3 that stimulate 
neutrophil development. F. nucleatum also up-regulated the genes encoding 
antimicrobial peptides and proteins. Multiple protease inhibitors were also up-
regulated in response to F. nucleatum cell wall extracts (Signat et al., 2011). 
These inhibitors can target the proteases released by neutrophils (Magert et al., 
2005) and bacteria (P. gingivalis, T. denticola and T. forsythia) (Curtis et al., 
2001, Fenno et al., 2001, van der Reijden et al., 2006) and thereby control likely 
tissue damage. F. nucleatum can induce an inflammatory response by up-
regulating pro-inflammatory cytokines and metalloproteases (MMP-9 and MMP-
13) which has several functions in the regulation of inflammation. F. nucleatum 
can also secrete serine proteases which can damage the periodontal tissues. To 
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conclude, F. nucleatum has been shown to possess protective and aggressive 
qualities which asks the question if the bacteria is a commensal or a pathogen. 
 
1.2.3.3 Aggregatibacter actinomycetemcomitans 
A. actinomycetemcomitans are Gram-negative, microaerophilic and facultative 
anaerobic, non-sporulating, non-motile coccobacilli (Zambon, 1985, Pulverer and 
Ko, 1970). The colony morphology shows transparent rough surfaced and opaque 
smooth surfaced types. There is also a transparent smooth surfaced type, which 
is intermediate between the other two types. The colonial variation is 
associated with fimbriation (Inouye et al., 1990, Rosan et al., 1988, Scannapieco 
et al., 1987, Slots, 1982).  
 
A. actinomycetemcomitans possess numerous virulence factors that can enhance 
its survival and may be involved in the pathogenesis of periodontitis (Fives-
Taylor et al., 1999). These include the ability to attach to extracellular matrix 
proteins (Mintz and Fives-Taylor, 1999) and epithelial cells (Meyer and Fives-
Taylor, 1994); antibiotic resistance (Roe et al., 1995); a bacteriocin (Hammond 
et al., 1987, Stevens et al., 1987); bone resorption by either endotoxin (Saglie et 
al., 1990) or surface-associated material (Meghji et al., 1995); a chemotactic 
inhibitor (Ashkenazi et al., 1992a); a collagenase (Robertson et al., 1982); a 
cytotoxin (Shenker et al., 1982a); Fc-binding proteins (Mintz and Fives-Taylor, 
1994b); a leulotoxin (Baehni et al., 1979); immunosuppressive factors (Chen et 
al., 1991, Kinane et al., 1989, Kurita-Ochiai and Ochiai, 1996, Shenker et al., 
1982b, Shenker et al., 1990); and the ability to invade epithelial cells (Meyer et 
al., 1991) and tissues (Christersson et al., 1987).  
 
(i) Adhesion 
A. actinomycetemcomitans increase their numbers in the dental plaque by 
aggregation, intra-generic and inter-generic coaggregation. Vesicles and 
extracellular amorphous material are likely to mediate the aggregation (Meyer 
and Fives-Taylor, 1993, Meyer and Fives-Taylor, 1994). While the intra-generic 
coaggregation by A. actinomycetemcomitans has not been demonstrated 
(Kolenbrander et al., 1990), inter-generic coaggregation has been demonstrated 
with F. nucleatum (Kolenbrander, 1989).  
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The adhesion of A. actinomycetemcomitans to the gingival crevice epithelium is 
an important step in the colonization and subsequent tissue destruction 
associated with periodontal disease. The adhesion of the bacteria to the tooth 
surface has also been investigated using an in vitro tooth model which showed 
that bacteria with fimbriae adhere 3- to 4-fold better than non-fimbriated 
strains (Rosan et al., 1988). A. actinomyecetmcomitans fimbriae (Holt et al., 
1980, Scannapieco et al., 1983) are peritrichous (Scannapieco et al., 1987) and 
often occur in bundles (Rosan et al., 1988). The adhesion of A. 
actinomycetemcomitans has been shown to be strong with the epithelial cells 
with most of the strains (Meyer and Fives-Taylor, 1994). Cell surface 
ultramicroscopic structures that mediate adherence include fimbriae (Meyer and 
Fives-Taylor, 1994, Rosan et al., 1988), extracellular vesicles (Meyer and Fives-
Taylor, 1993) and extracellular amorphous material (Meyer and Fives-Taylor, 
1994). The fimbriae are implicated in the adherence of A. 
actinomycetemcomitans but some strains expressing the smooth colonial 
phenotype which have little or no fimbriae can still adhere to the epithelial cells 
(Meyer and Fives-Taylor, 1994, Mintz and Fives-Taylor, 1994a), indicating 
adhesion molecules or mechanisms unrelated to fimbriae. Poorly adherent A. 
actinomycetemcomitans which were suspended in extracellular amorphous 
material became coated with the material and exhibited increased adherence 
(Fives-Taylor et al., 1995). Vesicles, which are a major feature of the non-
fimbriated A. actinomycetemcomitans surface, are associated with a non-
fimbrial A. actinomycetemcomitans adherence mechanism (Meyer and Fives-
Taylor, 1993). To conclude, the adhesion of A. actinomycetemcomitans to 
epithelial cells is multi-factorial with several adhesins and mechanisms playing a 
role.  
 
(ii) Invasion of epithelial cells 
Many pathogenic bacteria have the capability of penetrating and surviving within 
eukaryotic cells (Finlay and Falkow, 1997, Meyer et al., 1997). A. 
actinomycetemcomitans has been shown to penetrate the gingival epithelium 
(Christersson et al., 1987, Saglie et al., 1986). Based on in vitro models using 
cultured cell lines it has been shown that A. actinomycetemcomitans invasion of 
epithelial cells is a highly dynamic complex involving the attachment of bacteria 
to the host cell with initiation of some form of signalling, binding to a receptor, 
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entry into a vacuole, escape from the vacuole, rapid multiplication, intracellular 
spread, exit from the cell and cell-to-cell spread (Meyer et al., 1996). Many 
clinical and laboratory isolates have shown invading capabilities in a variety of 
cell lines but invasion efficiencies vary with individual strains and cell lines used 
(Blix et al., 1992, Meyer et al., 1991, Sreenivasan et al., 1993). The invasion is 
initiated by A. actinomycetemcomitans coming into contact with microvilli of 
the epithelial cells. The contact induces the epithelial cells to produce ruffled 
apertures and the bacteria seems to pass through these apertures into the 
interior of the host cell (Meyer et al., 1996). The invasion of phagocytes by A. 
actinomycetemcomitans involves the rearrangement of the host cytoskeletal 
network which is inhibited by cytochalsin-D demonstrating a role of actin in the 
invasion process (Brissette and Fives-Taylor, 1999). There are a few A. 
actinomycetemcomitans  isolates which enter the cells via receptor-mediated 
endocytosis exhibit actin-independent entry, suggesting multiple mechanisms for 
the A. actinomycetemcomitans entry into the epithelial cells (Brissette and 
Fives-Taylor, 1999). Host-derived membrane bound vacuole takes up A. 
actinomycetemcomitans which the bacteria lyses to enter the cytoplasm 
(Sreenivasan et al., 1993). The bacteria now transits through the cell to 
adjacent cells via bacteria-induced protrusions. If there are no adjacent or 
neighbouring cells, bacteria are just released from the host cell (Meyer et al., 
1996). Microtubules have been strongly implicated in the intra- and inter-cellular 
spread of A. actinomycetemcomitans and its release into the extra-cellular 
environment (Meyer et al., 1996). All these observations show a dynamic process 
by which A. actinomycetemcomtans invades the epithelial cells to enable it to 
spread to the gingival and connective tissue and initiate the tissue destruction 
associated with periodontal disease. 
 
(iii) Immunosuppressive factors 
A. actinomycetemcomitans has been shown to possess many factors to suppress 
the host defense mechanisms which play a major role in controlling the 
concentrations of bacteria in the dental plaque. The bacteria produces a protein 
which inhibits DNA, RNA and protein synthesis in mitogen-activated human T 
cells (Shenker et al., 1982a). The protein has also been shown to inhibit IgG and 
IgM synthesis by human lymphocytes (Shenker et al., 1982b). In addition to this, 
leukotoxin also impairs the ability of lymphocytes to respond to mitogens by 
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inhibiting DNA, RNA, protein, IgG and IgM synthesis (Rabie et al., 1988). A. 
actinomycetemcomitans secretes a low-molecular-weight compound which 
inhibits polymorphonuclear leukocyte chemotaxis which is the host’s first line of 
defense against invading bacteria (Van Dyke et al., 1982). A. 
actinomycetemcomitans has also been shown to be capable of inhibiting 
polymorphonuclear leukocytes from producing certain compounds which aid in 
the the fusing of PMN leukocytes with lysosomes. This protein in A. 
actinomycetemcomitans inhibits the production of hydrogen peroxide by PMN 
leukocytes and some strains are naturally resistant to high concentrations of 
hydrogen peroxide (Ashkenazi et al., 1992b, Miyasaki et al., 1984). A. 
actinomycetemcomitans are also resistant to defensins that are found in 
neutrophils (Miyasaki et al., 1990). 
 
(iv) Tissue destruction 
A. actinomycetemcomitans has been shown to stimulate bone resorption by 
several different mechanisms: lipopolysaccharide (LPS) (Kiley and Holt, 1980), 
proteolysis-sensitive factor in microvesicles (Nowotny et al., 1982) and surface-
associated material (Meghji et al., 1995). A. acinomycetemcomitans LPS 
(endotoxins) has been well characterized in tissue destruction (Kiley and Holt, 
1980). Low concentrations of A. actinomycetemcomitans LPS stimulate 
macrophages to produce IL-1 α, IL-1 β and TNF-α, which are cytokines involved 
in tissue inflammation and bone resorption (Saglie et al., 1990).  
 
(v) Leukotoxin 
Leukotoxin is one of the most studied virulence factors of A. 
actinomycetemcomitans which is produced by 56% of the strains isolated from 
aggressive periodontitis patients (Zambon et al., 1983). The leukotoxin binds to 
neutrophils, monocytes and a subset of lymphocytes to form pores in the 
membranes of these target cells (Iwase et al., 1990, Taichman et al., 1987) 
which reduces the ability of these cells to sustain osmotic homeostasis, resulting 
in cell death (Karakelian et al., 1998).  
 
1.2.3.4 Streptococcus mitis 
S. mitis are Gram-positive, facultative anaerobic, non-sporulating, non-motile, 
chains of cocci (Bensing et al., 2001). S. mitis is a primary coloniser which is 
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predominantly associated with the early stages of plaque formation and is a 
member of Socransky’s yellow complex (Socransky and Haffajee, 2005). S. mitis 
and other streptococcal species can bind to the acquired pellicle through a 
number of adherence strategies such as proline-rich proteins (PRP-1) and lectin-
like bacterial proteins. PRP-1 is found within the saliva and different regions of 
PRP-1’s can bind to early colonisers such as streptococcal species. Lectin-like 
protein is a bacterial protein which can interact with pellicle-associated 
glycoproteins causing adhesion of primary colonisers to the pellicle (Marsh, 
2006). This pioneer bacterium allows other bacteria to bind receptors such as 
adhesion molecules, which are present on its surface, leading to biofilm 
formation (Lindhe, 2008, Sardin et al., 2004).  
 
(i) Commensal properties 
S. mitis have generally been considered a somewhat benign oral streptococcus 
and a member of the oral commensal flora. The interaction of S. mitis with the 
host innate immune system is not known exactly. It has shown some strong 
immunomodulatory effects on human cells. S. mitis can induce the expression of 
human β-defensin 2 (hBD2) after incubation with gingival epithelial cells 
(Eberhard et al., 2009), which is a host antimicrobial peptide which can kill oral 
pathogens. S. mitis is also very tolerant to the action of antimicrobial peptides 
(Nishimura et al., 2004, Ouhara et al., 2005). S. mitis also modulates the 
expression of IL-8, which is a pro-inflammatory chemokine responsible for the 
chemotaxis of neutrophils to the site of infection (Eberhard et al., 2009). S. 
mitis does not promote IL-8 expression on its own but with co-incubation of S. 
mitis with other oral pathogens F. nucleatum or A. actinomycetemcomitans can 
dampen the production of IL-8 induced in response to the pathogens (Zhang et 
al., 2008, Sliepen et al., 2009). From these observations, it can be concluded 
that S. mitis can supplement host immunity and can survive in the complex oral 
environment from the competition of oral pathogens, as a beneficial commensal. 
 
Overall, these four oral bacteria that have been described all possess unique 
properties that allow them to persist within the oral cavity to different extents. 
However, it is clear from this literature that the immune system plays an 
important role in protecting the host from these bacteria. This will now be 
discussed. 
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1.3 Immunology of periodontal disease 
Microbial plaque is considered necessary, but not sufficient for the progression 
of periodontal disease. Thus, the host response plays a pivotal role in disease 
pathogenesis (Graves, 2008, Preshaw, 2008). Many studies, both in vivo and in 
vitro, have confirmed the periodontopathic virulence of many key oral 
pathogens (Holt and Ebersole, 2005). Nevertheless, it has been clearly 
demonstrated that the presence of dental plaque does not necessarily lead to 
advanced periodontal disease. Moreover, key periodontal pathogens can be 
found at sites of relative periodontal health (Wolff et al., 1993, Van der Velden 
et al., 2006). Therefore, it can be concluded that in addition to the necessary 
role of the dental biofilm in initiating the inflammatory response, other host 
factors must also be involved (Kinane et al., 2006). These factors may determine 
whether the inflammatory response will be an effective protective/preventive 
one, or whether an inappropriate/inefficient inflammatory response leads to 
host induced tissue destruction.  
 
The pathogenesis of periodontal disease is categorised into four stages, based on 
histopathological examination of the development of periodontal inflammation 
as a result of plaque accumulation. These stages are called the (i) initial, (ii) the 
early, (iii) the established, and (iv) the advanced lesion (Page and Schroeder, 
1976).  A brief description of each stage in lesion progression follows. 
 
(i) Initial lesion 
Without normal oral hygiene measures, within 2 - 4 days of plaque 
accumulation, the early inflammatory response is observed histologically.  It is 
characterised by vasodilatation, loss of perivascular collagen, and active 
migration of neutrophils and monocytes into the periodontal tissues and 
junctional epithelium mediated by intercellular adhesion molecules (ICAM) and 
endothelial leucocyte adhesion molecules (ELAM) are observed. The exudation of 
serum proteins from the dilated capillaries leads to an increase in GCF fluid 
flow. 
 
(ii) Early lesion 
The early lesion presents after 7 - 14 days plaque accumulation. This is clinically 
detectable as gingivitis, with more pronounced vascular changes and an increase 
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in extra-vascular neutrophils. Histologically the inflammatory infiltrate consists 
of numerous lymphocytes (predominantly T lymphocytes), immediately below 
the proliferating basal cells of the junctional epithelium. Destruction of the 
gingival connective tissue occurs, through apoptosis of fibroblasts and a 
reduction in the collagen fibre network of the marginal gingivae, via host and 
pathogen derived matrix metalloproteinases (Page and Schroeder, 1976, 
Takahashi et al., 1995). 
 
(iii) Established lesion 
This is similar to the established with a shift in the cell population in the 
inflammatory infiltrate. Here, a large numbers of plasma cells are the main 
histological feature in older patients, whereas in younger patients the infiltrate 
continues to be dominated by lymphocytes (Fransson et al., 1996). Clinically, 
inflammation becomes more pronounced with an increase in swelling, and the 
development of false pocketing. T and B lymphocytes and antibodies and 
complement are present in the inflamed marginal gingivae and gingival sulcus. 
 
(iv) Advanced lesion 
At this stage the inflammatory lesion extends into the periodontal ligament and 
alveolar bone. There is destruction of connective tissue attachment to the 
tooth.  The junctional epithelium migrates down the root surface to form a true 
periodontal pocket. Destruction of the periodontal ligament and the surrounding 
alveolar bone is mediated through matrix metalloproteinases and through 
enhanced osteolytic activity. Direct tissue damage can occur through direct 
cytotoxicity of bacterial products such as proteinases, collagenases, 
epitheliotoxin, cytolethal distending toxin, hemolysin, hydrogen sulphide and 
ammonia (Haffajee and Socransky, 1994). Moreover, dysregulation of host 
derived factors such as proteinases and proteinase inhibitors, matrix 
metalloproteinases (MMPs) and TIMPs, pro-inflammatory cytokines such as IL-1α, 
IL1β, TNFα and others, prostaglandins and the products of polymorphonuclear 
leukocytes lead to damage to the connective tissue attachment (Kornman, 
2008).  
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1.3.1 Innate immune response to periodontal biofilms 
The innate host response primarily involves the recognition of microbial 
components such as LPS, bacterial DNA, and peptidoglycan by the host cells and 
subsequent production of inflammatory mediators. The Toll-like receptors 
(TLRs), which are expressed by leukocytes and resident cells in the periodontal 
tissues, can activate the innate immune response by the binding to various 
bacterial components (Garlet, 2010, Mahanonda and Pichyangkul, 2007). The 
developing biofilm consists of initially Gram-positive cocci in health, changing to 
increased numbers of motile Gram-negative anaerobes in gingivitis and 
periodontitis (Moore and Moore, 1994, Socransky and Haffajee, 1997). Gram-
negative bacteria possess cell wall endotoxin (lipopolysacharide [LPS]), a potent 
stimulator of TLR4. LPS is released from Gram-negative bacteria through cell 
lysis and becomes linked to the extracellular acute phase protein LPS binding 
protein before binding to CD14. This leads to transfer of LPS to the extracellular 
domain of the TLR4 receptor and subsequent TLR4 signalling (Akira, 2006). 
Gram-negative bacteria also activate TLR2 through their cell membrane 
proteins, TLR5 through flagella, TLR9 through recognition of bacterial CpG DNA 
and nucleotide-binding oligomerization domain-containing protein 1 and 2 (NOD 
1,NOD 2) through peptidoglycan derivatives (Akira, 2006, Mogensen, 2009).  
Periodontal pathogens have been reported to stimulate TLRs in vitro.  For 
example, P. gingivalis LPS and fimbriae is a potent TLR2 agonists (Hirschfeld et 
al., 2001, Asai et al., 2001, Erridge et al., 2004). A actinomycetemcomitans and 
F. nucleatum LPS, and whole P gingivalis will stimulate (Kikkert et al., 2007, 
Nussbaum et al., 2009, Darveau et al., 2004, Mochizuki et al., 1999, Yoshimura 
et al., 2002).  Moreover, many bacteria can initiate an immune response via 
TLR9, which also detects viable bacterial DNA (Bauer et al., 2001). It is 
therefore clear that the myriad of bacteria that are present in both health and 
increasing severity of periodontal disease will present a challenge to the innate 
immune response in the periodontal tissues. Following TLR activation, an 
intracellular signalling cascade occurs which can lead to the activation of 
transcription factors and subsequent inflammatory cytokine expression, 
leukocyte migration and tissue destruction (Nakamura et al., 2008, Ukai et al., 
2008, Gelani et al., 2009, Lima et al., 2010). The nucleotide-binding 
oligomerization domain (NOD) and the inflammosome system have also been 
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suggested as possible accessory molecules in the induction of innate immune 
response against periodontal pathogens (Uehara and Takada, 2007, Okugawa et 
al., 2010, Bostanci et al., 2009).  
The junctional epithelium is the front line between the host and the oral 
microflora. It is well equipped to recognise invading pathogens, with studies 
showing the presence of mRNA encoding TLR2, 3, 4, 5, 6 and 9 in gingival 
epithelial cells (Kusumoto et al., 2004). Tissue dendritic cells and Langerhans 
cells are also present within the gingival epithelium and the underlying 
connective tissue.  These antigen-presenting cells express a wide range of TLRs 
including TLR1, 2, 3, 4, 5, 6, 8 and 10 (Mogensen, 2009, Mahanonda and 
Pichyangkul, 2007). These cells will monitor invasion of the bacteria or bacterial 
products initiating the adaptive immune response.  
The alveolar bone is the supporting structure into which the periodontal 
ligament inserts and is the tissue that is ultimately destroyed by the 
inflammatory lesion of periodontal disease.  Osteoblasts and osteoclasts involved 
in bone turnover also express TLR1, 4, 5, 6 and 9 (Asai et al., 2001) and TLR1, 2, 
3, 4, 5, 6, 7, 8 and 9 (Itoh et al., 2003), respectively. It is therefore possible 
that TLR signalling within the bone can generate an inflammatory response to 
invading pathogens, leading to pathological resorption of bone through excessive 
or prolonged production of osteolytic host molecules, including: IL-1, Tumour 
Necrosis Factor-α (TNFα) and Prostaglandin E2 (PGE2), which stimulate 
osteoblast inhibition and osteoclast activation and maturation through the 
receptor activator of nuclear factor kappa-B ligand/osteoprotegering 
(RANKL/OPG).  
 
Many biological events in periodontal disease are strictly regulated by cell-cell 
interactions, which may be categorized into two forms: cognate (adhesive) 
interaction, achieved by mutual recognition between membrane bound cell-
surface molecules, and cytokine-mediated interactions (Okada and Murakami, 
1998). Adhesion molecules include ICAM-1 (Intercellular Adhesion Molecule-1, 
CD54) and ITGB2 (Integrin Beta 2, CD18), which stabilize cell-cell interactions 
and facilitate leukocyte migration across the endothelial barrier (Yang et al., 
2005, Kotovuori et al., 1999).  
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1.3.2 Pro-inflammatory cytokines 
Cytokines are a large and diverse family of soluble mediators including 
interleukins, colony stimulating factors, growth factors, and cytotoxic factors. 
Cytokines play an important role in numerous biological activities including 
proliferation, development, differentiation, homeostasis, regeneration, repair 
and inflammation (Okada and Murakami, 1998). Cytokines networks are an 
important aspect of periodontal inflammation, and subject to several excellent 
reviews, and are illustrated in their complexity in Figure 1.6 (Preshaw and 
Taylor, 2011, Kinane et al., 2011). Pro-inflammatory cytokines IL-1α and IL-1β 
belong to the IL-1 family of cytokines, which has diverse activities and roles in 
immunity, inflammation, tissue breakdown, and tissue homeostasis (Dinarello, 
1988, Gowen et al., 1986, Havemose-Poulsen and Holmstrup, 1997, Mizel, 1989, 
Mizel et al., 1981, Nguyen et al., 1991, Schmidt et al., 1982, Stashenko et al., 
1987b, Tatakis, 1993, Stashenko et al., 1987a). TNF-α is a pro-inflammatory 
cytokine that is secreted mainly by monocytes and macrophages. It induces the 
secretion of collagenase by fibroblasts, resorption of cartilage and bone, and has 
been implicated in the destruction of periodontal tissue in periodontitis 
(Alexander and Damoulis, 1994, Chaudhary et al., 1992, Elias et al., 1987, Meikle 
et al., 1989). IL-1α, IL-1β and TNF-α stimulates bone resorption and inhibit bone 
formation (Stashenko et al., 1987a, Nguyen et al., 1991, Tatakis, 1993). IL-6 is a 
pleiotrophic cytokine influencing immune responses and inflammatory reactions 
(Hirano T, 1991). IL-6 is of particular importance in the human B-cell responses, 
hence it has been speculated that the expansion of B-cells/plasma cells seen in 
periodontitis lesions may result from an increased production of IL-6 at diseased 
sites (Fujihashi et al., 1993). It has also been suggested that IL-6 plays an 
important role in the local regulation of bone turnover (Ishimi et al., 1990, 
Lowik et al., 1989, Kurihara et al., 1990). 
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Figure 1.6: Cytokine networks in periodontal diseases. Schematic to illustrate the 
multiple interactions between cytokines and cellular functions in periodontal diseases. 
Taken from Kinane and colleagues (Kinane et al., 2011). 
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1.3.2.1 Interleukin-1 α and β (IL-1 α/ β)  
IL-1 is a polypeptide, which has diverse activities and roles in immunity, 
inflammation, tissue breakdown, and tissue homeostasis (Dinarello, 1988, Gowen 
et al., 1986, Havemose-Poulsen and Holmstrup, 1997, Mizel, 1989, Mizel et al., 
1981, Nguyen et al., 1991, Schmidt et al., 1982, Stashenko et al., 1987b, 
Tatakis, 1993, Stashenko et al., 1987a). IL-1 is synthesized by various cell types, 
including fibroblasts, lymphocytes, skin cells, macrophages, monocytes, vascular 
cells and bone cells, following its activation. IL-1α and IL-1β belong to the IL-1 
family of cytokines which have similar biological functions and bind to the same 
receptors found on many cell types (Okada and Murakami, 1998). Local excessive 
production of IL-1 by periodontal ligament cells stimulates gingival and 
periodontal ligament fibroblasts to induce the production of other mediators, 
prostaglandin E2 (PGE2) and matrix degrading enzymes that can cause 
connective tissue destruction and attachment loss. IL-1 has also been implicated 
in the pathogenesis of periodontitis, which involves bone destruction (Okada and 
Murakami, 1998). IL-1 α and IL-1 β have been shown to stimulate bone resorption 
and inhibit bone formation (Stashenko et al., 1987b, Nguyen et al., 1991, 
Tatakis, 1993) and also accentuates the bone resorptive actions of TNF-α 
(Bertolini et al., 1986, van der Pluijm et al., 1991). IL-1 β has been shown to 
have significantly more potent in mediating bone resorption compared with IL-1 
α and TNF-α (Alexander and Damoulis, 1994). IL-1 can also stimulate elevated 
production of matrix metalloproteinases (MMPs) (Havemose-Poulsen and 
Holmstrup, 1997), procollagenase (Meikle et al., 1989, Lark et al., 1990) and 
plasminogen activator (Mochan et al., 1988) but no significant change in the 
synthesis of TIMP (Meikle et al., 1989).  
 
1.3.2.2 Interleukin-6 (IL-6) 
IL-6, which belongs to the IL-6 family of cytokines, is a pleiotropic cytokine with 
a wide range of biological functions including influencing immune response, 
inflammatory reactions, acute phase response, oncogenesis and hematopoiesis 
(Kishimoto, 1989, Le and Vilcek, 1989, Sehgal, 1990, Heinrich et al., 1990, 
Hirano and Kishimoto, 1992, Van Snick, 1990). Stimulated monocytes, 
macrophages, T- and B- cells, fibroblasts, keratinocytes and endothelial cells 
have been shown to produce IL-6 after stimulation (Okada and Murakami, 1998). 
In the periodontium, IL-6 is expressed by osteoblasts (Feyen et al., 1989), 
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gingival fibroblasts (Takashiba et al., 2003) and periodontal ligament cells 
(Jonsson et al., 2008). Increased levels of IL-6 have been detected in the 
gingival crevicular fluid (Lin et al., 2005). IL-6 has been implicated in the local 
regulation of bone turnover (Lowik et al., 1989, Ishimi et al., 1990, Kurihara et 
al., 1990). The cytokine has also been shown to stimulate bone resorption in 
mouse calvarial bone (Palmqvist et al., 2002, Ahlen et al., 2002). Simultaneous 
treatment of mouse osteoblastic cells and bone marrow cells with soluble IL-6 
and IL-6 receptors induced osteoclast formation, in an in vitro study (Tamura et 
al., 1993). These observations imply a role for IL-6 in the pathogenesis of 
periodontal tissue destruction in periodontal disease.  
 
1.3.2.3 Tumor Necrosis Factor alpha (TNF-α) 
TNF-α is a pro-inflammatory cytokine released by activated monocytes and 
macrophages (Okada and Murakami, 1998). TNF-α functions include inducing the 
up-regulation of adhesion molecules and chemokines which are involved in the 
cell migration to inflamed and infected sites (Peschon et al., 1998, Dinarello, 
2000, Wajant et al., 2003, Kindle et al., 2006). The cytokine can also induce the 
secretion of collagenase by fibroblasts, resorption of cartilage and bone, and 
destruction of periodontal tissue (Elias et al., 1987, Meikle et al., 1989, 
Chaudhary et al., 1992). Both gingival crevicular fluid (GCF) and diseased 
periodontal tissues have shown high levels of TNF-α and showed positive 
correlation to MMP and RANKL expression (Graves and Cochran, 2003, Garlet et 
al., 2004). Animal studies also demonstrated that TNF-α plays a key role in 
inflammation and periodontal tissue destruction including bone resorption and 
loss of connective tissue attachment (Graves et al., 2008, Graves and Cochran, 
2003). TNF-α also up-regulates the production of other pro-inflammatory 
cytokines, such as IL-1 β and IL-6, which are also associated with inflammatory 
cell migration and bone resorption (Okada et al., 1997, Dinarello, 2000, Wajant 
et al., 2003, Kwan Tat et al., 2004, Musacchio et al., 2009, Graves, 2008, 
Fonseca et al., 2009).  
 
1.3.2.4 Interleukin 17 (IL-17) family 
IL-17A, which was initially identified in T cells (Liang et al., 2010), has been 
shown to be released from other cellular sources including γδ T cells, NK cells, 
neutrophils, eosinophils, LTi CD4 cells (Kimizuka et al., 2012) and mast cells 
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(Hueber et al., 2010). IL-17 A has the potential to induce production of cytokines 
(Fossiez et al., 1996, Numasaki et al., 2004a, Numasaki et al., 2004b), 
chemokines (Yang et al., 2008, Kawaguchi et al., 2003), matrix 
metalloproteinases (Yang et al., 2008, Park et al., 2005, Yagi et al., 2007) and 
antimicrobial peptides (Kao et al., 2004). IL-17 has been shown to participate in 
periodontal disease but the role which it plays, host protective or destructive, is 
not clear (Kramer and Gaffen, 2007). In sterile inflammatory situations, IL-17 is 
destructive but the protective role of IL-17 is in line with the protective role of 
Th17 cells in infectious diseases (Cua et al., 2003). Conversely, IL-17 has also 
been shown to take part in the destructive phase of periodontal disease (Oda et 
al., 2003). Figure 1.7 illustrates the central role it plays in periodontal disease 
and its interaction with other key cytokines. 
  
  35
 
Figure 1.7: Cytokine regulation of matrix degradation and bone resorption in 
periodontal and periapical environments. The presence of microbial pathogens 
in periodontal and periapical environments trigger an initial production of 
proinflammatory cytokines, such as TNF-α and IL1β, which stimulate expression 
and activation of MMPs that degrade extracellular connective tissue matrix. 
Cytokines such as TNF-α can stimulate osteoclastogenesis independently while 
other cytokines stimulate RANKL expression that leads to formation of 
osteoclasts and osteoclast activity. The combined innate and adaptive immune 
responses are likely to lead to the high levels of inflammation and bone 
resorption. These proinflammatory cytokines are thought to generate an 
amplification loop that contributes to periodontal and periapical lesion 
progression. Conversely, cytokines produced by Th2 cells and Tregs, such as IL-4 
and IL-10 have the opposite effect, in part, through stimulating production of 
TIMPs and OPG as well as restrain inflammatory cytokine production. Taken from 
Graves and colleagues (Graves et al., 2011).  
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1.3.3 Chemokines  
Development of the periodontal diseases seems to be related to the progression 
of the inflammatory cell infiltrate into the deeper periodontal tissues (Graves et 
al., 1998). The chemokines, which are found in the gingival tissue and GCF have 
been implicated in the immunopathogenesis of periodontal diseases (Silva et al., 
2007).  
 
1.3.3.1 Interleukin-8 (IL-8) 
IL-8/CXCL8 is a chemoattractant of polymorphonuclear leukocytes (PMNs) which 
has been detected in healthy periodontal tissues and low subclinical 
inflammation closely associated with PMNs (Payne et al., 1993, Mathur et al., 
1996). The levels of IL-8 increase rapidly in GCF preceding the clinical signs of 
disease (Zhang et al., 2002). In early periodontal lesions, PMNs are the first cell 
types found in high numbers (Garlet et al., 2005). Periodontitis patients show a 
drastic increase in the levels of IL-8 in both periodontal tissue and GCF which 
has been correlated with disease severity (Tsai et al., 1995). IL-8 production has 
been shown in gingival fibroblasts, gingival epithelial cells, endothelial cells, and 
in in vitro studies (Takashiba et al., 1992, Takigawa et al., 1994, Huang et al., 
1998, Yumoto et al., 1999). Figure 1.8 illustrates the central role of the 
chemokine IL-8 in periodontal disease. 
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Figure 1.8: Chemokines and chemokine receptors in oral tissues: potential 
involvement in the induction and maintenance of inflammatory reactions. A 
schematic representation of chemokine and chemokine receptor networks in oral 
tissues. Chemokine expression can be triggered by microbial components, 
inflammatory mediators, host factors such as dentin proteins, or even by 
mechanical stress. Both resident (such as osteoblasts, fibroblasts, mast, 
epithelial, and endothelial cells) and inflammatory cells (polymorphonuclear 
leukocytes [PMNs], lymphocytes, monocytes/ macrophages) can be sources of 
chemokines in the oral environment. The chemokines produced in oral tissues 
selectively attract different cell types to the tissues, such as PMNs, lymphocyte 
subsets, monocytes/macrophages, and osteoclasts, and, consequently, can 
determine the course of inflammatory reactions and the clinical outcome of 
potentially associated diseases (Silva et al., 2007). 
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1.3.4 Antimicrobial peptides 
It has been shown that gingival epithelial cells serve as physical barriers to 
microbial challenge and also play an active role in sensing and initiating host 
response, by expression of various pattern recognition receptors and other 
innate host defense molecules such as antimicrobial host defense peptides 
(Dale, 2002). Antimicrobial peptides are very important functional components 
of the innate defense system (Boman, 1995, Zasloff, 2002), which have strong 
antimicrobial activity against both Gram-positive and Gram-negative bacteria by 
disrupting the integrity of their cell membranes (Boman, 1995, Harder et al., 
1997). They also contribute to the homeostasis of the microbe-host interactions 
through immunoregulation of innate and adaptive host response (Boman, 1995, 
Peschel and Sahl, 2006). Defense peptides consist of mainly defensins, 
cathelicidin LL-37 and histatins (Dale, 2002, Marshall, 2004). 
 
1.3.5 Human defensins 
Human defensins are classified into α and β subforms based on the cysteine 
spacing and connecting patterns of three sulphide bonds (Ganz and Lehrer, 
1995). Human β-defensins are produced by the epithelial cells. Human β-
defensin 1 is constitutively expressed in various epithelial cells, suggesting a 
surveillance-like role in the absence of infection and a protective role in the 
presence of infection (Mathews et al., 1999, Zhao et al., 1996). Human β-
defensin 2 is an inflammation-induced defensin and can be detected in saliva 
and gingival (Mathews et al., 1999) which are active against Gram-negative 
bacteria but not so much against Gram-positive bacteria (Harder et al., 1997). 
Human β-defensin 2 expression has been shown in inflamed tissues (Lehmann et 
al., 2002, Mathews et al., 1999). Exposure of human keratinocytes to 
inflammatory cytokines and microbes have shown induction of human β-defensin 
2, in in vitro studies, suggesting a more specialized role in the innate epithelial 
defence compared with human β-defensin 1 (Krisanaprakornkit et al., 2000, 
Mathews et al., 1999).    
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1.4 Periodontal disease models 
To facilitate our understanding of the complexity of periodontal disease, various 
in vitro and in vivo models have been used. The following section describes 
some of the key models and how these have contributed to the literature. 
 
1.4.1 Human in vivo study models  
The pathogenesis of human periodontal disease is a dynamic and complex 
process. Interpreting and translating data from studies, which have investigated 
the pathogenesis of periodontal disease in laboratory or animal models can be 
tricky. The optimal model to study this would obviously be in humans, even 
though this would be an expensive and highly regulated process. Experimental 
gingivitis model in man was first developed by Löe et al as early as 1965 (Löe et 
al., 1965). This was a seminal paper in understanding the causal aspects of 
gingivitis. This study significantly impacted on periodontal research because of 
the simple and instructive demonstration of the causal role of plaque bacteria in 
gingivitis. The experimental gingivitis model described by Löe et al. (1965) 
inspired many researchers in the field to modify and use this within their area of 
interest (Johnson et al., 1997, Biesbrock and Yeh, 2000, Offenbacher et al., 
2010, Grant et al., 2010, Smith et al., 1978, Offenbacher et al., 2009). These 
studies investigated various aspects in the pathogenesis of gingivitis and other 
periodontal diseases. Cell mediated immune responses to plaque antigens was 
also investigated in an experimental gingivitis model in man (Smith et al., 1978). 
Offenbacher and co-workers performed investigated changes in gingival 
crevicular fluid inflammatory mediator levels and gingival transcriptome during 
the induction and resolution of experimental gingivitis in humans (Offenbacher 
et al., 2010, Offenbacher et al., 2009). 
 
Of notable interest was the recent seminal study by Offenbacher and colleagues 
(Offenbacher et al., 2009). An experimental gingivitis study was performed in 
humans to understand changes in patterns of whole-transcriptome gene 
expression that occur during the induction and resolution of experimental 
gingivitis in humans. Gingival biopsy samples were collected from 14 subjects 
during a 28-day plaque-induced experimental gingivitis model. This was followed 
by treatment and resolution at days 28 through to day 35. Biopsy samples were 
collected at different sites within each subject at baseline (day 0), at the peak 
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of gingivitis (day 28), and at resolution (day 35) and processed using whole-
transcriptome gene-expression arrays (Offenbacher et al., 2009). Interestingly, a 
high proportion of the genes demonstrating greatest differences between health 
and disease were genes encoding chemokines, cytokines, adhesion molecules, 
antimicrobial peptides.   
 
Another practical use of these models is for the assessment of chemical agents, 
such as chlorhexidine, for their potential to inhibit plaque formation and 
prevent gingivitis (Löe and Schiott, 1970), which over time has been shown 
through systematic review to be an effective anti-plaque compound (Van 
Strydonck et al., 2012).  
 
1.4.2 Animal in vivo study models  
Prospective studies to investigate the mechanisms underlying the progression of 
periodontitis cannot always be answered by in vivo studies of humans due to 
important ethical considerations. Instead, several rodent models have been used 
to study host-bacterial interactions that have assisted in elucidating the 
mechanisms of periodontitis (Graves et al., 2008).   
 
1.4.2.1 Calvarial model 
A calvarial, or scalp, model was developed by Boyce and colleagues to study the 
effect of cytokines on osteoclastogenesis (Boyce et al., 1989). Other workers 
adapted this model to study host-bacterial interactions in vivo by inoculating P. 
gingivalis into the connective tissue overlying the calvarial bone to study the 
inflammatory infiltrate and fibroblast death stimulated by this organism (Graves 
et al., 2001, Leone et al., 2006). This model introduces the bacteria into the 
connective tissue but has no interactions with the epithelial cells. Therefore, no 
information about the immune response in the epithelial cells is obtained.  
 
1.4.2.2 Oral gavage model  
Most periodontal pathogens are not present in the oral microflora of mice and 
laboratory mouse strains, so alternative models introduced human strains of 
bacteria by oral gavage and the consequent impact on the periodontium has 
been investigated (Chang et al., 1988, Klausen et al., 1991). A mouse 
periodontitis model was developed, in which P. gingivalis oral gavage induced 
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pro-inflammatory cytokines, gamma interferon and interleukin-6, which 
contributed to alveolar bone loss (Baker et al., 1999, Lalla et al., 1998). Other 
studies have looked at similar immune responses involved in bone loss using 
other periodontal pathogens, including A. actinomycetemcomitans (Garlet et al., 
2006) and Tannerella forsythia (Sharma et al., 2005). For enhanced 
reproducibility of the model, prior antibiotic treatment to reduce the oral flora 
and repeated inoculations of the organisms are needed, which leads to 
complexity of the model (Graves et al., 2008).  
 
1.4.2.3 Airpouch model  
The airpouch model was originally developed in mice and rats by the Willoughby 
group to study the function of synovial membrane by producing an airpouch 
subcutaneously followed by the analysis of both the exudate fluid and the 
epithelial lining of the airpouch to assess the acute immune response (Edwards 
et al., 1981). This model was adapted for periodontitis by Pouliot and co-
workers to study the acute inflammatory response to P. gingivalis (Pouliot et al., 
2000). By injecting P. gingivalis into the airpouch, Pouliot and colleagues 
demonstrated that P. gingivalis is a strong pro-inflammatory stimulus. Another 
observation was that PGE2, which is an important marker in the pathogenesis of 
periodontitis, was found in neutrophils in addition to monocyte/macrophage in 
the inflammatory lesion (Pouliot et al., 2000). The main drawback of this model 
is that chronic inflammation experiments could not be performed because 
maintenance of the airpouch is a limiting factor, so inflammatory response could 
be assessed only in the acute context.  
 
1.4.2.4 Tissue cage and Chamber model  
The chamber model is a modification of the airpouch model to study the chronic 
aspect of inflammation. The chamber is a coiled stainless steel wire that is 
surgically implanted subcutaneously into the back of the mouse and the wound 
allowed to heal for 10 days. The interior of the chamber becomes epitheliasised 
and it also allows the injection of bacteria into the lumen of the chamber. Fluid 
can be aspirated from the chamber or the entire chamber can be excised for 
histological studies (Graves et al., 2008). This model was adapted for use in 
periodontal studies by Genco and colleagues mainly for the assessment of the 
virulence of bacteria (Genco et al., 1991). The chamber model was used to 
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demonstrate the development of acquired immune response to P. gingivalis and 
strain differences within the bacteria by injecting the bacteria into the chamber 
(Genco et al., 1991). It has also been utilised to examine the role of 
complement in the clearance of P. gingivalis (Schenkein, 1989), immunisation 
studies (Genco et al., 1992), and the activation of the kinin system which is 
involved in the breach of the vascular barrier and the subsequent dissemination 
of P. gingivalis (Hu et al., 2006). The main advantage of the chamber models is 
the ability to perform long-term experiments that can be adapted to chronic 
inflammation and pathogenesis experiments. The limitation of all animal models 
is that there is no single model that represents all aspects of the human 
periodontal disease (Graves et al., 2008). 
 
1.4.3 In vitro study models  
1.4.3.1 Multi-species biofilm models 
Various plaque biofilm models have been used to study plaque formation, 
structure and antimicrobial susceptibility (Table 1.1). Guggenheim has used a 
defined multi-species model of supragingival and subgingival plaque to study 
structure, antimicrobial susceptibility and host-pathogen interaction 
(Guggenheim et al., 2001a, Guggenheim et al., 2009, Guggenheim and Meier, 
2011, Guggenheim et al., 2001b). Figure 1.9 illustrates the Guggenheim multi-
species biofilm structure as visualized by CLSM and TEM, showing the various 
bacteria in the model stained by multiplex fluorescent in situ hybridisation. 
Moreover, constant depth film fermenter (CDFF) models have been used to study 
the structure and spatial distribution of plaque bacteria (Netuschil et al., 1998). 
 
These defined multi-species biofilm models have been used to mimic gingival 
plaque (Guggenheim et al., 2009, Guggenheim et al., 2004, Periasamy and 
Kolenbrander, 2009b, Peyyala et al., 2011b), while others have used undefined 
microcosm of bacteria from either pooled saliva or pooled plaque samples (Hope 
et al., 2012, Pratten, 2007). Table 1.1 summarises some of the key in vitro 
biofilm models reported in the literature that have been used to study supra-
gingival and sub-gingival plaque structures. In some instances biofilms have been 
produced using undefined bacteria from pooled saliva or plaque samples. 
Although structurally the composition of the biofilm retains the complexities of 
the original sample (Pratten et al., 2003), it is difficult to delineate from these 
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the exact mechanisms used in host-pathogen interaction model when compared 
with the defined multi-species biofilm models.  
 
 
 
 
Figure 1.10: Example of model multi-species biofilm structure visualized by 
CLSM and TEM. CLSM images of a 9-species biofilm stained by multiplex FISH for 
(A) V. dispar (purple), C. rectus (blue), F. nucleatum (red), and P. intermedia 
(green), (B) V. dispar (purple), A. naeslundii (red), S. intermedius (green), and 
S. oralis (blue), and (C) V. dispar (purple), T. forsythia (green), P. gingivalis 
(red), and C. rectus (blue). Images are 1-μm-thick transverse (large images), 
sagittal (right) and coronal (bottom) slices at the positions indicated by the fine 
lines. The length of the bars indicates 20 μm. (D) TEM image of a multi-species 
biofilm demonstrating the predominance of varius cocci or very short rods (S. 
oralis, S. intermedius, V. dispar, P. intermedia) and of the fusiform F. 
nucleatum cells. Bar = 5 μm (Guggenheim et al., 2009). 
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1.4.3.2 Host-pathogen interaction models 
Supra-gingival and sub-gingival in vitro biofilm models have been used to study 
antimicrobial agents against the biofilms, chemical and biological components of 
the biofilms and host-pathogen interaction. Guggenheim’s group have 
investigated host-pathogen interaction using multi-species biofilm-epithelial cell 
co-culture model looking at apoptosis and inflammatory mediator response of 
the epithelium to bacterial biofilms (Belibasakis et al., 2011b, Belibasakis et al., 
2011a). In these studies, primary gingival epithelial cells were challenged with 
the bacterial biofilms to study host-pathogen interactions. The Ebersole group 
used immortalized epithelial cell line OKF4 to co-culture with bacterial biofilms 
and planktonic cells to investigate host-pathogen interactions by investigating 
the inflammatory mediator response of the epithelial cells to the bacteria 
(Peyyala et al., 2012, Peyyala et al., 2011a).  
 
Organotypic 3-dimensional tissue models have also been used to study host-
pathogen interaction and test antimicrobials (Dongari-Bagtzoglou and Kashleva, 
2006a, Gursoy et al., 2012, Oksanen and Hormia, 2002). Even though these 
tissue models are more representative of the oral and gingival mucosa in vivo, 
they are time-consuming and labour-intensive to develop. The Dongari-
Bagtzoglou 3-D model takes about 2-3 weeks to develop with a sub-mucosal 
component to and the multi-layered epithelium (Dongari-Bagtzoglou and 
Kashleva, 2006a, Gursoy et al., 2012, Oksanen and Hormia, 2002). It uses 
immortalized OKF6-TERT2 oral epithelial cells, which has been used in the 
current study. This model has been used to study the Candidal and Candida-
Streptococcal interaction with the tissue model (Dongari-Bagtzoglou and 
Kashleva, 2006b, Diaz et al., 2012), but has the capacity to be used in the 
context of periodontal disease. Other investigators have investigated the effect 
of F. nucleatum biofilms in the 3-D models  (Gursoy et al., 2012). Primary oral 
epithelial cells have also been used to develop the 3-D tissue models 
(Moharamzadeh et al., 2009).  
 
Commercially available organotypic tissue models have also been described, 
including Mattek® and SkinEthic®, which have human epithelial and gingival 
tissue models with a submucosal component. These models have been used for 
toxicological studies and host-pathogen interaction studies (Yadev et al., 2011, 
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Kimball et al., 2006). These studies show the potential of using the organotypic 
3-dimensional tissue models for the study of host-pathogen interaction in 
periodontal disease. There is a range of models which can be used to investigate 
host-pathogen interaction in periodontal disease in vitro including monolayer of 
primary gingival epithelial cells, monolayer of immortalized oral epithelial cell 
lines, primary organotypic 3-D tissue models and organotypic 3-D tissue models 
using immortalized oral epithelial cells. Selection of the models for host-
pathogen interaction would depend on the reproducibility of the model, time 
involved in its development, labour-intensity, cost factor and the application it 
is intended for.  
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Biofilm model Media Substrate Innoculum Application Reference 
Marsh’s Porcine gastric mucin, 
2.5 g/L; KC1 2.5 g/L; 
proteose peptone 2 g/L; 
yeast extract 1 g/L; 
trypticase peptone 1 
g/L ; cysteine 
hydrochloride 0.1 g/L; 
haemin, 0.001 g/L. 
Polytetrafluor
oethylene 
(PTFE) 
Multispecies biofilm: 
Streptococcus mutans R9 
Streptococcus oralis EF186 
Streptococcus sanguis 209 
Lactobacillus casei AC413 
Actinomyces naeslundii WVU627 
Neisseria subfava A1 078 
Veillonella dispar ATCC 17745 
Porpbyromonas gingivalis W50 
Prevotella nigrescens T588 
Fusobacterium nucleaturn ATCC 10953 
Assay chemical and 
biological components 
of the biofilm. For 
example, pH 
(Kinniment et al., 1996a) 
 
(Kinniment et al., 1996b) 
Zurich 60% Human saliva, 10% 
Human serum, 30% 
modified fluid universal 
medium 
Pellicle-
coated HA disc 
Multispecies biofilm: 
C. rectus OMZ 697 
F. nucleatum subsp. vincentii KP-F2 (OMZ 596) 
P. gingivalis ATCC 33277T (OMZ 925) 
 P. intermedia ATCC 25611T (OMZ 278) 
T. forsythia OMZ 1047 
T. lecithinolyticum ATCC 700332T (OMZ 684),  
V. dispar ATCC 17748T (OMZ 493) 
A. naeslundii OMZ 745 
S. intermedius ATCC 27335 (OMZ 512) 
S. oralis SK 248 (OMZ 607) 
Epithelial cell 
apoptosis 
 Inflammatory 
mediator response 
 
Antimicrobial testing 
(Guggenheim et al., 
2009) 
 
(Belibasakis et al., 
2011b) 
 
(Belibasakis et al., 2011a) 
 
(Stathopoulou et al., 
2010) 
 
(Guggenheim and Meier, 
2011) 
  47
Kentucky Brain heart infusion 
medium supplemented 
with 5 g hemin/mL and 
1 g menadione/mL 
Rigid gas-
permeable 
hard contact 
lenses 
Multispecies biofilm: 
S. gordonii, S. oralis, and S. sanguinis or  
S. gordonii, A. naeslundii, and F. nucleatum or 
S. gordonii, F. nucleatum and P. gingivalis 
Monospecies biofilm: 
S. gordonii 
S. oralis 
S. sanguinis 
A. naeslundii 
F. nucleatum 
P. gingivalis 
Inflammatory 
mediator response 
(Peyyala et al., 2011b) 
 
(Peyyala et al., 2012) 
CDFF Artificial saliva with 
mucin 
HA discs Undefined oral bacterial inoculum from pooled 
saliva 
Antimicrobial testing (Hope and Wilson, 2003) 
 
(O'Neill et al., 2002) 
Florida Trypticase soy broth Pellicle-
coated HA disc 
Undefined subgingival bacterial inoculum Antibiotic resistance 
studies 
(Walker and Sedlacek, 
2007) 
 
(Sedlacek and Walker, 
2007) 
Eastman Artificial saliva with 
mucin 
Bovine enamel 
discs 
Undefined oral bacterial inoculum from pooled 
saliva 
Antimicrobial testing (Pratten, 2007) 
 
(Pratten et al., 2003) 
 
(Pratten and Wilson, 
1999) 
 
(Pratten et al., 1998a) 
 
(Pratten et al., 1998b) 
 
 
Table 1.1 Summary of in vitro supragingival and subgingival multi-species biofilm models. The table summarises some of the models 
which have been developed of supragingival and subgingival periodontal plaque biofilms. The models use a variety of growth media, 
substrates and inoculum for the biofilm development.  
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1.5 Summary and aims of study 
From this brief review of the literature it can be seen that both microbiological 
and immunological factors are pivotally important for the development and 
progression/or otherwise of periodontal disease. Plaque, or microbial biofilm, 
resides at the gingival margin and on the root surface, setting up an interface 
with host cells and tissues. The composition of the microbial biofilm determines 
the extent of host cell interactions, whilst the highly adaptable pathogens within 
the biofilm aim to subvert the protective effects of host immune factors. 
Nevertheless, innate immune factors continue to protect the gingivae through 
cell signalling from the first line of defense, the epithelium. Both in vivo and in 
vitro models have been developed to investigate these complex interactions, 
which have provided greater knowledge into host-pathogen interactions.  
 
To gain further insight into this, the aim of this study was to develop an in vitro 
multi-species biofilm model relevant to periodontal disease, which can be used 
to investigate host-pathogen interactions. The specific aims were as follows: 
 
1) Develop a multi-species biofilm of periodontal  biofilms 
2) Create a host (epithelial) - pathogen (biofilm) model 
3) Investigate how in vitro periodontal biofilms impact cellular responses  
4) Investigate how cytokines modulate immune response in periodontal 
disease
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CHAPTER 2:  
DEVELOPMENT AND 
VALIDATION OF A 
PERIODONTAL BIOFILM 
MODEL 
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2.1 INTRODUCTION 
Microbiologically the oral cavity is an important milieu where complex interplay 
exists between host immune factors and diverse microbial populations. This 
environment is abundant with heterogeneous planktonic bacterial suspensions in 
saliva or as adherent biofilm communities contained within distinct 
microenvironments (Kolenbrander, 2000). Molecular analysis of oral microbial 
communities by cloning and sequencing the bacterial 16S rRNA genes present has 
indicated that the oral cavity provides a habitat for approximately 700 species of 
bacteria, of which between 100 and 200 different species are present in the 
healthy mouth of any individual (Kolenbrander et al., 2010).  
 
The gingival crevice represents an important site within the oral cavity where 
bacterial biofilm adheres to an enamel surface and bathes within gingival 
crevicular fluid. Here the biofilm (or plaque) is a diverse population of inter-
connected bacteria that coexist within an oxygen-limited environment, that are 
anchored to the enamel surface by pioneer species, such as oral streptococci 
(Rogers et al., 2001, Kolenbrander et al., 2002). Understanding their growth 
requirements, interactions and composition will help provide clues as to how the 
biofilm is formed and regulated, and how this structure interacts with its 
environment. However, with hundreds of bacteria associated with both supra- 
and sub-gingival plaque it is difficult to delineate how each of these bacteria 
interacts specifically with its environment. Therefore, oral microbiologists have 
developed a variety of methods to grow and study periodontal biofilms. 
 
Many groups have undertaken work to develop complex periodontal biofilm 
models using a variety of approaches (Belibasakis et al., 2011a, Guggenheim et 
al., 2009, Kinniment et al., 1996a, Kolenbrander et al., 2010, Stathopoulou et 
al., 2010, Hope and Wilson, 2006). Systems reliant on flow and perfusion, static 
models, media composition and selection of appropriate substrates are all 
considered paramount, and that is before consideration of the microbial 
composition and the research question being asked (Sissons, 1997).   
 
Philip Marsh’s group first reported the development of a 9-species oral biofilm 
using the CDFF. Spatially differentiated steady-state biofilm communities 
composed of obligate and facultative anaerobes were described (Kinniment et 
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al., 1996a), and these could be employed to evaluate orally relevant 
antimicrobial compounds (Kinniment et al., 1996b). More recently the model has 
been utilised to produce undefined biofilms created from inoculation from 
pooled saliva (Hope et al., 2002). This study illustrated differential viability of 
bacteria throughout different layers of the biofilms using vital dyes, which has 
implications for host-pathogen interactions. Moreover, the choice of growth 
media has implications for the final biofilm structural composition. For example, 
artificial saliva and a model glycoprotein have both been used in model biofilm 
systems (Kinniment et al., 1996a, Hope et al., 2012), whereas Guggenheim and 
colleagues (2009) reported the use a more orally relevant nutrient source, i.e. 
human saliva and human serum (Guggenheim et al., 2009). This is in stark 
contrast to other studies that have relied on conventional bacteriological media, 
such as brain heart infusion (Peyyala et al., 2011b), or a selection of different 
media such as chemically defined media (Standar et al., 2010). Clearly, these 
factors play a critical role in the resultant biofilms that are formed. 
 
Other groups have used alternative methods to grow biofilms, including flow cell 
models. It has been recently reported that flow cells preferentially enable two- 
and three-species biofilms to demonstrate mutualistic behaviour compared to a 
static peg-based model (Periasamy and Kolenbrander, 2009a). These same 
systems have been used to demonstrate the structural and spatial role of P. 
gingivalis throughout biofilm formation (Periasamy and Kolenbrander, 2009b). 
However, these excellent models are technically complex and labour intensive, 
so others have opted for the more traditional static model.  For example, a rigid 
gas permeable lens has recently been described for the development of a multi-
species biofilm model (Peyyala et al., 2011b). Biofilms of early and late 
colonising species were produced and evaluated by qPCR and fluorescence 
microscopy. Here it was shown that substantial qualitative and quantitative 
differences were observed, with spatial heterogeneity between the biofilms 
evident. Notably, Guggenheim and colleagues described a sub-gingival biofilm 
model used for host-pathogen interaction studies that was grown on 
hydroxyapatite (HA) discs using nine species of periodontal bacteria 
(Guggenheim et al., 2009). These biofilms were shown to be thick (50um) with 
evidence of defined architecture, including microcolonies, with a considerable 
variety of cell morphotypes. 
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Collectively, these models show a plethora of different ways of developing 
periodontal biofilms, which has its advantages and disadvantages depending on 
its downstream applications. Therefore, the purpose of this piece of work was to 
design and develop a simple, reproducible and defined in vitro multi-species 
biofilm that could be used to investigate host cell interactions with sub-gingival 
biofilm. 
 
2.2 AIMS 
Gingival biofilms are heterogeneous with complex three-dimensional 
architecture, which are therefore difficult to reproduce accurately within the 
laboratory. Moreover, several key species of bacteria are implicated in 
periodontal disease progression, either through direct pathogenic mechanisms or 
indirectly through host mediated pathogenesis. In order to understand host-
pathogen interactions more carefully the initial aim of this study was to: 
1. Create a simplified and reproducible gingival biofilm model 
2. Qualitatively and quantitatively compare and contrast mono- and multi-
species biofilms  
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2.3 MATERIALS & METHODS 
2.3.1 Growth conditions and standardisation of periodontal bacteria 
Porphyromonas gingivalis ATCC 33277, Fusobacterium nucleatum ATCC 10953, 
Aggregatibacter actinomycetemcomitans ATCC 43718 and Streptococcus mitis 
ATCC 12261 were used in the course of these studies. The bacteria were stored 
in the -80oC freezer in cryovials (Fisher Scientific, Loughborough, UK). From 
beads P. gingivalis and F. nucleatum bacteria were revived at 37oC on fastidious 
anaerobic agar (Oxoid, Cambridge, UK) with 5% defibrinated horse blood (E&O 
laboratories, Bonnybridge, UK) in an anaerobic chamber (85% N2, 10% CO2 and 5% 
H2, [Don Whitley Scientific Limited, Shipley, UK]) for 3 days and 2 days, 
respectively. From beads A. actinomycetemcomitans and S. mitis bacteria were 
revived at 37oC on blood agar (Oxoid, Cambridge, UK) in microaerophilic 
conditions (5% CO2, [Binder GmbH, Tuttlingen, Germany]) for 1 day. These 
bacterial strains were used for experimental procedures after the second 
passage. These strains were maintained on the respective agar plates as 
described above.  
 
For experimental procedures, P. gingivalis and F. nucleatum were grown at 37oC 
in Schaedler anaerobe broth (Oxoid, Cambridge, UK) for 2 days and 1 day, 
respectively. A. actinomycetemcomitans and S. mitis were grown at 37oC in 
tryptic soy broth (Sigma, Poole, UK) supplemented with 0.8% w/v glucose (BDH, 
Poole, UK) and 0.6% w/v yeast extract (Oxoid, Cambridge, UK) for 1 day in 5% 
CO2.  
 
All four bacterial species were centrifuged individually at 3000 rpm for 5 min 
and the pellet washed 3 times with phosphate buffered saline (PBS; pH 7.4, 
Oxoid, Cambridge, UK). P. gingivalis, F. nucleatum and A. 
actinomycetemcomitans were standardized at an OD550 of 0.2 in a colourimeter 
(Model 45, Fisher Scientific, Loughborough, UK) to obtain approximately 1  108 
cfu/mL. S. mitis was standardized at an OD550 of 0.5 in a colourimeter (Model 45, 
Fisher Scientific, Loughborough, UK) to obtain approximately 1  108 cfu/mL. 
This was confirmed by standard plate counting method using the Miles and Misra 
method (Miles et al., 1938).  
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2.3.2 Artificial saliva 
Artificial saliva (AS) was prepared as previously described (Pratten et al., 
1998b), containing the following constituents: porcine stomach mucins Type III 
(0.25% w/v), sodium chloride (0.35 w/v), potassium chloride (0.02 w/v), calcium 
chloride dihydrate (0.02 w/v), yeast extract (0.2 w/v), lab lemco powder (0.1 
w/v), proteose peptone (0.5 w/v) in ddH2O (Sigma, Poole, UK). Urea was then 
added to independently to a final concentration of 0.05% (v/v). 
 
2.3.3 Development of bacterial biofilms 
2.3.3.1 Mono-species biofilm 
P. gingivalis and F. nucleatum were standardized to 1  107 cfu/mL in AS, 
Schaedler anaerobe broth, chemically defined medium (Milner et al., 1996), 
tryptic soy broth (Sigma, Poole, UK), tryptic soy broth + 5% defibrinated horse 
blood, brain heart infusion broth and brain heart infusion broth + 5% 
defibrinated horse blood. The standardized bacteria (500 µL) were transferred to 
24 well plates (Corning, NY, USA) containing customised hydroxyapatite (HA) 
discs (13 mm diameter, 1.5 mm thick [Plasma Biotal Ltd, Tideswell, Derbyshire, 
UK]) and Thermanox™ coverslips (13 mm diameter [Thermo Scientific, NY, USA]). 
P. gingivalis was incubated at 37oC in an anaerobic environment for 48 and 96 h. 
F. nucleatum was incubated at 37oC in an anaerobic environment for 48 h. A. 
actinomycetemcomitans and S. mitis were standardized to 1  107 cfu/mL in AS, 
Schaedler anaerobe broth and chemically defined medium; and 500 µL 
transferred to 24 well plates (Corning, NY, USA) containing customised 
hydroxyapatite (HA) discs (13 mm diameter, 1.5 mm thick) and Thermanox™ 
coverslips (13 mm diameter). A. actinomycetemcomitans was incubated at 37oC 
in 5% CO2 for 48 and 96 h. S. mitis was incubated at 37oC in 5% CO2 for 48 h. For 
all bacterial species the media was replaced daily.  
 
After incubation the HA discs were washed 3  with sterile PBS to remove the 
non-adherent cells, and biofilms disaggregated by mild sonication in a sonic bath 
at 35 kHz (FB11021, Fisherbrand, Loughborough, UK) for 5 min. The sonicate was 
then used for viable cell counting using the Miles and Misra plate technique 
(Miles et al., 1938). This was performed in triplicate on at least two separate 
occasions for each organism.  
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2.3.3.2 Multi-species biofilm 
S. mitis biofilms were formed for 24 h, as described above. The media was 
removed, and standardised F. nucleatum in AS added to the 24 h S. mitis 
biofilm. These were incubated at 37oC in an anaerobic environment for a further 
24 h. The media was then removed and standardised P. gingivalis and A. 
actinomycetemcomitans in AS added to the S. mitis/F. nucleatum biofilm. This 
was incubated at 37oC in an anaerobic environment for a further 4 days, each 
day replacing the AS, to finally produce a four species biofilm (Figure 2.1). Total 
viable cell counts were performed on bacterial species-specific plates. This was 
performed in triplicate on at least two separate occasions. 
 
 
 
Figure 2.1: Development of mixed species biofilm. Diagrammatic 
representation of the sequence of events for developing the four-species biofilm 
consisting of S. mitis, F. nucleatum, P. gingivalis and A. actinomycetemcomitans 
over a period of 7 days.  
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2.3.3.3 Bacterial species-specific agar plates 
(i) A. actinomycetemcomitans agar: This agar contains 4% w/v of tryptic soy 
agar (Oxoid, Cambridge, UK) and 0.1% w/v of yeast extract (Fluka analytical, 
Sigma, Poole, UK) in ddH2O. After autoclaving and cooling, 10 mL of 75 µg/mL 
bacitracin (Sigma, Poole, UK), 10 mL of 5 µg/mL vancomycin hydrochloride from 
Streptomyces orientalis (Sigma, Poole, UK) and 100 mL of filtered horse serum 
(E&O laboratories, Bonnybridge, UK) was added to the agar. 
 
(ii) Mitis salivarius agar (S. mitis): The agar contains 9% w/v of mitis salivarius 
agar powder (MSA) (Fluka analytical, Sigma, Poole, UK) in ddH2O. After 
autoclaving and cooling to 50oC, 1 mL of potassium tellurite solution (Fluka 
analytical, Sigma, Poole, UK) was added to the cooled agar.  
 
(iii) P. gingivalis agar: These plates were commercially sourced and consisted of 
42.5g of Columbia agar, 5 mL (0.1%) hemin, 1 mL (1%) vitamin K1, 6.5 g of agar, 
15 mg of nalidixic acid, 15.37 mg of colistin methanesulfonate, 10 mg of 
bacitracin, 5% sheep blood in 1 L of ddH2O (Anaerobe systems, CA, USA) 
 
(iv) Fastidious anaerobic agar for F. nucleatum: The agar contains 4.6% w/v of 
fastidious anaerobic agar (E&O laboratories, Bonnybridge, UK) in ddH2O. After 
autoclaving and cooling, 5% defibrinated horse blood (E&O laboratories, 
Bonnybridge, UK) was added to the cooled agar. 
 
2.3.4 Impact of freezing on biofilm viability 
To assess the effects of freezing the biofilm, as a means of creating reproducible 
biofilm stocks, media was removed from the mono- and multi-species biofilms, 
which were then sealed within 24 well plates and stored at -80oC. These were 
latterly revived by adding 500 L of AS and incubating within respective 
environments at 37oC for 24 h. Total viable cell counts were then performed as 
described above to compare to the fresh biofilms. The experiment was 
performed in triplicate on least two separate occasions.   
 
2.3.5 Survival of biofilms in cell culture media 
Frozen biofilms were revived in AS overnight at 37oC in the respective 
environments at 37oC. The biofilms were maintained in defined keratinocyte 
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serum-free media (K-SFM, Invitrogen) for 4 and 24 h at 37oC in 5% CO2. After 
incubation, the bacterial biofilms were washed three times with sterile PBS to 
remove the non-adherent biofilm, sonicated and viable counts obtained using 
standard plate counting method, as described above. 
 
2.3.6 Scanning electron microscopy (SEM) 
All biofilms on HA were examined by SEM, as previously described (Erlandsen et 
al., 2004). Briefly, the biofilms were fixed in 2% para-formaldehyde, 2% 
gluteraldehyde and 0.15M sodium cacodylate and 0.15% alcian blue (pH 7.4). The 
fixative was then replaced with 0.15M sodium cacodylate buffer and samples 
washed 3  5 min. A 1% (w/v) osmium tetroxide (OsO4) was then added to an 
equal volume of 0.15M sodium cacodylate buffer for 1 h. Samples were rinsed 3 
 with ddH2O for 10 min. 0.5% (v/v) aqueous uranyl acetate was then added to 
the wells and incubated in the dark for 30 min at room temperature. Samples 
were then dehydrated in an ascending ethanol series (30%, 50%, 70%, 90%, 
absolute alcohol and dried absolute alcohol) then fixed in hexamethyldisilazane 
(HMDS, TAAB, Berks, UK) for 2  5 min in separate containers. These were then 
placed in a dessicator overnight. The fixed and dried denture base samples were 
sputter-coated with gold/paladium and viewed under a JEOL JSM-6400 scanning 
electron microscope.  
 
2.3.7 Statistical analysis  
The statistical analyses on the difference in viable bacteria recovered from the 
biofilms were performed with GraphPad Prism (San Diego, CA, USA) using two-
tailed unpaired student t test. This method gives an unpaired two sample 
student t test with a confidence interval for the difference between the means. 
The unpaired t method tests the null hypothesis that the population means 
related to two independent, random samples from an approximately normal 
distribution are equal (Altman, 1991; Armitage and Berry, 1991). The 
significance level was set at p < 0.05 in a two-sided test.   
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2.4 RESULTS 
2.4.1 Quantitative and structural analysis of mono-species biofilms grown in 
different media. Periodontal bacteria exist in the oral cavity as heterogeneous 
and structurally complex biofilms (Kolenbrander, 2000, Rosan and Lamont, 
2000). However, in order to gain a clearer understanding of how different 
bacteria influence biofilm composition and architecture then analysis of biofilms 
formed by single species was first performed. Taking this reductionist approach 
mono-species biofilm development of P. gingivalis, F. nucleatum, A. 
actinomycetemcomitans and S. mitis was investigated, as described in section 
2.3.3.  
 
The quantitative recovery of bacteria from monospecies biofilms grown on 
Thermanox™ coverslips in the different media is presented in Table 2.1. P. 
gingivalis biofilms grew marginally better in AS (6.44 X 104 CFU/mm2) compared 
to THM (5.41 X 104 CFU/mm2). No viable P. gingivalis was recovered when grown 
in SAB. F. nucleatum biofilms grew preferentially in BHI+B (1.61 X 107 
CFU/mm2), followed by TSB (5.16 X 106 CFU/mm2), AS (1 X 106 CFU/mm2), SAB 
(3.25 X 105 CFU/mm2) and TSB+B (1.93 X 105 CFU/mm2). No growth was observed 
in the F. nucleatum biofilms grown in THM, CDM and BHI. A. 
actinomycetemcomitans biofilms grew preferentially in SAB (4.56 X 105 
CFU/mm2), followed by SAB (2.65 X 105 CFU/mm2) and AS (1.62 x 105 CFU/mm2). 
Finally, S. mitis biofilms grew preferentially in AS (7.90 X 105 CFU/mm2), 
compared with those grown in SAB (2.25 x 102 CFU/mm2) and THM (5.72 x 103 
CFU/mm2).  
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Table 2.1: Quantitative analysis of mono-species biofilms grown in different media on Thermanox coverslips for 48 h 
 CFU/mm2 (SD) 
 P. gingivalis F. nucleatum A. actinomycetemcomitans S. mitis 
 mean SD mean SD mean SD mean SD 
AS 6.44 X 104 
 
1.15 X 104 1 X 106 
 
4.57 X 105 
 
1.62 X 105 
 
1.94 X 103 
 
7.90 X 105 
 
3.87 X 104 
 
SAB NG  3.25 X 105 2.46 X 105 
 
4.56 X 105 
 
2.22 X 104 
 
2.25 X 102 
 
5.04 
 
THM 5.41 X 104 
 
1.98 X 104 
 
NG  2.65 X 105 
 
1.27 X 104 
 
5.72 X 103 
 
2.22 X 102 
 
CDM NG  NG  ND  ND  
TSB NG  5.16 X 106 1.49 X 105 ND  ND  
TSB+B NG  1.93 X 105 
 
1.31 X 104 
 
ND  ND  
BHI NG  NG  ND  ND  
BHI+B NG  1.61 X 107 
 
6.22 X 105 
 
ND  ND  
AS = Artificial saliva; SAB = Schaedlers anaerobic broth; THM = Tryptic soy broth supplemented with haemin and menadione; CDM = 
chemically defined media; TSB = Tryptic soy broth; TSB+B = TSB plus blood; BHI = Brain heart infusion broth; BHI+B = BHI plus blood; NG 
= No growth; ND = Not determined. (n=3) 
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The structure of these monospecies biofilms was evaluated using SEM. For P. 
gingivalis, diffuse clusters of bacterial cells were observed at low magnification 
(1000x) when it was grown in AS and THM. In SAB the biofilms were very sparse 
with no evidence of 3-D architecture. At higher magnification (5000x), 
microcolonies of short rod-shaped P. gingivalis with extracellular matrix were 
observed when it was grown in AS and THM (Figure 2.2A). However, in SAB whilst 
occasional adherent cells were observed, there were no microcolonies with 3-D 
architecture.  
F. nucleatum biofilms grown in AS and SAB were densely populated (1000x), 
particularly compared to the sparse monolayers of those grown in THM (Figure 
2.2B). At higher magnification (5000x) the biofilms grown in AS and SAB were 
structurally complex, with those in AS showing the presence of matrix material. 
A. actinomycetemcomitans biofilms grew sparsely with minimal architectural 
complexity when it was viewed under low magnification in AS, SAB and THM 
(Figure 2.2C). However, under higher magnification (5000x) these biofilms 
showed evidence of microcolonies with matrix production within all the media 
tested. 
S. mitis biofilms displayed contrasting biofilm architecture when grown in the 
different media. At low magnification (1000x) the biofilm grown in SAB was 
densely packed compared to those in AS and THM (Figure 2.2D). At higher 
magnification (5000x) the SAB grown biofilms were shown to be chains of cocci 
densely packed, whereas those in AS and THM showed microcolony architecture 
with pairs of cooci and matrix material. 
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 (A) P. gingivalis biofilm  
 
  
(B) F. nucleatum biofilm 
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(C) A. actinomycetemcomitans 
 
 
(D) S. mitis biofilm 
 
Figure 2.2: Scanning electron micrographs of 48 h biofilms grown in artificial 
saliva. (A) P. gingivalis and (B) F. nucleatum were grown as monospecies 
biofilms in AS, SAB and THM on Thermanox™ coverslips for 48 h in the anaerobic 
chamber at 37oC. (C) A. actinomycetemcomitans and (D) S. mitis were grown as 
monospecies biofilms in AS, SAB and THM on Thermanox™ coverslips for 48 h in 
5% CO2 at 37oC. The coverslips were dip-washed three times in sterile PBS before 
fixing for SEM. Biofilms were viewed under JEOL JSM-6400 scanning electron 
microscope using 1000x and 5000x magnifications. The red arrows denote 
microcolonies and extrapolymeric matrix.  
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2.4.2 Quantitative and structural analysis of P. gingivalis and A. 
actinomycetemcomitans biofilms grown in artificial saliva for 96 h. F. 
nucleatum and S. mitis yielded dense mono-species biofilms with 3-D structure 
when grown in AS for 48 h compared to P. gingivalis and A. 
actinomycetemcomitans, which were sparse monolayers. Therefore, to 
investigate if the poor biofilm phenotypes was a factor of time P. gingivalis and 
A. actinomycetemcomitans were grown in AS for 48 and 96 h at 37oC in the 
anaerobic chamber and 5% CO2, respectively.  
 
Significantly more bacteria were recovered from the 96 h P. gingivalis biofilm 
(5.38 x 105 CFU/mm2, p<0.0001) compared with the 48 h biofilm (6.44 x 104 
CFU/mm2) (Figure 2.3). SEM analysis also revealed increased numbers of 
bacterial cells present as microcolonies of greater complexity after 96 h 
compared with the 48 h P. gingivalis biofilms (Figure 2.4A). Similarly, A. 
actinomycetemcomitans biofilms yielded significantly more viable bacterial cells 
after 96 h biofilm growth (2.61 x 105 CFU/mm2, p<0.0001) compared with the 48 
h biofilm (1.62 x 105 CFU/mm2). SEM analysis showed greater coverage of the 
coverslip clearly covered in extra polymeric material.  
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Figure 2.3: Viable cell recovery of P. gingivalis and A. 
actinomycetemcomitans. P. gingivalis and A. actinomycetemcomitans were 
grown as monospecies biofilms in AS on Thermanox™ coverslips for 48 and 96 h in 
the anaerobic chamber and 5% CO2 respectively at 37oC. The coverslips were dip-
washed three times in sterile PBS before sonicating in sterile PBS for 5 min in an 
ultrasonic bath. Viable counts of the bacteria were obtained by performing Miles 
and Misra plate counting method on the bacterial agar plates. Data shown are 
viable bacteria recovered from the monospecies biofilms in CFU/mm2. Five 
technical replicates were performed for three independent biofilms. 
(***p<0.0001). 
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(A) P. gingivalis biofilm 
 
 
(B) A. actinomycetemcomitans biofilm 
 
 
Figure 2.4: Scanning electron micrographs of 48 and 96 h P. gingivalis and A. 
actinomycetemcomitans biofilms grown in artificial saliva on Thermanox 
coverslips. (A) P. gingivalis and (B) A. actinomycetemcomitans were grown as 
monospecies biofilms in AS on Thermanox™ coverslips for 48 and 96 h in the 
anaerobic chamber and 5% CO2 respectively at 37oC. The coverslips were dip-
washed three times in sterile PBS before fixing for scanning electron microscopy. 
The bacterial biofilms were viewed under JEOL JSM-6400 scanning electron 
microscope using 1000X and 5000X magnifications. In the panels, the biofilms are 
shown between the red arrows and extracellular matrix within yellow arrows. 
  66
2.4.3 Quantitative analysis of monospecies biofilms grown on different 
substrates. The main biomineral component of the human hard tissues, tooth 
and bone, is hydroxyapatite (HA), which is represented by the formula 
Ca10(PO4)6(OH)2 (LeGeros, 2002, Santos et al., 2004). Therefore, HA surfaces 
were selected to investigate mono-species bacterial biofilm formation of P. 
gingivalis, F. nucleatum, A. actinomycetemcomitans and S. mitis, grown in AS 
and compared to biofilms grown on Thermanox™ coverslips.  
 
Significantly less viable bacteria were recovered from the P. gingivalis biofilm 
grown on HA (2.60 x 105 CFU/mm2, p<0.0001) compared with those grown on CS 
(5.40 x 105 CFU/mm2). Similarly, significantly less viable F. nucleatum and A. 
actinomycetemcomitans were recovered from those biofilms on HA compared 
with CS. For F. nucleatum biofilms 3.09 x 105 CFU/mm2 were recovered from CS 
compared with 3.41 x 104 CFU/mm2 from HA biofilms (p<0.0001), and for A. 
actinomycetemcomitans 4.22 x 104 CFU/mm2 were recovered from CS compared 
with 8.03 x 102 CFU/mm2 from HA (p<0.0001).  S. mitis biofilms also showed a 
reduction in the viable recoverable bacteria on the HA compared with CS, but 
this was not significant (Figure 2.5).  
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Figure 2.5: Viable cell recovery of optimised mono-species biofilms grown on 
Thermanox coverslips and hydroxyapatite discs. P. gingivalis and A. 
actinomycetemcomitans were grown as mono-species biofilms in AS on CS and 
HA substrates for 96 h in the anaerobic chamber and 5% CO2, respectively, at 
37oC. F. nucleatum and S. mitis were grown as mono-species biofilms in AS on CS 
and HA substrates for 48 h in the anaerobic chamber and 5% CO2, respectively, at 
37oC. Thereafter, biofilms were processed for total viable cell counting using the 
Miles and Misra plate counting method on the species-specific bacterial agar 
plates. Data shown are viable bacteria recovered from the monospecies biofilms 
in CFU/mm2. Five technical replicates were performed for three independent 
biofilms. Statistical analysis was performed by two-tailed unpaired t test 
(***p<0.0001).  
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2.4.4 Quantitative analysis of multi-species biofilms grown by two different 
methods. Periodontal bacteria exist in the oral cavity as complex multi-species 
biofilms opposed to simple mono-species biofilms (Kolenbrander, 2000, Rosan 
and Lamont, 2000). Attachment and growth of these different bacterial species 
occur in a sequential manner to form dental plaque (Kolenbrander and London, 
1993). Therefore, it was an aim of this study to create a defined multi-species 
biofilm. Biofilms were grown using two defined methods: (A) P. gingivalis, F. 
nucleatum, A. actinomycetemcomitans and S. mitis were mixed together at 
defined concentrations and grown collectively for 96 h (4 days) in AS, and (B) 
early colonising S. mitis grown in artificial for 24 h, followed by intermediate 
coloniser F. nucleatum for 24 h, followed by late colonisers P. gingivalis and A. 
actinomycetemcomitans for 96 h, as illustrated in Figure 2.1. Quantitative 
analysis was performed as described previously.  
 
Mixed species biofilms formed by two different methods yielded statistically 
more recoverable viable bacteria when they were grown on HA compared with 
CS (Figure 2.6). The mixed species biofilm grown by the basic combination of all 
4 bacteria (A) yielded more total recoverable bacteria when it was grown on HA 
(3.71 x 105 CFU/mm2, p<0.001) compared with CS (2.87 x 105 CFU/mm2). Multi-
species biofilms formed by the sequential method (B) contained statistically 
greater quantities of bacteria on HA (3.44 x 106 CFU/mm2, p<0.001) compared 
with CS (2.28 x 106 CFU/mm2). Of both methods statistically greater quantities 
of bacteria were recovered from the mixed species grown on HA using the 
sequential method (3.44 x 106 CFU/mm2, p<0.0001) compared with the 
combined method (3.71 x 105 CFU/mm2). 
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Figure 2.6: Viable cell recovery of multi-species biofilms grown by two 
different methods on Thermanox coverslips and hydroxyapatite discs. (A) P. 
gingivalis, F. nucleatum, A. actinomycetemcomitans and S. mitis were grown 
together on CS and HA substrates in AS for 96 h in the anaerobic chamber at 
37oC. (B) S. mitis was grown in AS for 24 h in 5% CO2, followed by F. nucleatum 
for 24 h in the anaerobic chamber, followed by P. gingivalis and A. 
actinomycetemcomitans for 96 h in the anaerobic chamber at 37oC. Thereafter, 
biofilms were processed for total viable cell counting using the Miles and Misra 
plate counting method on the species-specific bacterial agar plates. Data shown 
are viable bacteria recovered from the multi-species biofilms in CFU/mm2. Five 
technical replicates were done for three independent biofilms. Statistical 
analysis was performed by two-tailed unpaired t test (**p<0.01, ***p<0.001).  
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2.4.5 Quantitative and structural analysis of fresh and frozen mono-species 
and multi-species biofilms grown on hydroxyapatite discs. Mono-species and 
multi-species bacterial biofilm growth is lengthy and labour intensive, therefore 
to improve efficiency of the model system the effects of freezing the biofilm as 
a means of creating biofilm stocks was explored, as described in section 2.3.4.  
 
Significantly more viable bacteria were recovered from the fresh P. gingivalis 
biofilms (1.97 x 105 CFU/mm2, p<0.001) compared with the frozen biofilms (7.67 
x 104 CFU/mm2) (Figure 2.7). The micrographs appeared to show similar 
bacterial quantities for the fresh and frozen P. gingivalis biofilms, but the P. 
gingivalis revived from the frozen biofilms cellular structure was more defined 
and absent of extrapolymeric matrix (Figure 2.8A). In contrast, significantly 
greater viable bacteria recovered from frozen F. nucleatum biofilms (7.22 x 106 
CFU/mm2, p<0.01) than the fresh biofilms (7.97 x 105 CFU/mm2). The structure 
of the fresh F. nucleatum biofilm was comparable to its frozen form, as was the 
cellular abundance (Figure 2.8B). Viable bacteria recovered from A. 
actinomycetemcomitans and S. mitis biofilms did not show significant 
differences when its fresh and frozen forms were compared. Fresh A. 
actinomycetemcomitans biofilms yielded 1.99 x 105 CFU/mm2 compared to 1.76 
x 105 CFU/mL. The micrographs revealed comparable bacterial structure and 
abundance for the fresh and frozen (Figure 2.8C). Viable bacteria recovered 
from fresh S. mitis biofilms yielded 6.90 x 105 CFU/mm2 compared to 7.14 x 105 
CFU/mm2). Visually bacterial numbers were comparable, both showing similar 
cocci structure in its fresh and frozen forms (Figure 2.8D).  
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Figure 2.7: Viable cell recovery of fresh and frozen optimised mono-species 
biofilms grown on hydroxyapatite discs. P. gingivalis and A. 
actinomycetemcomitans were grown as mono-species biofilms in AS on HA discs 
for 96 h in the anaerobic chamber and 5% CO2, respectively, at 37oC. F. 
nucleatum and S. mitis were grown as mono-species biofilms in AS on HA for 48 
h in the anaerobic chamber and 5% CO2 respectively at 37oC. The AS was 
removed; plates sealed with parafilm and kept in the -80oC freezer till used. The 
frozen biofilms were revived by thawing the biofilms and incubating with fresh 
AS within respective environments at 37oC for 24 h. Thereafter, biofilms were 
processed for total viable cell counting using the Miles and Misra plate counting 
method on the species-specific bacterial agar plates. Data shown are viable 
bacteria recovered from the mono-species biofilms in CFU/mm2. Three 
replicates were performed for two independent experiments. Statistical analysis 
was performed by two-tailed unpaired t test (*p<0.01, **p<0.001). 
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(A) P. gingivalis biofilm  
 
 
 
(B) F. nucleatum biofilm 
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(C) A. actinomycetemcomitans biofilm 
 
 
 
(D) S. mitis biofilm 
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Figure 2.8: Scanning electron micrographs of fresh and frozen mono-species 
biofilms grown on hydroxyapatite discs. (A) P. gingivalis and (C) A. 
actinomycetemcomitans were grown as monospecies biofilms in AS on HA for 96 
h in the anaerobic chamber and 5% CO2, respectively, at 37oC. (B) F. nucleatum 
and (D) S. mitis were grown as mono-species biofilms in AS on HA for 48 h in the 
anaerobic chamber and 5% CO2, respectively, at 37oC. The AS was removed; 
plates sealed with parafilm and kept in the -80oC freezer till used. The frozen 
biofilms were revived by thawing the biofilms and incubating with fresh AS 
within respective at 37oC for 24 h. The biofilms were dip-washed three times in 
sterile PBS before fixing for scanning electron microscopy. The bacterial biofilms 
were viewed under JEOL JSM-6400 scanning electron microscope using 1000X and 
5000X magnifications. The bacterial biofilms are shown between the red arrows 
on the panels. 
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Significantly more viable P. gingivalis were recovered from the fresh multi-
species biofilms (1.10 x 106 CFU/mm2, p<0.01) compared with the frozen 
biofilms (5.73 x 105 CFU/mm2) (Figure 2.9), whereas marginally more viable F. 
nucleatum were recovered from the frozen multi-species biofilms (4.57 x 106 
CFU/mm2) compared with the fresh biofilms (3.54 x 106 CFU/mm2). Comparable 
quantities of viable A. actinomycetemcomitans were recovered from fresh multi-
species biofilms (1.91 x 106 CFU/mm2) compared with the frozen biofilms (1.75 x 
106 CFU/mm2). Finally, significantly more S. mitis was recovered from the fresh 
multi-species biofilms (1.29 x 106 CFU/mm2, p<0.0001) compared with the 
frozen biofilms (6.13 x 105 CFU/mm2).  
Structural analysis by SEM of the fresh and frozen multispecies biofilms revealed 
showed similar bacterial distribution, which contained 3-D architecture in both 
types of biofilm. At higher magnification (5000x), the four constituent bacteria 
were shown to be present as indicated by arrows on the micrographs for both 
the fresh and frozen biofilms (Figure 2.10A and B). 
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Figure 2.9: Viable cell recovery of fresh and frozen multi-species biofilms 
grown on hydroxyapatite discs. S. mitis was grown in AS for 24 h in 5% CO2, 
followed by F. nucleatum for 24 h in the anaerobic chamber, followed by P. 
gingivalis and A. actinomycetemcomitans for 96 h in the anaerobic chamber at 
37oC. The AS was removed; plates sealed with parafilm and kept in the -80oC 
freezer till used. The frozen biofilms were revived by thawing the biofilms and 
incubating with fresh AS within respective at 37oC for 24 h. Thereafter, biofilms 
were processed for total viable cell counting using the Miles and Misra plate 
counting method on the species-specific bacterial agar plates. Data shown are 
viable bacteria recovered from the multi-species biofilms in CFU/mm2. Three 
replicates were done for two independent experiments. Statistical analysis was 
performed by two-tailed unpaired t test (*p<0.01, ***p<0.0001). 
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 (A) Fresh multi-species biofilm 
 
(B) Frozen multi-species biofilm 
 
 
Figure 2.10: Scanning electron micrographs of (A) fresh and (B) frozen multi-
species biofilms grown on hydroxyapatite discs. S. mitis was grown in artificial 
for 24 h in 5% CO2, followed by F. nucleatum for 24 h in the anaerobic chamber, 
followed by P. gingivalis and A. actinomycetemcomitans for 96 h in the 
anaerobic chamber at 37oC. The AS was removed; plates sealed with parafilm 
and kept in the -80oC freezer till used. The frozen biofilms were revived by 
thawing the biofilms and incubating with fresh AS within respective at 37oC for 
24 h. The biofilms were dip-washed three times in sterile PBS before fixing for 
scanning electron microscopy. The bacterial biofilms were viewed under JEOL 
JSM-6400 scanning electron microscope using 1000x and 5000x magnifications.  
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2.4.6 Survival of mono-species and multi-species biofilms in cell culture 
conditions. Periodontal bacteria survive under a range of harsh microaerophilic 
and hypoxic conditions within the oral cavity. The ultimate aim of the study was 
to investigate host-pathogen interactions between these biofilms and epithelial 
cells. Therefore, investigating the survival of the periodontal bacterial biofilms 
under cell culture conditions was a critical component of these studies. To 
investigate the survival of periodontal bacterial biofilms under cell culture 
conditions, mono-species and multi-species biofilms were suspended in cell 
culture media as described in section 2.3.5.  
 
Significantly less viable bacteria were recovered from the P. gingivalis mono-
species biofilms grown in cell culture media after both 4 h (3.62 x 103 CFU/mm2, 
p<0.001) and 24 h (7.74 x 102 CFU/mm2, p<0.001) compared with those control 
biofilms not exposed to cell culture media (7.67 x 104 CFU/mm2). F. nucleatum 
biofilms showed a significant reduction in viable bacterial numbers within cell 
culture media after 4 h (5.63 x 105 CFU/mm2, p<0.01) and 24 h (2.99 x 104 
CFU/mm2, p<0.01) compared with bacteria not maintained in cell culture 
conditions (7.23 x 106 CFU/mm2). For A. actinomycetemcomitans biofilms, a 
significant reduction in viable bacteria was observed after 4 h (3.17 x 104 
CFU/m2, p<0.0001) in cell culture media compared with the bacteria not 
maintained in cell culture conditions (1.75 x 105 CFU/mm2), but not at 24 h. 
Finally, significantly more viable S. mitis were recovered after 24 h (3.08 x 107 
CFU/mm2, p<0.01) in cell culture media compared with the bacteria not 
maintained in cell culture conditions (7.14 x 105 CFU/mm2). A marginal 
reduction in viable S. mitis was observed after 4 h (4.72 x 105 CFU/mm2) in cell 
culture media compared with the bacteria not maintained in cell culture 
conditions (Figure 2.11). 
  79
 
Figure 2.11: Survival of monospecies biofilms in cell culture conditions. The 
mono-species biofilms were grown in AS on HA discs. The biofilms were dip-
washed three times in sterile PBS before adding into 24-well cell culture plates 
containing 1 mL of defined K-SFM and incubated at 37oC in 5% CO2 for 4 and 24 
h. The biofilms were dip-washed three times in sterile PBS before sonicating in 
sterile PBS for 5 min in an ultrasonic bath. Total viable counts of the bacteria 
were obtained by performing Miles and Misra plate counting method on the 
bacterial agar plates. Data shown are viable bacteria recovered from the mono-
species biofilms in CFU/mm2. Three replicates were done for two independent 
experiments. Statistical analysis was performed by two-tailed unpaired t test 
(*p<0.01, **p<0.001, p<0.0001). 
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Viable P. gingivalis recovered from multi-species biofilms was shown to be 
significantly greater after 24 h (9.89 x 105 CFU/mm2, p<0.01) in cell culture 
conditions compared with the biofilms not maintained in cell culture conditions 
(5.73 x 105 CFU/mm2). P. gingivalis recovered from the multi-species biofilms 
not maintained in cell culture conditions and which were maintained in these 
conditions for 4 h (5.70 x 105 CFU/mm2) were comparable. There was 
significantly less viable F. nucleatum recovered from multi-species biofilms after 
4 h (7.39 x 105 CFU/mm2, p<0.0001) and 24 h (1.72 x 106 CFU/mm2, p<0.001) in 
cell culture conditions compared with those recovered from the biofilms not 
maintained in cell culture media (4.57 x 106 CFU/mm2). Similarly, viable A. 
actinomycetemcomitans recovered from multi-species maintained in cell culture 
media for 4 h (7.03 x 105 CFU/mm2, p<0.0001) and 24 h (7.79 x 105 CFU/mm2, 
p<0.001) were significantly less compared with those recovered from the 
biofilms not maintained in cell culture (1.75 x 106 CFU/mm2). S. mitis recovered 
from multi-species biofilms was significantly less after 4 h (8.61 x 104 CFU/mm2, 
p<0.001) in cell culture media compared with those which were not maintained 
(6.13 x 105 CFU/mm2). More viable S. mitis was recovered from multi-species 
biofilms maintained in cell culture media for 24 h (1.34 x 106 CFU/mm2) 
compared with those that were not maintained (Figure 2.12).  
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Figure 2.12: Survival of multispecies biofilms in cell culture conditions. The 
multi-species biofilms were grown in AS on HA. The biofilms were dip-washed 
three times in sterile PBS before adding into 24-well cell culture plates 
containing 1 mL of defined K-SFM and incubated at 37oC in 5% CO2 for 4 and 24 
h. The biofilms were dip-washed three times in sterile PBS before sonicating in 
sterile PBS for 5 mins in an ultrasonic bath. Total viable counts of the bacteria 
were obtained by performing Miles and Misra plate counting method on species-
specific bacterial agar plates. Data shown are viable bacteria recovered from 
the multi-species biofilms in CFU/mm2. Three replicates were done for two 
independent experiments. Statistical analysis was performed by two-tailed 
unpaired t test (*p<0.01, **p<0.001, p<0.0001). 
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2.5 DISCUSSION 
The data described herein reports a simple and reproducible in vitro model 
capable of comparing and contrasting the composition and structural 
arrangement of mono- and multi-species periodontal biofilms. This model has 
been shown to grow optimally on HA discs grown in AS over a defined time 
period of 2-4 days and 7 days, respectively. Biofilms of a multi-species nature 
were shown to be the most complex, which were densely packed with structural 
heterogeneity. Conversely, those mono-species biofilms of P. gingivalis and A. 
actinomycetemcomitans displayed sparse monolayers with occasional micro-
colonies observed. The ability of these mono-species biofilms to survive in cell 
culture conditions was poor compared to the multi-species biofilm. Moreover, 
the multi-species biofilms were conducive to freezing. Some of the caveats of 
the development of this model will now be discussed.  
 
Initially, in order to evaluate the bacterial composition of the biofilms, total 
viable cell counts were performed using specialised media, as described 
elsewhere (Hunt et al., 1986). For mono-species biofilms the resultant colony 
counts was minimally variable in AS under optimised conditions, ranging from 
~105 to 106 CFU/mm2 for all four species. However, this could not be verified 
through SEM analysis. For example, densely packed biofilms of F. nucleatum 
were in stark contrast to those of P. gingivalis. This difference could be 
explained by the dense nature of the F. nucleatum biofilms, which would be 
difficult to make into a homogenous suspension following sonication. Therefore, 
clumps of dislodged cells may have represented only one colony, therefore 
impacting and underestimating the cell counts, as has been reported elsewhere 
(Coco et al., 2008, Yadev et al., 2011). This may be an inherent problem with 
this methodology for biofilm enumeration (Childers et al., 2011). In fact, several 
other studies have relied on molecular techniques to quantify their biofilm 
numbers. qPCR was shown to be an effective method for enumerating biofilm 
composition in a three-species lens model system (Peyyala et al., 2011b). The 
data from this study showed substantial differences in cell numbers when mono-
species and multi-species biofilm were compared, often 2 or 3 log differences, 
and which were consistently 1-2 log above what was reported herein. However, 
the numbers are similar to those reported from a 9-species for both F. 
nucleatum and P. gingivalis, of approximately 107 CFU/mL (Kinniment et al., 
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1996a). Nevertheless, consideration of nuclease activity should be given, as this 
has been shown to alter qPCR sensitivity (Nadkarni et al., 2009).  
 
The multi-species biofilms in this study were also quantitatively superior (1 log) 
to the mono-species biofilms. In this case the SEM analysis clearly showed 
structural differences. The biofilms showed evidence of 3-D architecture, spatial 
heterogeneity and an increased biomass. However, SEM may not have been the 
optimal method for this analysis due to the inherent problems with SEM and 
post-processing, i.e. dehydration of sample resulting in altered morphology and 
ultrastructure. Confocal laser scanning microscopy (CLSM) may have been useful 
in this context for both qualitative and quantitative analysis, but was not 
available at the time of this work. It was interesting that the cells within this 
biofilm multi-species environment were able to flourish compared to those 
grown as mono-species biofilms. Biofilms of this structural complexity have been 
reported by others, both in vitro and in vivo (Walker and Sedlacek, 2007, Zijnge 
et al., 2012). Various studies have consistently reported that once the cells 
within the biofilm are heterogeneous then the resultant biofilms form a robust 
biofilm with stable proportions of each organism present (Guggenheim et al., 
2009, Periasamy and Kolenbrander, 2009b, Peyyala et al., 2011b). However, the 
use of colony counts is limited in these studies. 
 
The use of molecular tools combined with fluorescence microscopy has become 
more frequently utilised by researchers as an alternative (Childers et al., 2011). 
Recently, Sanchez and coworkers (2011) reported the use of CLSM and RFLP to 
study biofilm development of a 6-species sub-gingival model on HA (Sanchez et 
al., 2011). Here it was used to show the developmental characteristics, 
structural composition and relative abundance of each bacterial species as the 
biofilms reached a steady state. Similarly, Guggenheim and coworkers (2009) 
demonstrated the structural composition of the nine species by using CLSM and 
transmission electron microscopy (TEM). Using fluorescence in situ hybridisation 
(FISH) it was shown that the biofilms after 64.5 h were approximately 40-60um, 
and TEM demonstrated a morphological abundance of short cocci and rods. 
Peyyala and colleagues (2011) also examined the three species biofilms under 
CSLM, where they found substantial differences in the quantities and distribution 
of the species in the multi-species biofilm. As observed from the studies 
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mentioned above multi-species biofilm development is a very complex and time-
consuming process. This study has tried to create a simple multi-species 
periodontal biofilm, which could be used in industrial setting to screen active 
compounds in a quick and reproducible manner. Here an organism characterised 
for its pioneer status was used (S. mitis). Furthermore, F. nucleatum was used, 
which is one of the first Gram-negative species to become established in dental 
plaque and is considered as an intermediate colonizer, helping bridge 
attachment of non-pathogens (commensals) and true pathogens (Kolenbrander, 
2000, Kolenbrander et al., 2002). These two pivotal organisms provided the 
structural stability of the biofilm in the early phases of growth, allowing the 
successful introduction of A. actinomycetemcomitans and P. gingivalis, which 
judging from SEM analysis were unable to form structurally secure biofilms. The 
sequential attachment of the periodontal bacteria on the tooth surface to form 
the periodontal plaque biofilm has been reported by various researchers 
(Socransky et al., 1998). In this study HA was used, representative of enamel. 
This has been shown to be an acceptable substrate for studies of this nature 
(Guggenheim et al., 2009). However, alternative substrates, such as contact 
lenses have been used (Peyyala et al., 2011b). Collectively each of the 
organisms selected in this study represent bacteria that play a critical function 
in periodontal biofilm formation, and which also represent organisms across the 
pathogenic spectrum. This was an essential requirement for downstream host-
pathogen analysis.  
 
Overall, the data from this study and those performed by other groups 
demonstrate that although biofilm models are diverse in terms of the substrate, 
nutrients and the specific oral bacteria used, the multi-species biofilms that are 
formed are largely similar, i.e. being spatially heterogeneous and abundant in 
different species. However, given that the end-point of this study was to 
investigate host-pathogen interactions, it was important to evaluate how the 
biofilm responded to an environment optimised for cell culture. Here it was 
shown that the mono-species biofilms, particularly P. gingivalis and F. 
nucleatum (obligate anaerobes), did not tolerate the 5% CO2 conditions well 
compared to S. mitis. Interestingly, within the multi-species biofilm there was a 
minimal fluctuation of the cells over 24 h incubation. Given that the gingival 
crevice has differential microenvironments that enables different bacteria to 
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survive and flourish, it is likely that an element of mutualism enables the four 
species to maintain a homeostatic balance within the biofilm, as has been shown 
elsewhere (Periasamy and Kolenbrander, 2009b). Several analogous studies have 
recently reported biofilm models to investigate host-pathogen interactions 
(Belibasakis et al., 2011b, Belibasakis et al., 2011a). From these studies it is not 
apparent that any consideration has been given to how the multi-species 
biofilms from these studies respond to cell culture environments. Moreover, 
these biofilms are able to survive freezing, as shown from our investigations. 
The structure and composition is maintained when revived. This was critical in 
developing robust and reproducible biofilms for downstream testing in a host-
pathogen co-culture system.   
 
In summary, this initial component of the entire investigation has provided a 
quantitative and qualitative assessment of both mono- and multi-species 
biofilms that can be used to investigate how oral biofilms interact with the host 
epithelium.  
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CHAPTER 3:  
ASSESSING IMPACT OF 
PERIODONTAL BIOFILMS ON 
EPITHELIAL CELLS 
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3.1 INTRODUCTION 
The previous chapter presented a novel biofilm model for use in host-pathogen 
interaction studies. Various oral bacteria associated with periodontal disease 
have been shown to possess virulence factors that aid intracellular invasion, 
intracellular persistence and host cell apoptosis (programmed cell death), of 
which P. gingivalis is a paradigm (Curtis et al., 2005, Curtis et al., 2011, Curtis 
et al., 2001, Kinane et al., 2008). These are factors that have the potential to 
significantly affect mammalian cell viability and function.   
 
Apoptosis is prevalent in the gingivae at sites of chronic bacteria-induced 
inflammation (Koulouri et al., 1999, Tonetti et al., 1998), particularly in the 
superficial cells of the junctional epithelium (Tonetti et al., 1998). The caspases 
(cysteine-dependent aspartate-specific proteases) are of central importance to 
apoptotic signalling network which are activated in most cases of apoptotic cell 
death (Bratton et al., 2000). So far, 14 different members of the caspase family 
have been identified which are divided into two subfamilies, initiator and 
executor caspases. The initiator caspases are activated by forming heteromeric 
complexes with accessory molecules. This is followed by the cleavage and 
subsequent activation of downstream caspases, such as caspases 3 and 6 
(Nakata, 2000). Cleavage of a select group of substrates by downstream caspases 
(Stroh and Schulze-Osthoff, 1998) is responsible for the dismantling of essential 
cell components, which results in the morphological and biochemical changes 
that characterize apoptotic cell death.  
 
A frequently activated death protease is caspase-3 which is also required for 
some of the characteristic changes in cell morphology and certain biochemical 
events associated with the execution and completion of apoptosis (Porter and 
Janicke, 1999). Caspase-3 is also required for apoptotic chromatin condensation 
and DNA fragmentation in all cell types (Woo et al., 1998, Janicke et al., 1998, 
Oberhammer et al., 1993). Thus caspase-3 is essential for certain processes 
associated with the dismantling of the cell and the formation of apoptotic 
bodies, but it may also function before or at the stage when commitment to loss 
of cell viability is made (Porter and Janicke, 1999). The degradation of nuclear 
DNA into nucleosomal units is one of the best-characterized biochemical 
features of apoptotic cell death (Wyllie, 1980, Earnshaw, 1995). When cells are 
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induced to undergo apoptosis, caspases, in particular caspase-3, cleave ICAD to 
dissociate the CAD:ICAD complex, allowing CAD to cleave chromosomal DNA 
(Nakata, 2000). Oral bacteria, including P. gingivalis, have been shown to use 
this strategy to survive within the gingivae. 
 
P. gingivalis has been shown to induce apoptosis in a time and dose dependent 
manner with significant apoptosis occurring between 12 and 24 h hours of 
challenge via a gingipain-dependent (arginine or lysine) mechanism 
(Stathopoulou et al., 2009). This was demonstrated was through caspase-3 
activity. It was shown that live bacteria strongly up-regulate intrinsic apoptotic 
pathway, such as caspase-3, -8, -9, and that DNA fragmentation was present. It 
was also shown that P. gingivalis blocks camptothecin-mediated apoptosis of 
epithelial cells, up-regulates anti-apoptotic molecule expression Bcl-2 
expression, and down-regulates pro-apoptotic molecule Bax expression (Nakhjiri 
et al., 2001). These studies collectively indicate that P. gingivalis has multiple 
mechanisms to interfere with apoptosis and cellular functions, unlike other 
bacteria of the oral cavity that are considered commensals, such as oral 
streptococci. However, its distant relatives, S. pneumoniae, have been shown to 
induce apoptosis (Marriott and Dockrell, 2006).   
 
Modulation of cellular functions by periodontal bacteria has also been reported 
elsewhere. For example, apoptosis (characterized by Annexin-V staining) was 
shown to increase in the gingival epithelial cells (GEC) multi-layers following 
challenge with A. actinomycetemcomitans, F. nucleatum and S. gordonii. In 
contrast, P. gingivalis induced a transient increase in early apoptotic markers, 
which returned to control levels after 24 h (Dickinson et al., 2011). It was also 
shown that P. gingivalis was able to up-regulate the anti-apoptotic pathways in 
GECs in a time-dependent manner (Mao et al., 2007). Therefore, apoptotic 
events depend not only on the species present but also on the 
duration/frequency of interaction. Moreover, it was shown that P. gingivalis 
blocks apoptotic pathways in GECs through manipulation of the JAK/Stat 
pathway (Mao et al., 2007). This controls the intrinsic mitochondrial cell death 
pathways. As P. gingivalis is predominantly located intracellularly, this is 
thought to represent a strategy of the bacteria to prolong the life of its 
eukaryotic host cell (Mao et al., 2007). Clearly, P. gingivalis is adept at living 
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within differential microenvironments of the gingival crevice and resisting 
immune defence mechanisms.  
 
3.2 AIM 
In order to investigate the impact that a multi-species biofilm model has upon 
oral epithelial cells when compared to mono-species biofilms, the direct cellular 
effects must first be investigated. For this component of the study P. gingivalis 
and S. mitis were selected for use, each representing a pathogenic and 
commensal mono-species biofilm. Each of these was compared to a multi-species 
biofilm, as described in Chapter 2.   
 
Therefore, the aim of these experiments was to investigate the responses of oral 
epithelial cells to bacterial biofilms with respect to (i) viability and (ii) 
apoptosis.  
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3.3 MATERIALS AND METHODS 
3.3.1 Oral keratinocyte cell line growth and maintenance 
OKF6-TERT2 cells (kind gift of the Rheinwald laboratory, Brigham and Woman’s 
Hospital, Boston) are an immortalized human oral keratinocyte cell line. These 
cells have been immortalized by forced expression of telomerase, and resemble 
primary oral keratinocytes in studies of cytotoxicity or inducible cytokine and 
beta-defensin expression (Dongari-Bagtzoglou and Kashleva, 2003). All cell 
culture media and supplements were purchased from Invitrogen (Paisley, 
Scotland) unless otherwise indicated.  
 
OKF6-TERT2 cells were cultured in keratinocyte serum-free medium (KSFM) 
[37010-022 Invitrogen, Paisley, UK] supplemented with 100 IU penicillin, and 100 
µg/mL streptomycin, 25 µg/mL bovine pituitary extract (BPE), 0.2 ng/mL 
epidermal growth factor (EGF) and 0.3 mM CaCl2 (0.4 mM total Ca2+). BPE and 
EGF were filter-sterilised (0.2 µm). Cells were seeded at 5 x 105 cells/mL in a 75 
cm2 cell culture flask (Corning, NY, USA). Cells were passaged at approximately 
90% confluence, with 0.05% Trypsin EDTA. Following detachment of the cells the 
trypsin was neutralized with 15 mL of Dulbecco’s modified Eagle’s media (Sigma, 
Poole, UK) supplemented with 10% foetal calf serum (Sigma, Poole, UK). Cells 
were washed in Hanks balanced salt solution (Sigma, Poole, UK). The cells (20 
µL) were mixed with Trypan blue (10 µL) (Sigma, Poole, UK) to obtain a dilution 
factor of 1.5. The cells were then transferred to a haemocytometer and viewed 
under the microscope to count the cells and study cell morphology. Dead cells 
were observed as blue because of the loss of cell wall integrity, which allows the 
Trypan blue to enter the cells. Live healthy cells were round and transparent, 
which were counted using the haemocytometer grids. The cells were re-seeded 
at around 5 x 104 cells/ mL (1 x 106 cells / flask). For assays, cells were cultured 
with defined-KSFM to remove batch variability found in BPE. In defined-KSFM, 
BPE is replaced with defined growth-promoting additives including insulin and 
fibroblast growth factor (proprietary solution). Also, BPE has only 4-week 
stability in medium (may deteriorate before this), compared to 3 months 
stability of defined-KSFM. 
 
Frozen stocks of OKF6-TERT2 epithelial cells were also prepared. The epithelial 
cells (2 x 106 cells/mL) were resuspended in DMEM containing 20% foetal calf 
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serum. Equal volumes of the resuspended epithelial cells and 20% DMSO were 
transferred to a cryo tube to obtain a final volume of 1 mL. The vials were kept 
in an insulated box in the -80oC freezer overnight, for slow cooling, and then 
transferred into liquid nitrogen for prolonged storage. The cells were revived 
from frozen by thawing the cells rapidly in a 37oC water bath and transferring 
the cells into a cell culture flask containing warm K-SFM. The cells were 
passaged after it reached 90% confluence. The OKF6-TERT2 cells were harvested 
after the third or fourth passage for use in the experiments.   
 
3.3.2 Development of an epithelial biofilm co-culture model  
The OKF6-TERT2 cells were harvested, seeded at a density of 1 x 105 cells per 
well in 24 well cell culture plates (Corning, NY, USA) with Thermanox™ 
coverslips in a total volume of 1 mL of defined K-SFM. When the cells reached 
80-90% confluence, the cells were washed once with defined K-SFM to remove 
the non-adherent cells. The epithelial cells were then challenged with previously 
frozen inverted biofilms (as described in chapter 2). These were adhered using 
Vaseline® to hanging cell culture inserts (Millipore, MA, USA) and inserted into 
24 well plates with the epithelial cells at the bottom of the well, as illustrated 
in Figure 3.1. The biofilms on the HA discs were separated from the epithelial 
cells on the bottom of the well by 0.5 mm gap, which modelled the gingival 
crevicular fluid filled space. After 4 and 24 h, cell culture supernatants were 
harvested and stored at -80oC for subsequent protein evaluation.  
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(B) 
 
 
 
 
 
 
 
 
 
Figure 3.1: Epithelial biofilm co-culture model system. (A) Transverse view of hanging basket design. Hanging inserts (Millipore) with the 
HA discs were introduced into each well of a 24 well plate (Corning). (B) Close-up transverse view of the hanging insert, HA disc and 0.5 
mm space between the HA disc and epithelial cells. An inverted HA disc was secured to the hanging insert using sterile Vaseline®.  
OKF6 Oral Epithelial Cells 
0.5mm 
Hydroxyapatite 
Disc with Biofilm 
Hanging 
Basket 
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3.3.3 Assessment of epithelial cell viability 
The viability of epithelial cells challenged with bacterial biofilms for 4 and 24 h 
were analysed using AlamarBlue® dye (Invitrogen, CA, USA). The epithelial cells 
were washed with fresh K-SFM and replaced with fresh K-SFM containing 10% 
AlamarBlue® for 4 h. AlamarBlue® is a sensitive oxidation-reduction indicator 
that fluoresces and changes colour upon reduction by living cells. The reduction 
of Alamar blue is believed to be mediated by mitochondrial enzymes (O'Brien et 
al., 2000). Viable cells elicit a colour change from blue to pink. The percentage 
reduction of the absorbance values was calculated using the AlamarBlue® 
colorimetric calculator, as per manufacturer’s instructions, which indicates the 
viability of the epithelial cells.  
 
3.3.4 Histone-associated cell death detection apoptosis ELISA 
The OKF6-TERT2 epithelial cells challenged with bacterial biofilms for 4 and 24 h 
were analyzed for cell death by determination of cytoplasmic histone-
associated-DNA-fragments (mono- and oligonucleosomes) by using the Cell Death 
Detection ELISAPLUS (Roche Applied Science, Mannheim, Germany) according to 
manufacturer’s instructions. The assay is based on a quantitative sandwich-
enzyme-immunoassay-principle using monoclonal antibodies, directed against 
DNA and histones, respectively. This allows the specific determination of mono- 
and oligonucleosomes in the cytoplasmic fraction of cell lysates. 
 
To obtain epithelial cells with induced apoptosis, the OKF6-TERT2 epithelial 
cells were incubated at 37oC for 24 h with a titration of camptothecin (CAM, 
Sigma, Poole, UK) in serially declining concentrations from 4 µg/mL to 2 ng/mL. 
After incubation, the cells were lysed by adding 1 mL of Lysis buffer (provided 
with the kit) for 30 min at room temperature. The lysed cells were stored at -
80oC for subsequent use.  
 
The biofilm challenged epithelial cells were also lysed as mentioned above and 
the cell lysates stored. Before use in the assay the cell lysates were centrifuged 
at 200 x g for 10 min. The lysates (20 µL) of the CAM and biofilm treated cells 
were transferred into the streptavidin coated microtitre plate with 80 µL of the 
Immunoreagent. The plate was incubated under gentle shaking (300 rpm) for 2 h 
at room temperature. After thorough rinsing using Incubation buffer, ABTS 
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solution was added to the wells and incubated by shaking until sufficient colour 
was developed. The stop solution was added to the ABTS solution. The 
developed colour was measured at 405 nm against ABTS solution + ABTS stop 
solution as a blank (reference wavelength 490 nm). The values from the double 
absorbance measurements of the samples were averaged and the background 
value subtracted from each of these averages. The specific enrichment of mono- 
and oligonucleosomes released into the cytoplasm from these values was 
calculated using the formula:  
 
Enrichment factor = mU of the sample (dying/dead cells)        
                                  mU of the corresponding negative control  
   (cells without CAM treatment) 
 
   mU = absorbance (10-3) 
 
3.3.5 Statistical analysis  
The statistical analyses on the difference in viable bacteria recovered from the 
biofilms were performed with GraphPad Prism (San Diego, CA, USA) using two-
tailed unpaired student t test. This method gives an unpaired two sample 
student t test with a confidence interval for the difference between the means. 
The unpaired t method tests the null hypothesis that the population means 
related to two independent, random samples from an approximately normal 
distribution are equal (Altman, 1991; Armitage and Berry, 1991). The 
significance level was set at p < 0.05 in a two-sided test.   
  95
RESULTS 
3.4.1 Metabolic changes in epithelial cells after challenge with bacterial 
biofilms. To investigate changes in cellular metabolism that may reflect changes 
in cell viability, OKF6-TERT2 epithelial cells were challenged with live or 
methanol-fixed (dead) mixed or single species biofilms (mixed: P. gingivalis, F. 
nucleatum, A. actinomycetemcomitans and S. mitis), P. gingivalis biofilm and S. 
mitis biofilm for 4 and 24 h. The viability of the epithelial cells was assessed 
with fresh media containing 10% AlamarBlue® and the percentage reduction of 
the absorbance values was calculated using the AlamarBlue® colorimetric 
calculator which indicates the viability of the epithelial cells. Data shown are 
percent survival of the epithelial cells relative to OKF6-TERT2 cells cultured with 
cell culture medium (medium control). Statistical analysis was performed using 
an unpaired t-test.  
 
Epithelial cells challenged with live mixed or single species biofilms maintained 
their viability for 4 h, However, a reduction in viability was observed after 24 h. 
Assuming 100% viability after culture in medium alone, epithelial cells 
challenged with live mixed species biofilm demonstrated 93% survival after 4 h, 
compared with 57% after 24 h (p<0.001) (Figure 3.2). Interestingly, the viability 
of the epithelial cells after 4 h of challenge with live P. gingivalis and S. mitis 
was maintained but the viability dropped to 19% (p<0.0001) and 60% (p<0.001) 
respectively after 24 h. The viability of the epithelial cells reduced to about 54% 
after 4 h when challenged with dead mixed species, P. gingivalis and S. mitis 
biofilm. The epithelial cell viability reduced further after 24 h challenge when 
challenged with dead mixed species biofilm (47%). However, the epithelial cell 
viability reduced to 87% (p < 0.001) and 71% after 24 h challenge with dead P. 
gingivalis and S. mitis biofilms, respectively. Overall, the epithelial cell viability 
reduced after 24 h challenge with live biofilms compared with 4 h. Live P. 
gingivalis biofilm caused more epithelial cell death than the other biofilms after 
24 h.   
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                                        A                   B                   C                           A                  B                   C 
 
Figure 3.2: Survival of epithelial cells after challenge with live or dead bacterial biofilms. OKF6-TERT2 epithelial cells were challenged 
with (A) multi-species, (B) P. gingivalis and (C) S. mitis biofilm for 4 and 24 h. The media was removed from the epithelial and washed 
with fresh media before replacing with fresh media containing 10% AlamarBlue™. Cell viability was calculated as percentage of the 
difference between the reductions of Alamar Blue in treated cells versus controls. Results are presented as percentage of controls, means ± 
SEM of triplicate measurements of two independent experiments and analysed using an unpaired t-test (**p<0.001; ***p<0.0001). 
  97
3.4.2 Apoptosis of epithelial cells after bacterial biofilm challenge assessed 
by DNA fragmentation. The plaque bacterial biofilms may express numerous 
virulence factors which promote host cell apoptosis (Kinane et al., 2008). To 
characterize the biofilm-associated apoptosis of epithelial cells under various 
conditions, OKF6-TERT2 cells were challenged with live or methanol-fixed (dead) 
mixed- or mono-species biofilms (mixed: P. gingivalis, F. nucleatum, A. 
actinomycetemcomitans and S. mitis), P. gingivalis biofilm and S. mitis biofilm 
for 4 and 24 h. The apoptosis of the epithelial cells were determined by the 
detection of DNA fragmentation by ELISA. Statistical analysis was performed 
using an unpaired t-test. 
 
Unchallenged OKF6-TERT2 cells were used as negative controls and the positive 
control was OKF6-TERT2 cells challenged with 4 µg/mL camptothecin for 24 h. 
Data represents the enrichment factor (EF) of the specific mono- and oligo-
nucleosomes in the cytoplasm of the epithelial cells.  
 
Increased DNA fragmentation was observed in the epithelial cells after 24 h 
challenge with bacterial biofilms compared with 4 h (Figure 3.3). Time-
dependent increase in DNA fragmentation was observed in epithelial cells 
challenged with live mixed species (4 h, 1.9 EF; 24 h, 3.6 EF), P. gingivalis (4 h, 
1.6 EF; 24 h, 8.6 EF [p<0.01]) and S. mitis biofilm (4 h, 1.6 EF; 24 h, 6.8 EF). 
Dead P. gingivalis biofilm (11.2 EF) induced greater DNA fragmentation in the 
epithelial cells compared with live biofilms (8.6 EF) after 24 h challenge. DNA 
fragmentation was observed more in the epithelial cells stimulated with live or 
dead mixed-species and mono-species biofilms compared with the unstimulated 
medium control after 24 h. Significantly increased DNA fragmentation was 
observed in the epithelial cells after it was challenged with live and dead P. 
gingivalis (Live; p<0.01, Dead; p<0.05) and S. mitis biofilm (Live; p<0.05, Dead; 
p<0.05) compared with unstimulated media control. Overall, some degree of cell 
death of the epithelial cells due to DNA fragmentation was observed after 
challenge with bacterial biofilms. 
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Figure 3.3: Histone-associated apoptosis of epithelial cells after challenge with bacterial biofilms. OKF6-TERT2 epithelial cells were 
challenged with mixed species, P. gingivalis and S. mitis biofilm for 4 and 24h. Medium control was unchallenged OKF6-TERT2 cells. 
Positive control was OKF6-TERT2 cells challenged with camptothecin 4 µg/mL. Histone concentration in the epithelial cells was assessed by 
ELISA. Data represents the enrichment factor of mono- and oligo-nucleosomes released into the cytoplasm of the epithelial cells. Values 
are means ± SEM of two independent wells of two independent experiments that were analysed using an unpaired t-test (*p<0.05; 
**p<0.001). 
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3.5 DISCUSSION 
A pathogenic (P. gingivalis) and commensal (S. mitis) mono-species biofilm were 
compared with a multi-species biofilm, both dead and live, with respect to 
epithelial cell viability and apoptosis. It was demonstrated that the OKF6-TERT2 
epithelial cells challenged with both live multi-species biofilms or P. gingivalis and 
S. mitis mono-species biofilms for 24 h resulted in reduced cell viability when 
compared both media control and 4 h stimulated cells. Dead biofilms on the other 
hand were shown to variably reduce cell viability at both 4 and 24 h. When 
apoptosis was evaluated, both live and dead biofilms showed a progressive increase 
from 4 to 24 h, with P. gingivalis showing the greatest levels, followed by S. mitis 
and then multi-species biofilms. Collectively, these data show that biofilms have a 
negative impact on cellular function, which will now be discussed (Zhang et al., 
2008). 
  
In this study, all biofilms were shown to affect cellular viability, and have variable 
effects upon apoptosis. This is in agreement with other studies, which have shown 
P. gingivalis planktonic cells to negatively impact cellular viability of GECs 
(Johansson et al., 1996, Sandros et al., 1993). Johansson et al (1996) showed that 
P. gingivalis ATCC 33277 were cytotoxic to the target cell lines used after 24 h of 
incubation. Guggenheim and colleagues also demonstrated that their 9-species 
biofilm model affected apoptosis and cell morphology (Guggenheim et al., 2009), 
which is supported from observations within mono-species infection cell culture 
models (Stathopoulou et al., 2009). In contrast, however, other studies that have 
used multi-species periodontal biofilm models have failed to take this into account 
for their downstream analysis (Peyyala et al., 2012). This has direct implications for 
the interpretation of cellular effects, particularly cytokine analysis. The study 
discussed herein also tried to investigate the epithelial cell morphology after 
incubation with the bacterial biofilms, using Rapi-Diff II stain pack. Due to technical 
difficulties in the capture of the images, the data has not been presented here. 
 
For cell viability assessment Alamar blue is often used as an assay to determine 
cytotoxicity of the epithelial cells exposed to different stimuli. For example, it has 
been used in studies of oral epithelial cells (TR146) and in a reconstituted human 
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epithelial (RHE) organotypic model to evaluate the effects of dentally relevant 
compounds (Moharamzadeh et al., 2008, Boyle et al., 2010). Alamar blue is a 
sensitive oxidation-reduction indicator that fluoresces and changes colour upon 
reduction by living cells. The reduction of Alamar blue is believed to be mediated 
by mitochondrial enzymes (O'Brien et al., 2000). There are several other commonly 
used cytotoxicity screening assay that are currently being used, including ATP 
measurement (Untch et al., 1994), MTT (Mosmann, 1983), neutral red (Babich and 
Borenfreund, 1991), XTT (Ramage et al., 2012), membrane integrity/LDH release 
(Korzeniewski and Callewaert, 1983), macromolecular synthesis (Grojean et al., 
2000) and glutathione depletion (Baker et al., 1990). A study compared the Alamar 
blue assay to the most common in vitro toxicity assay, MTT, by evaluating the 
cytotoxicity of 117 drugs on a human hepatoma cell line HepG2 (Hamid et al., 
2004). It was shown that MTT assay was less sensitive compared with the Alamar 
blue assay in detecting an effect for certain drugs, as defined by the improved Z-
factor, a statistical parameter of assay quality.  
 
In this study, it was shown that live and dead mixed species, P. gingivalis and S. 
mitis biofilms all induced cell death in epithelial cells after 24 h of stimulation, as 
evidenced by DNA fragmentation (Figure 3.3). These results agree partly with 
previous reports on epithelial cells (Stathopoulou et al., 2009). They showed that 
live P. gingivalis induced more apoptosis in epithelial cells after 24 h of challenge, 
while the dead P. gingivalis did not, using the same assay system. Two other studies 
contradicted these results, stating that P. gingivalis did not induce apoptosis in 
epithelial cells even after 24 h (Nakhjiri et al., 2001, Dickinson et al., 2011). It was 
shown that even though apoptosis in GEC multilayers was increased following 
challenge with A. actinomycetemcomitans, F. nucleatum or S. gordonii, only P. 
gingivalis induced a transient increase in early apoptotic markers, which returned 
to control levels after 24 h. Nakhjiri and co-workers (2001) also showed that P. 
gingivalis inhibited apoptosis in epithelial cells by up-regulation of the anti-
apoptotic molecule Bcl-2. Both these studies used planktonic P. gingivalis instead of 
biofilms for the challenge of the epithelial cells. This may explain the differences in 
apoptosis observed in the study described herein, as the different cell phenotypes, 
i.e. biofilm and planktonic behave differently (Lo et al., 2009).  
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The reason why the dead biofilms induced more apoptosis in the epithelial cells 
compared with the live after 24 h is not clear. One hypothesis is that the there was 
still some residual methanol, which was used to fix the biofilms, retained within the 
biofilms which could have reacted with the epithelial cells. Another hypothesis is 
that the dying cells may be releasing some undefined secreted protein or molecule, 
which may induce apoptosis in the epithelial cells (Kravchenko et al., 2011). In this 
study, only DNA fragmentation was used to ascertain the apoptosis in the epithelial 
cells. Evaluation of apoptotic factors, such as Bax (Bcl-2 associated X protein), 
Caspase 3 and anti-apoptotic factors (Bcl-2) may provide a more thorough 
understanding of the overall role of apoptosis in these cellular interactions.  
 
Apoptosis of host cells by P. gingivalis has been attributed to gingipains (Urnowey 
et al., 2006, Sheets et al., 2005, Sheets et al., 2006, Chen et al., 2001b, Kobayashi-
Sakamoto et al., 2006). Gingipains are cysteine proteases produced by P. gingivalis 
that are either secreted or membrane bound and are arginine or lysine specific 
(Kadowaki et al., 2000). For future studies, gingipain deficient P. gingivalis mutants 
could be used, or wild-type P. gingivalis pre-treated with specific gingipain 
inhibitors. Another useful study would be to use filtered cell-free supernatants to 
stimulate the epithelial cells to evaluate if gingipains on their own can induce 
apoptosis.  
 
From this study, it was concluded that bacterial biofilms have the ability to induce 
cytotoxicity and apoptosis in epithelial cells. This induction is dependent on the 
type of the biofilm (pathogen or commensal) and the form (live or dead) of the 
biofilm.   
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CHAPTER 4:  
THE INFLAMMATORY 
RESPONSE OF ORAL 
EPITHELIUM TO 
PERIODONTAL BIOFILMS  
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4.1 INTRODUCTION 
Periodontal disease is induced by bacterial biofilms that accumulate at the gingival 
margin. A series of aberrant inflammatory responses are initiated in periodontal 
tissues by a small subset of gram-negative periodontal bacteria, including P. 
gingivalis, A. actinomycetemcomitans and F. nucleatum (Feng and Weinberg, 
2006). These microbes possess numerous potent virulence factors aimed at 
neutralizing local host defences and destroying periodontal tissues, as evidenced 
from studies in the previous chapter. However, periodontal diseases progresses in 
only a limited number of individuals harbouring the pathogens, suggesting a 
complex multifactorial aetiology relating to an imbalance between host and 
pathogen (Kinane et al., 2007). Therefore, the interactions between the microbes 
and the immune system have been a major topic of investigation with regard to 
aetiology of periodontal disease.  
 
There are numerous microbiological factors affecting the host-oral bacteria 
relationship. For the purposes of these investigations, these have been categorized 
as: 
 
1. Bacterial species and whether they are pathogens or commensals?  
2.   Whether the bacteria are present in planktonic or biofilm state? 
3.   Whether the bacteria are dead or alive?   
 
Oral bacteria can be broadly classified as commensals or pathogens (Feng and 
Weinberg, 2006). Previous studies have concluded that different dental plaque 
bacteria, both in planktonic and biofilm states, induce different host response 
profiles depending on the their pathogenic or commensal status (Hasegawa et al., 
2007, Krisanaprakornkit et al., 2000, Sliepen et al., 2009, Stathopoulou et al., 
2010, Zhang et al., 2008). For example, it has been shown that F. nucleatum 
preferentially induced IL-6 and IL-8 production from epithelial cells compared to S. 
gordonii (Hasegawa et al., 2007). This was also shown in a study of primary human 
gingival epithelial cells (Stathopoulou et al., 2010). Moreover, in this same study 
cellular challenge with P. gingivalis was shown to produce high levels of IL-1β, and 
challenge with A. actinomycetemcomitans induced high levels of IL-8.  
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Host-pathogen interaction studies previously used putative periodontal pathogens in 
planktonic state to stimulate human primary cells or cell lines (Mans et al., 2006). 
However, the periodontal bacteria in dental plaque exist as a complex microbial 
biofilm (Kolenbrander, 2000, Rosan and Lamont, 2000); therefore in vitro 
planktonic bacteria are far disconnected from the in vivo situation. A number of 
investigators have more recently used mono-species and multi-species periodontal 
bacterial biofilms to study host-pathogen interactions and demonstrated differences 
in the host response to biofilms and planktonic bacteria (Oscarsson et al., 2008, 
Daep et al., 2008, Ramsey and Whiteley, 2009, Guggenheim et al., 2009, Peyyala et 
al., 2011b). The periodontal pathogen A. actinomycetemcomitans strain D7S, in 
both planktonic and in biofilm form were shown to release free-soluble surface 
material independent of outer membrane vesicles. This material enhanced 
production of pro-inflammatory cytokines (IL-1β, TNFα, IL-6, IL-8, MIP-1 β), as 
evidenced by using a cytokine antibody array. There was enhanced pro-
inflammatory cytokine production with the biofilms as compared with the 
planktonic form (Oscarsson et al., 2008). 
 
Until recently, heat-killed bacteria were the method of choice to study host-
pathogen interactions in vitro. Bacteria considered putative periodontal pathogens 
elicit a strong inflammatory response. When these bacteria are killed cytokines that 
are released early (IL-1β) and later (IL-6 and IL-8) are reversed; i.e., IL-1β levels 
were reduced and IL-6 and IL-8 levels enhanced (Eskan et al., 2008, Hasegawa et 
al., 2007, Stathopoulou et al., 2010, Zambon, 1985). The differential regulation of 
the host response to live and dead bacteria should be considered when conducting 
host-pathogen relationship studies in vitro.  
 
Microbial plaque is considered necessary, but not sufficient, for the progression of 
periodontal disease. Thus, the host response plays a pivotal role in disease 
pathogenesis. Many biological events in periodontal disease are strictly regulated by 
cell-cell interactions, which may be categorized into two forms: cognate (adhesive) 
interaction, achieved by mutual recognition between membrane bound cell-surface 
molecules, and cytokine-mediated interactions (Okada and Murakami, 1998). 
Adhesion molecules include ICAM-1 (Intercellular Adhesion Molecule-1, CD54) and 
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ITGB2 (Integrin Beta 2, CD18), which stabilize cell-cell interactions and facilitate 
leukocyte migration across the endothelial barrier (Yang et al., 2005, Kotovuori et 
al., 1999). Cytokines are a large and diverse family of soluble mediators including 
interleukins, colony stimulating factors, growth factors, and cytotoxic factors. 
Cytokines play an important role in numerous biological activities including 
proliferation, development, differentiation, homeostasis, regeneration, repair and 
inflammation (Okada and Murakami, 1998). Epithelial cells are not only physical 
barriers but also a source of potent cytokines and other soluble mediators including 
antimicrobial peptides. Antimicrobial peptides, such as human beta-defensins and 
S100A8 are produced by epithelial cells and induced by microbial products, 
inflammatory cytokines and epidermal growth factor (McCormick and Weinberg, 
Hiroshima et al.). 
 
Offenbacher and colleagues (2009) performed an experimental gingivitis study in 
humans to understand changes in patterns of whole-transcriptome gene expression 
that occur during the induction and resolution of experimental gingivitis in humans 
using bioinformatics tools (Offenbacher et al., 2009). Gingival biopsy samples were 
collected from 14 subjects during a 28-day stent-induced experimental gingivitis 
model, followed by treatment, and resolution at days 28 through 35 were analysed 
using gene-expression arrays. Biopsy samples were collected at different sites 
within each subject at baseline (day 0), at the peak of gingivitis (day 28), and at 
resolution (day 35) and processed using whole-transcriptome gene-expression arrays 
(Offenbacher et al., 2009). Interestingly, a high proportion of the genes 
demonstrating greatest differences between health and disease were genes 
encoding chemokines, cytokines, adhesion molecules, antimicrobial peptides, and a 
number of these have been selected for an in vitro model of experimental 
gingivitis.  
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4.2 AIMS  
The aim of this study was to investigate the response of oral epithelial cells to 
bacterial biofilms with respect to (i) biofilms versus planktonic microbes, (ii) live 
biofilms versus dead biofilms and, (iii) pathogenic biofilms versus commensal 
biofilms. The response of the epithelium was investigated by assessing cytokine and 
chemokine mRNA and protein expression at various times following exposure to 
biofilms.  
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4.3 MATERIALS AND METHODS 
4.3.1 Gene expression studies 
Analysis of inflammatory mediators was initially performed using gene expression 
analysis using two different methods. A list of genes of interest are shown in Table 
4.1 
 
4.3.1.1 RNA extraction and purification 
Biofilms were formed as described in chapter 2 and epithelial cells challenged as 
described in chapter 3. RNA extraction and purification from these epithelial cells 
was performed using the RNeasy Mini Kit (Qiagen, Hilden, Germany), according to 
the manufacturer’s instructions. Buffer RLT (350 μL) was added to the monolayer 
epithelial cells in the 24 well cell culture plates (Corning, NY, USA) to dislodge and 
lyse the cell, mixed and transferred to RNA free microcentrifuge tubes. An equal 
volume of 70% ethanol was added to the lysed cells, mixed and transferred to the 
RNeasy spin column and centrifuged at 13,000 rpm for 15 sec. The RNA on the spin 
column membrane was washed with buffer RW1 by centrifugation at 13,000 rpm for 
15 sec. DNase 1 solution (Qiagen, Hilden, Germany) was added directly to the 
membrane and incubated at room temperature for 10 min. The membrane was then 
washed with buffer RW1 by centrifugation at 13,000 rpm for 15 sec. The RNA on the 
membrane was precipitated by adding buffer RPE and centrifuged at 13,000 rpm for 
15 sec and then again for 2 min. The RNA was then eluted into RNase free water 
and stored in -80oC freezer. 
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Table 4.1: List of genes assessed in the study 
Gene Name Class Functions 
1. IL-1 α Interleukin-1 alpha Cytokine Initiates cytokine cascade & vascular adhesion 
molecule expression 
2. IL-1 β Interleukin-1 beta Cytokine Initiates cytokine cascade & vascular adhesion 
molecule expression 
3. IL-6 Interleukin-6 Cytokine Pro-inflammatory pleiotrophic cytokine 
4. TNF α TNF-alpha Cytokine Regulation of immune cells 
5. CSF2 GM-CSF Cytokine Stimulates stem cells to produce granulocytes 
& monocytes 
6. CSF3 G-CSF Cytokine Initiates differentiation, proliferation and 
survival of PMNs & macrophages 
7. IL-8 Interleukin-8 Chemokine PMN chemoattractant 
8. CXCL1 Gro alpha Chemokine PMN chemoattractant  
9. CXCL3 Gro gamma Chemokine Suppresses hematopoietic progenitor cell 
proliferation 
10. CXCL5 ENA78 Chemokine Chemotaxis of neutrophils promoting 
angiogenesis 
11. CCL5 RANTES Chemokine Promotion of inflammatory infiltrate & T-cell 
chemotaxis 
12. CCL4 MIP-1 beta Chemokine Attracts CD4+ T lymphocytes 
13. CX3CR1 Chemokine receptor 
1 
Chemokine Mediates leukocyte migration and adhesion 
14. CCL3L3 Chemokine ligand 3 
like 3 
Chemokine Immune response and chemotaxis 
15. CXCL10 IP-10 Chemokine Chemotactic effect on activated T, NK and 
TH-1 cells 
16. CXCL11 I-TAC Chemokine Interferon inducible T-cell alpha 
chemoattractant 
17. ICAM1 Intercellular adhesion 
molecule-1 
Adhesion 
molecule 
Stabilizing cell-cell interactions 
18. ITGB2 Beta integrin 2 Adhesion 
molecule 
Facilitate leukocyte migration across 
endothelial barrier 
19. DEFB4 Beta-defensin 2 Antimicrobial 
peptide 
Antimicrobial activity against Gram negative 
& monocyte chemoattractant 
20. S100A8 S100 calcium binding 
protein A8 
Antimicrobial 
peptide 
Phagocytic granule protein 
21. PROK2 Prokineticin 2 Angiogenic Regulates angiogenesis 
22. NFκB Nuclear factor kappa-
light-chain enhancer 
of activated B cells 
Pathway Regulates immune response to infection 
23. TBP TATA binding protein Endogenous  Transcription factor that specifically bind to 
DNA sequence  called TATA box 
24. GAPDH Glyceraldehyde 3-
phosphate 
dehyrogenase 
Endogenous Catalyses the conversion of glyceraldehydes 
3-phosphate 
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4.3.1.2 RNA quantification and quality check 
A NanoDrop 1000 spectrophotometer (Thermo Scientific, DE, USA) was used to 
assess RNA concentration and quality. The pedestal was wiped clean and 1.5 μL of 
RNA samples in solution added to the pedestal to quantify the RNA. An A260 reading 
of 1.0 is equivalent to 40 ng/μL of RNA and the OD at 260 nm is used to determine 
the RNA concentration in a solution. The quality of the RNA was assessed by the 
ratio of the absorbance at 260 nm and 280 nm. Pure RNA has an A260/A280 of 2.1 and 
a value of 1.8 and 2.1 indicates that the RNA is pure. 
 
4.3.1.3 Reverse transcription  
The purified RNA was reverse transcribed into complementary DNA (cDNA) using 
high capacity RNA to cDNA kits (Applied Biosystems, Foster City, CA, USA), 
according to the manufacturer’s instructions. To reverse transcribe the RNA, 500 ng 
of RNA was added to each reverse transcription reaction. A no-RT control was also 
included for each RNA sample, where reverse transcriptase enzyme was not 
included in the reaction. This was to ascertain that there was no genomic DNA in 
any of the cDNA samples.  
 
4.3.1.4 Real time PCR analysis of cDNA samples using SYBR® Green 
SYBR® Green and the primers were purchased from Invitrogen (Paisley, Scotland) 
unless otherwise indicated. For each condition, 1 µL of cDNA sample was PCR-
amplified using 200 nM of the IL-8 and GAPDH primers (0.5 µL forward and reverse 
primers at 10 µM), as illustrated in Table 4.2. Each 25 µL real-time PCR reaction 
contained the following: 1 µL of 500 ng/µL cDNA, 0.5 µL forward and reverse primer 
(10 nM), 12.5 µL SYBR® Green and 10.5 µL of molecular biology grade dH2O. 
Reactions were performed in triplicate in 0.2 mL optical tube strips (Agilent 
Technologies, South Queensferry, West Lothian, UK) using the Mx3000P QPCR 
machine (Stratgene, Amsterdam, Netherlands). A standard dissociation curve 
protocol was included after the 40 amplification cycles to confirm that only one 
product was made. The threshold cycle (Ct) was automatically determined and 
verified manually. Amplification plots were observed at the logarithmic scale and 
threshold selected to be above any baseline fluorescence, in the region where 
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amplification was exponential and where the majority of replicates gave similar Ct 
values, i.e. where triplicate amplification plots were parallel. IL-8 was normalised 
using GAPDH as a housekeeping gene. No-RT controls were included to check for 
DNA contamination and no template controls, with water, were run to rule out 
other contamination problems. The no-RT and no-template controls should ideally 
show no amplification and therefore no Ct values.  
 
Table 4.2: PCR primer sequences of IL-8 and GAPDH 
Target Primer sequence Binding site Product size (Base pairs) 
IL-8 F CAGAGACAGCAGAGCACACAA 21-41 170 
IL-8 R TTAGCACTCCTTGGCAAAAC 171-190 
GAPDH F CAAGGCTGAGAACGGGAAG 282-300 133 
GAPDH R GGTGGTGAAGACGCCAGT 397-414 
 
 
4.3.1.5 Real time PCR analysis of cDNA samples using Taqman® Low Density 
Array (TLDA) 
For gene expression analysis Custom-designed ABI microfluidic Taqman® Low 
Density Array ([TLDA] Applied Biosystems, Foster City, CA, USA) was used in a 
reverse transcriptase polymerase chain reaction (RT-PCR) process using the ABI 
Prism 7900 HT Sequence Detection System (Applied Biosystems, Foster City, CA, 
USA). This allowed 384 real time PCR reactions to be carried out simultaneously in 
order to determine the transcription of several genes. The TLDA used in this study 
was designed to contain gene expression assays to measure mRNA levels of NFκB, 
PROK2, CSF3, ITGB2, IL-8, IL-1α, CCL5, IL-1β, CXCL3, CCL3L3, CX3CR1, S100A8, 
CCL4, CXCL10, CXCL11, TNFα, GM-CSF, GROα, IL-6, ICAM1, DEFB4 and CXCL5 
(Offenbacher et al, 2009). Two control genes, TBP and GAPDH were utilized to span 
the relative abundance/Ct range of the genes on the card. A total of 100 uL 
reaction mixture with 20 μL cDNA template, 30 µl of RNAse free water and 50 µL of 
TaqMan universal master mix (Applied Biosystems, Foster City, CA, USA) was added 
to each port of TLDA after gentle pipetting to mix. Thermal cycler conditions were 
as follows: 10 min at 94.5°C and 30 s at 97°C and 1 min at 59.7°C for 40 cycles and 
thermal cycling and fluorescence detection was performed on Applied Bio-Systems 
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ABI Prism 7900HT Sequence Detection System with ABI Prism 7900HT SDS Software 
2.1.  
 
4.3.1.6 Gene expression analysis 
Gene expression was quantified using the comparative threshold (Ct) method as 
suggested by the manufacturer.  This technique utilises the formula 2−ΔΔCt in order 
to calculate the relative number of gene transcripts (Livak and Schmittgen, 2001).  
The Ct value represents the PCR cycle at which the amplified gene target reaches a 
defined threshold.  40 PCR cycles were performed; accordingly the Ct values can 
range from 0 to 40.  Ct values for each immunological molecule were calculated. Ct 
values were calculated for the bacterial stimulated samples and the unstimulated 
medium controls.  The Ct of the endogenous control genes was also calculated.  
GAPDH was calculated to be the most reliable endogenous control.  The ΔCt value 
was calculated [ΔCt = Ct (target gene) − Ct (GAPDH)].  This was performed for each 
gene in the bacterial stimulated samples and the unstimulated medium control 
samples.  The relative expression of each gene was then calculated with the 
formula ΔΔCT = ΔCt (positive sample) − ΔCt (control sample).  This was the expressed 
in terms of fold change relative to the control sample with the formula [fold change 
= 2- ΔΔCT] (Livak and Schmittgen, 2001).  For down regulated genes (value less than 
1) the negative inverse of the value was taken.  This allowed down regulation to be 
expressed as a negative value.   
 
4.3.2 Protein expression studies 
4.3.2.1 Protein analysis by human cytokine protein array 
A human cytokine protein array kit, Proteome Profiler panel A (ARY005, R&D 
Systems, Abingdon, UK), was used to measure cytokine production from OKF6-TERT 
epithelial cells in response to medium control, mixed biofilm (P. gingivalis, F. 
nucleatum, A. actinomycetemcomitans and S. mitis), P. gingivalis biofilm and S. 
mitis biofilm for 24 h. The kit contains nitrocellulose membranes pre-blotted with 
duplicates of 36 capture antibodies to human cytokine proteins (Figure 4.1). Figure 
4.1A illustrates the position of each protein on the nitrocellulose membrane, and 
Figure 4.1B illustrates an example of the array following processing. Cell 
supernatants can be mixed with a cocktail of biotinylated detection antibodies and 
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incubated with the membrane. Any cytokine/detection antibody complex will bind 
to the membrane via the capture antibody. Proteins are detected using 
streptavidin-horseradish peroxidase and chemiluminescent detection reagents. The 
level of light produced at each spot is proportional to the amount of bound 
cytokine. The densitometry analysis was performed on X-ray film using the Quantity 
One® 1-D Analysis Software (Gel Doc™, Bio-Rad, Hertfordshire, UK) by calculating 
the adjusted volume of the spots from the pixel density after subtracting from the 
background. 
 
 
Figure 4.1: Human cytokine protein array. (A) Schematic of the membrane 
layout. (B) Example of a processed membrane. 
 
4.3.2.2 Protein analysis by Luminex® multiplex beads 
Supernatants harvested from OKF6 epithelial cells at 4 and 24h after bacterial 
biofilms and planktonic cells challenge were tested for the presence of IL-1β, TNF-
α, IL-6, IL-8, GM-CSF and G-CSF using Luminex® multiplex beads (Invitrogen, UK) 
according to the manufacturer’s instructions. Briefly, 25 μL of 1 x beads (2.5 × 106 
beads/mL/cytokine) with defined spectral properties were covalently conjugated to 
analyte specific monoclonal antibodies and then pipetted into each well of a 96 
well filter bottom microplate.  The conjugated beads were exposed to 50 μl of cell 
culture supernatant sample or standard solution containing a known concentration 
of each cytokine [IL-1 β (7330 pg/mL), TNF-α (7410 pg/mL), IL-6 (5350 pg/mL), IL-8 
(10010 pg/mL), GM-CSF (9820 pg/mL), G-CSF (28670 pg/mL)] and incubated at 
room temperature on an orbital shaker (500-600 rpm) for two hours in the dark.  
After three washes and filtration by vacuum manifold to remove unbound protein, 
(A) 
(B) 
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biotinylated detection antibodies specific for a different epitope on the analyte was 
added to the reaction and incubated for 1 hour at room temperature on an orbital 
shaker (500 – 600 rpm).  Following this incubation step, two sets of washes and 
vacuum filtration were performed to remove unbound antibody. To the reaction 
mixture, 100 µL of Streptavidin – R Phycoerythrin (Streptavidin-RPE) was added, 
which binds with high affinity to the biotinylated antibodies.  A further three sets 
of washes and vacuum filtrations were then performed to remove any unbound 
material.  The beads were then resuspended in 100 μl of working wash solution.  
The reaction mixtures were analysed using Luminex® 100 hardware (Luminex, USA) 
and the concentrations of the analytes were determined using the software 
compared with a standard curve for each assessment. The instrument monitors the 
spectral properties of the capture beads while simultaneously measuring the 
quantity of associated fluorophore. The standard curves were obtained using a five 
parameter algorithm. Samples from two separate experiments were tested. 
 
4.3.2.3 Protein analysis by Enzyme Linked Immunosorbent Assay (ELISA) 
Supernatants harvested from OKF6 epithelial cells at 4 and 24h, after challenge 
with bacterial biofilms and planktonic cells, were analyzed for the presence of 
CXCL1 (Gro-α), CXCL10 (IP-10) and CCL5 (RANTES) using ELISA (Peprotech, London, 
UK), according to the manufacturer’s instructions. Fresh solution of antigen-specific 
antibody (capture antibody) was prepared in PBS (1.0 μg/mL) and 100 μL aliquots 
added to each well of Nunc Maxisorp® Flat Bottom Microtiter® Plates (Fisher, 
Loughborough, UK). The plates were sealed and incubated at room temperature 
overnight. After washing, blocking agent (1% bovine serum albumin [BSA]) was 
added to the wells and incubated for at room temperature to block non-specific 
proteins. The plates were washed again and standards, samples and controls added 
to the wells. The plates were incubated at room temperature. After washing, 
biotinylated antigen-specific antibody (detection antibody) was added to each well 
and incubated at room temperature. After washing and drying, avidin-peroxidase 
conjugate was added to each well and incubated at room temperature for 30 
minutes. After washing and drying, 3,3’,5,5’-tetra-methylbenzidine (TMB, R&D 
systems, Abingdon, UK) was added to each well and the developing optical density 
read at 5 minute intervals using a plate reader (FLUOstar Omega. BMG Labtech, VA, 
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USA) set at 405 nm with a 650nm wavelength correction. A standard curve was 
generated using a four-parameter algorithm to calculate the concentration of the 
cytokines in the samples. The standard curve was obtained by plotting the mean 
absorbance for each standard (x-axis) against the target protein concentration (y-
axis) using Omega Analysis Software. The R2 for the standard curve, which predicts 
the outcome of one value from the other, must be greater than 0.98.  
 
4.3.3 Statistical analysis 
The statistical analyses on the difference in gene expression and the protein release 
from the epithelial cells after the different treatments were performed with 
GraphPad Prism using one-way analysis of variance (ANOVA) with Bonferroni 
correction. One-way ANOVA is a method used to compare means of two or more 
samples with numerical data. The ANOVA tests the null hypothesis that samples in 
two or more groups are drawn from populations with the same mean values 
(Howell, 2002). Bonferroni correction is a method used to counteract the problem 
of multiple comparisons. The problem of multiplicity occurs when there is an 
increase in the number of hypotheses in a test, there is also a likelihood of 
witnessing a rare event, and a chance to reject the null hypotheses when it’s true. 
Bonferroni correction is the most naive way to address this issue (Dunnett, 1955). 
Differences were considered significant if p<0.5. 
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4.4 RESULTS 
4.4.1 IL-8 mRNA expression in epithelial cells stimulated with P. gingivalis 
biofilms or planktonic cells. IL-8 release is a key function of epithelial cells, 
promoting neutrophil recruitment and activation (Tonetti et al., 1994). Therefore, 
this chemokine was investigated initially as a likely candidate for demonstrating 
epithelial cell regulation. To investigate the variability of IL-8 production of 
epithelial cells co-cultured with bacterial biofilms or planktonic cells, OKF6-TERT2 
epithelial cells were challenged with both live or dead (heat-killed) P. gingivalis 
biofilms and planktonic cells for 4 and 24 h. IL-8 mRNA expression was assessed by 
SYBR Green real time reverse-transcriptase PCR. Gene expression was normalised 
to GAPDH endogenous control. Data presented as fold change in gene expression 
relative to OKF6-TERT2 cells cultured only with cell culture medium (‘medium 
control’). Statistical analyses were performed by one-way ANOVA with Bonferoni 
correction using GraphPad Prism (San Diego, CA, USA). Differences were considered 
significant if p<0.5. 
 
Live P. gingivalis biofilm (4 h: ~61-fold vs medium control; 24 h: ~32-fold vs 
medium control) induced greater levels of IL-8 expression compared with live 
planktonic cells (4 h: ~2-fold vs medium control; 24 h: ~13-fold vs medium control). 
Dead biofilms and planktonic cells induced minimal changes in the IL-8 expression 
(maximal ~10-fold increase vs medium control) (Figure 4.2). To conclude, P. 
gingivalis biofilms induce more IL-8 expression than the planktonic cells.  
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Figure 4.2: IL-8 mRNA expression in OKF6-TERT2 epithelial cells challenged with 
live or dead (heat-killed) P. gingivalis biofilms or planktonic cells. OKF6-TERT2 
epithelial cells were challenged with P. gingivalis biofilm and planktonic cells for 4 
and 24 h. mRNA expression was assessed by SYBR Green real time PCR for IL-8. 
Gene expression was normalised to GAPDH endogenous control. Data shown are 
gene expression as fold change relative to medium control. 
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4.4.2 Expression of a panel of gingivitis-related genes in epithelial cells 
stimulated with P. gingivalis biofilms or planktonic cells. Marked changes in IL-8 
expression were observed following stimulation with the bacterial biofilms. To 
investigate the effect of P. gingivalis biofilms or planktonic cells on a broader 
spectrum of the epithelial cell inflammatory armamentarium, expression of a panel 
of gingivitis related genes was next investigated (gene functions described in Table 
4.1. The studies in the preceding section (4.4.1) were extended to include analysis 
of a larger panel of genes (NFB, PROK2, CSF3, ITGB2, IL-1α, CCL5, IL-1β, CXCL3, 
CCL3L3, CX3CR1, S100A8, CCL4, CXCL10, CXCL11, TNFα, CSF2, GROα, IL-6, ICAM1, 
DEFB4, CXCL5 and TBP). Gene expression was assessed by TaqMan low-density 
array (TLDA). Gene expression was normalised to GAPDH endogenous control and 
then data expressed as fold change relative to OKF6-TERT2 cells cultured only with 
cell culture medium. Bacterial biofilm co-culture with epithelial cells resulted in 
little change in gene expression of CXC3R1, CCL3L1, CCL4, ICAM1, ITGB2, S100A8, 
DEFB4, NFκB, and PROK2 (Figure 4.3 A & B). 
 
Minimal changes in chemokine gene expression were observed with both dead P. 
gingivalis biofilm and planktonic cells after 4 and 24 h, compared with medium 
control. Some chemokine gene expression was observed with live P. gingivalis 
planktonic cells after 24 h only. Similar to the observed effects on IL-8, a greater 
increase of CXCL1, CXCL3, CXCL5, CXCL10, CXCL11, CCL5 and IL-8 mRNA expression 
was observed following co-culture with live P. gingivalis biofilm compared with 
planktonic cells after 4 and 24 h (Figure 4.3 A & B). CXCL1 expression was greater 
following stimulation with live biofilms (~13-fold vs medium control) compared with 
planktonic cells (~1-fold vs medium control) after 4 h. Overall, epithelial cell 
chemokine gene expression was greater following co-culture with the biofilms 
compared with the planktonic cells.  
 
Similar to the chemokine expression, minimal changes were observed with live and 
dead P. gingivalis planktonic cells, and dead P. gingivalis after 4 and 24 h. The 
expression of IL-1α, IL-1β, IL-6, CSF2 and TNF-α were elevated following co-culture 
with the live P. gingivalis biofilms compared with planktonic cells after 4 and 24 h 
(Figure 4.3 A & B). Overall, inflammatory cytokine mRNA expression in epithelial 
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cells was increased more following stimulation with biofilms compared with 
planktonic cells. 
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 (A) P. gingivalis biofilm 
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(B) P. gingivalis planktonic 
 
 
Figure 4.3: Expression of a panel of gingivitis-related genes in epithelial cells 
with P. gingivalis biofilms or planktonic cells. OKF6-TERT2 epithelial cells were 
challenged with (A) P. gingivalis biofilm and (B) P. gingivalis planktonic cells for 4 
and 24 h. mRNA expression were assessed by TLDA for gingivitis-related genes 
(NFκB, PROK2, CSF3, ITGB2, IL-8, IL-1α, CCL5, IL-1β, CXCL3, CCL3L3, CX3CR1, 
S100A8, CCL4, CXCL10, CXCL11, TNFα, GM-CSF, GROα, IL-6, ICAM1, DEFB4, CXCL5). 
Gene expression was normalised to GAPDH endogenous control. Data shown are 
gene expression as fold change relative to medium control.  
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4.4.3 IL-8 mRNA expression in epithelial cells stimulated with mixed and mono-
species bacterial biofilms. The data presented above demonstrate that P. 
gingivalis biofilms induced greater levels of chemokine and cytokine mRNA 
expression in epithelial cells than planktonic cells. To investigate i) time-
dependant, ii) live versus dead, and iii) pathogen versus commensal variability of 
IL-8 production by epithelial cells co-cultured with more bacterial biofilms, OKF6-
TERT2 epithelial cells were challenged with live or dead (methanol-fixed) multi- or 
mon-species biofilms (multi: P. gingivalis, F. nucleatum, A. actinomycetemcomitans 
and S. mitis), P. gingivalis biofilm, and S. mitis biofilm for 1, 2, 4, 6, 8, 12, 18, 24 
and 48 h. IL-8 mRNA expression was assessed by SYBR Green real time RT-PCR. 
Gene expression was normalised to GAPDH endogenous control. Data shown are 
gene expression as fold change relative to OKF6-TERT2 cells cultured only with cell 
culture medium (‘medium control’).  
 
(i) Time-dependent regulation of IL-8. Live and dead multi-species biofilms 
induced time dependent up-regulation of IL-8 mRNA. Elevated IL-8 mRNA expression 
was evident after 6 h (~200-fold) and there was a continued modest increase in IL-8 
mRNA expression until 24 h (~1250-fold). IL-8 mRNA expression remained constant 
from 24 to 48 h (Figure 4.4A), suggesting the maximal response was reached by 24 
h. There were similar changes in IL-8 mRNA expression upon stimulation with live P. 
gingivalis biofilm (Figure 4.4B). Live S. mitis biofilm induced somewhat erratic 
changes in IL-8 mRNA expression. The IL-8 mRNA expression was increased after 2 h 
(~150-fold), decreased after 4 h (~3-fold), increased again after 6 h (~125-fold) and 
decrease again after 8 h (~65-fold) (Figure 4.4C). These data demonstrate that IL-8 
mRNA expression is regulated over time, and that this regulation varies depending 
on the nature of the biofilm to which the cells are exposed.  
 
(ii) IL-8 mRNA expression upon co-culture with live versus dead biofilms. Live 
mixed biofilm induced similar IL-8 mRNA expression compared with dead mixed 
biofilm (Figure 4.4A). IL-8 mRNA expression was elevated following stimulation with 
live, but not dead P. gingivalis nor live S. mitis biofilm. Stimulation with dead P. 
gingivalis or S. mitis biofilms resulted in minimal changes in IL-8 mRNA expression 
compared with medium control (maximal ~19-fold for P. gingivalis) (Figure 4.4B & 
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C). To conclude, live bacterial biofilms induce more IL-8 expression than dead 
biofilms. 
 
(iii) IL-8 mRNA expression following co-culture with pathogenic or commensal 
biofilms. The pathogenic P. gingivalis or multi-species biofilms elicited more IL-8 
expression than the commensal biofilm (Figure 4.4). Only the live P. gingivalis 
biofilm caused increased IL-8 mRNA expression. This demonstrates that pathogens 
and commensals differentially regulate IL-8 expression in epithelial cells. 
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Mixed 
P. gingivalis 
S. mitis 
(A) 
(B) 
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Figure 4.4: IL-8 mRNA expression in OKF6-TERT2 epithelial cells challenged with 
live and methanol-fixed (dead) bacterial biofilms. OKF6-TERT2 epithelial cells 
were challenged with (A) mixed biofilm (P. gingivalis, F. nucleatum, A. 
actinomycetemcomitans and S. mitis), (B) P. gingivalis biofilm and (C) S. mitis 
biofilm for 1, 2, 4, 6, 8, 12, 18, 24 and 48 h. mRNA expression was assessed by 
SYBR Green real time PCR for IL-8. Gene expression was normalised to GAPDH 
endogenous control. Data shown are gene expression as fold change relative to 
medium control.  
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4.4.4 Expression of a panel of gingivitis-related genes in epithelial cells with 
multi- or mono-species biofilms. Marked changes in IL-8 expression were observed 
following stimulation with different biofilms. To investigate the biofilm effect on a 
broader spectrum of the epithelial cell inflammatory armamentarium, expression of 
a panel of gingivitis related genes was next investigated (gene panel selection 
described in Table 4.1). The studies in section 4.4.3 were extended to include 
analysis of a larger panel of genes (NFκB, PROK2, CSF3, ITGB2, IL-8, IL-1α, CCL5, IL-
1β, CXCL3, CCL3L3, CX3CR1, S100A8, CCL4, CXCL10, CXCL11, TNFα, GM-CSF, GROα, 
IL-6, ICAM1, DEFB4, CXCL5 and TBP). Gene expression was assessed by TaqMan 
low density array (TLDA). Gene expression was normalised to GAPDH endogenous 
control and then data expressed as fold change relative to OKF6-TERT2 cells 
cultured only with cell culture medium. Bacterial biofilm co-culture with epithelial 
cells resulted in little measurable gene expression of CXC3R1, CCL3L1, CCL4, 
ICAM1, ITGB2, S100A8, DEFB4, NFκB, and PROK2.  
 
(i) Time-dependent regulation of genes. The kinetics of chemokine and cytokine 
gene regulation was investigated in epithelial cells co-cultured with bacterial 
biofilms. Similar to the effects on IL-8, there was time dependent upregulation of 
CXCL1 and CXCL3 following co-culture with live mixed species biofilm and P. 
gingivalis biofilm (Figure 4.5A & B; 4.6 A, B & D).  
 
Inflammatory cytokines, IL-1α, IL-1β, IL-6, GM-CSF and TNFα, were upregulated in a 
time-dependant manner following co-culture with live multi-species biofilm from 1 
to 6 h (Figure 4.5A; 4.6 E, F, G, I & J). For instance, TNFα gene expression 
increased from 6.54 fold after 1 h, then 60.85 fold and 129.56 fold after 4 and 6 h, 
respectively (Figure 4.5A; 4.6J). Live P. gingivalis biofilms induced mRNA 
upregulation of all cytokines analysed from 1 to 4 h in a time-dependent manner 
(Figure 4.5B; 4.6 E-J). After 6 h, there were minimal changes in cytokine gene 
expression indicating an early transcriptional upregulation following co-culture with 
the P. gingivalis biofilm. Thus, a range of inflammatory chemokines and cytokines 
are regulated in a time-dependent manner in the epithelial cells co-cultured with 
bacterial biofilms.   
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ii) Gene expression upon stimulation with live versus dead biofilms. Similar to 
the observed effects on IL-8, a greater increase in CXCL1 and CXCL3 mRNA 
expression was observed following co-culture with live mixed species biofilm 
compared with dead biofilms after 4, 6 and 24 h (Figure 4.5A & B; 4.6A, B & D). 
There was elevated expression of CXCL1, CXCL3, CXCL5, CXCL10, CXCL11, CCL5 and 
IL-8 following co-culture with live compared with dead P. gingivalis biofilm after 4 
and 6 h (Figure 4.5B; 4.6A-D). Live S. mitis biofilms induced more CXCL1, CXCL3, 
CXCL10, CXCL11, CCL5 and IL-8 gene expression after 6 and 24 h compared with 
dead biofilms (Figure 4.5C; 4.6A-D). Overall, epithelial chemokine gene expression 
was greater following co-culture with live biofilms compared with dead. 
 
The expression of IL-1α, IL-1β, IL-6, CSF2 and TNFα was elevated following co-
culture with live mixed species and P. gingivalis biofilms compared with dead after 
4, 6 and 24 h (Figure 4.5A & B; 4.6E, F, G, I & J). CSF3 expression was increased by 
co-culture with live mixed and P. gingivalis biofilm only after 4 and 24 h, as no 
detectable expression was observed after 6 h (Figure 4.6H). Live S. mitis biofilms 
induced a greater increase in expression of IL-1α, IL-1β, IL-6, CSF2 and TNFα after 6 
and 24 h compared with dead biofilm (Figure 4.5C; 4.6E, F, G, I & J). Overall, 
inflammatory cytokine mRNA expression was increased more with live biofilms 
compared with dead. 
 
iii) Gene expression following co-culture with pathogenic or commensal 
biofilms. Chemokine and cytokine mRNA expression was investigated to evaluate 
differences in the epithelial cell response to pathogenic (multi-species and P. 
gingivalis) or commensal (S. mitis) biofilms. 
 
Co-culture with pathogenic biofilms induced more CXCL1, CXCL3, CXCL5, CXCL10, 
CXCL11, CCL5 and IL-8 expression than co-culture with commensal biofilm after 4 h 
(Figure 4.5A, B & C; 4.6A-D). Interestingly, pathogenic mono-species P. gingivalis 
biofilm induced generally greater chemokine expression than the mmulti-species 
biofilm; only CXCL3 expression was greater following stimulation with the mixed 
biofilm compared with P. gingivalis biofilm.  
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Increased cytokine mRNA expression (IL-1α, IL-1β, IL-6, CSF2 and TNFα) was 
observed following co-culture with the pathogenic biofilms compared with 
commensal biofilm after 4 h (Figure 4.5A, B & C; 4.6E, F, G, I & J). P. gingivalis 
induced greater IL-1α and IL-6 expression than the mixed biofilm. Overall, 
pathogenic biofilms show a greater propensity to increase mRNA expression of 
numerous chemokines and cytokines than commensal biofilms. 
 
  
  128
 (A) Multi-species biofilm 
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(B) P. gingivalis biofilm 
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(C) S. mitis biofilm 
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Figure 4.5: Expression of a panel of gingivitis-related genes in epithelial cells 
with multi- or mono-species biofilms. OKF6-TERT2 epithelial cells were challenged 
with (A) multi-species biofilm (P. gingivalis, F. nucleatum, A. 
actinomycetemcomitans and S. mitis), (B) P. gingivalis biofilm and (C) S. mitis 
biofilm for 1, 4, 6 and 24 h. mRNA expression was assessed by TLDA for gingivitis-
related genes (NFκB, PROK2, CSF3, ITGB2, IL-8, IL-1α, CCL5, IL-1β, CXCL3, CCL3L3, 
CX3CR1, S100A8, CCL4, CXCL10, CXCL11, TNFα, GM-CSF, GROα, IL-6, ICAM1, DEFB4, 
CXCL5). Gene expression was normalised to GAPDH endogenous control. Data shown 
are gene expression as fold change relative to medium control. These graphs show a 
global view of the data, which includes all the inflammatory cytokine genes 
expressed by the epithelial cells after co-culture with the different biofilm 
conditions at all the time points tested. 
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(A) CXCL1 
 
(B) CXCL3 
 
(C) CXCL5 
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(D) IL-8 
 
(E) IL-1α 
 
(F) IL-1β 
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(G) IL-6 
 
(H) CSF3 
 
(I) CSF2 
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(J) TNFα 
 
Figure 4.6: Kinetics of mRNA expression in OKF6-TERT2 epithelial cells 
challenged with live and dead (methanol-fixed) bacterial biofilms. OKF6-TERT2 
epithelial cells were challenged with multi-species biofilm (P. gingivalis, F. 
nucleatum, A. actinomycetemcomitans and S. mitis), P. gingivalis biofilm, S. mitis 
biofilm for 1, 4, 6 and 24h. mRNA expression were assessed by TLDA for gingivitis-
related genes (A) CXCL1, (B) CXCL3, (C) CXCL5, (D) IL-8, (E) IL-1 α, (F) IL-1 β, (G) 
IL-6, (H) G-CSF, (I) GM-CSF and (J) TNF-α. Gene expression was normalised to 
GAPDH endogenous control. Data shown are gene expression as fold change relative 
to unstimulated control cells. These graphs represent the same data as in Figure 4.6 
but are presented as changes in individual genes. 
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The gene expression profiles of the epithelial cells challenged with the bacteria can 
be summarised from the heat map shown in Figure 4.7. Greater levels of gene 
expression are shown in red and lower levels of gene expression in green. In the 
right hand panel of the heat map, within the yellow box, the two left hand columns 
are the unstimulated cells. What is somewhat surprising is that there is some 
cytokine and chemokine gene regulation but not as much as might be expected 
compared with the unstimulated cells. This panel consists of epithelial cells 
stimulated with commensal bacteria (in either biofilm or planktonic state) or 
stimulated with pathogenic bacteria such as P. gingivalis in a planktonic state. 
However, the left hand panel of the heat map, within the blue box, shows striking 
changes in gene expression, i.e. a range of chemokines and cytokines are 
upregulated by the epithelial cells when these pathogens were presented to the 
cells as a biofilm. 
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Figure 4.7: mRNA expression in OKF6-TERT2 epithelial cells challenged with live 
and dead (methanol-fixed) bacterial biofilms. OKF6-TERT2 epithelial cells were 
challenged with live and dead (methanol-fixed) multi-species biofilm (P. gingivalis, 
F. nucleatum, A. actinomycetemcomitans and S. mitis), P. gingivalis biofilm, S. 
mitis biofilm and P. gingivalis planktonic cells. mRNA expression was assessed by 
TLDA for gingivitis-related genes (NFκB, PROK2, CSF3, ITGB2, IL-8, IL-1α, CCL5, IL-
1β, CXCL3, CCL3L3, CX3CR1, S100A8, CCL4, CXCL10, CXCL11, TNFα, GM-CSF, GROα, 
IL-6, ICAM1, DEFB4, CXCL5). Gene expression was normalized to GAPDH endogenous 
control. The gene expression is presented as heat maps, which graphically display 
results of hierarchical clustering based on the ΔCT values using Pearson’s 
Correlation, showing a global view of the average linkage of the various genes of 
duplicate measurements of two independent experiments. The x-axis represents 
the different bacterial conditions used to stimulate the epithelial cells. The y-axis 
represents the gingivitis-related genes that were expressed after stimulation with 
the different bacterial conditions. Each square represents the expression of one of 
the genes on the y-axis to the corresponding bacterial condition on the x-axis. The 
brighter the shade of red, the greater the up-regulation of the genes. The brighter 
the shade of green, the greater the down-regulation of the genes.  
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4.4.5 IL-8 release from epithelial cells stimulated with bacterial biofilms or 
planktonic cells. IL-8 mRNA expression was increased in epithelial cells co-cultured 
with P. gingivalis biofilms compared with planktonic cells (Section 4.4.1). To 
investigate whether this change in gene expression translated to protein expression 
and release, epithelial cells were co-cultured with bacterial biofilms and planktonic 
cells. OKF6-TERT2 epithelial cells were challenged with live and dead (heat-killed) 
P. gingivalis biofilms and planktonic cells for 4 and 24 h. IL-8 release from the 
epithelial cells was assessed by ELISA. Statistical analyses were performed by one-
way ANOVA using GraphPad Prism program (San Diego, CA, USA) with the 
Bonferonni correction. Bonferonni correction was used because many different data 
sets were being compared simultaneously. Differences were considered significant 
if p<0.05. 
 
Minimal changes in IL-8 release were observed after 4 h culture with dead P. 
gingivalis planktonic bacteria, or live P. gingivalis biofilm or planktonic cells co-
cultured for 4 and 24 h. IL-8 protein release was significantly increased in cell 
culture supernatants of epithelial cells stimulated with dead P. gingivalis biofilms 
after 4 (p<0.01) and 24 h (p<0.001) compared with medium controls. Dead P. 
gingivalis biofilms induced significantly more IL-8 release after 4 (308 pg/mL, 
p<0.001) and 24 h (962 pg/mL, p<0.001) compared with planktonic cells at the 
same time points, 4 (43 pg/mL) and 24 h (63 pg/mL) (Figure 4.8). To conclude, P. 
gingivalis biofilms induce more IL-8 release than the planktonic cells.  
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Figure 4.8: IL-8 release from OKF6-TERT2 epithelial cells challenged with live 
and dead (heat-killed) P. gingivalis biofilms and planktonic cells. OKF6-TERT2 
epithelial cells were challenged with P. gingivalis biofilms or planktonic bacteria for 
4 and 24 h. IL-8 release was assessed by ELISA. Data shown are protein 
concentrations in pg/mL. Values are means ± SEM of triplicate measurements of 
two independent experiments. Statistical comparisons are to the medium control 
and biofilms versus planktonic cells (**p<0.01, ***p<0.001).  
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4.4.6 Chemokine and cytokine release from epithelial cells co-cultured with 
bacterial biofilms or planktonic bacteria. The previous studies demonstrate 
changes in the IL-8 protein release were observed following stimulation with the 
bacterial biofilms. Biofilms induced expression of numerous cytokine and chemokine 
genes and therefore to investigate the biofilm and planktonic effect on a range of 
gingivitis-related proteins, these studies were extended to include analysis of 
protein products of a number of the upregulated genes, including: CXCL1, CXCL10, 
CCL5, IL-1β, IL-6, CSF2, CSF3 and TNF-α). Release of IL-1β, IL-6, IL-8, CSF2, CSF3 
and TNF-α were assessed by Luminex, while CXCL1, CXCL10 and CCL5 were 
assessed by ELISA. Data shown are protein concentrations in pg/mL.  
 
Minimal changes in the release of CCL5 were observed following stimulation with P. 
gingivalis biofilms and planktonic bacteria after 4 and 24 h. CXCL10 release 
remained constant with P. gingivalis biofilms and planktonic cells after 4 and 24 h. 
Similar to the observed effects on IL-8, greater increase of CXCL1 release was 
observed following co-culture with dead P. gingivalis biofilm (4 h: 1334 pg/mL; 24 
h: 1768 pg/mL) compared with planktonic cells after 4 (1029 pg/mL) and 24 h (904 
pg/mL) (Figure 4.9A & B). Overall, the chemokine protein release was greater 
following co-culture with biofilms compared with the planktonic bacteria in the 
epithelial cells.  
 
The inflammatory cytokine protein release from the epithelial cells was minimal 
with the planktonic cells after 4 and 24 h. Similarly, IL-1β, GM-CSF and TNFα 
protein release was minimal with the biofilms. Marginally higher protein release of 
IL-6 and G-CSF was observed from epithelial cells co-cultured with biofilms 
compared with planktonic cells (Figure 4.9A & B). To conclude, inflammatory 
cytokine protein release was marginally increased with the biofilms compared with 
the planktonic cells. To summarise, biofilms induce more protein release compared 
with planktonic cells in the epithelial cells. Interestingly, more protein release was 
observed with dead P. gingivalis compared with live.  
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(A) P. gingivalis biofilm 
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(B) P. gingivalis planktonic 
 
Figure 4.9: Protein release of a panel of gingivitis-related proteins in epithelial 
cells with bacterial biofilms. OKF6-TERT2 epithelial cells were challenged with (A) 
P. gingivalis biofilm & (B) P. gingivalis planktonic cells for 4 and 24 h. Protein 
release of IL-1β, IL-6, IL-8, GM-CSF, G-CSF and TNFα in the cell culture 
supernatants was assessed by Luminex while CXCL1, CXCL10 and CCL5 were 
assessed by ELISA. Data shown are protein concentrations in pg/mL. Values are 
means ± SEM of two independent experiments.  
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4.4.7 Protein release of IL-8 in epithelial cells stimulated with bacterial 
biofilms. The characteristics and advantages of using IL-8 have been described 
previously. It was also noted that the biofilms induced greater protein release than 
the planktonic cells in the epithelial cells. To investigate the time-dependant, live 
versus dead and pathogen versus commensal variability of IL-8 protein release from 
the epithelial cells with more gingivitis-related bacterial biofilms, OKF6-TERT2 
epithelial cells were challenged with live and dead (methanol-fixed) multi-species 
biofilm (P. gingivalis, F. nucleatum, A. actinomycetemcomitans and S. mitis), P. 
gingivalis biofilm, S. mitis biofilm for 1, 2, 4, 6, 8, 12, 18, 24, 48 and 72 h. Protein 
release of IL-8 was assessed by ELISA. Data shown are protein concentrations in 
pg/mL.  
 
(i) Time-dependent release of IL-8. Live multi-species and P. gingivalis biofilms 
induced time-dependent IL-8 release from the epithelial cells. Time-dependent 
increase of IL-8 was observed with dead mixed species biofilm from 8 to 18 h, after 
which it remained stable. IL-8 concentration was 121, 311 and 732 pg/mL after 8, 
12 and 18 h, respectively. Dead P. gingivalis and S. mitis induced somewhat erratic 
changes in IL-8 protein release (Figure 4.10A, B & C). These data suggest that IL-8 
protein release is regulated over time but the regulation varies depending on the 
nature of the biofilm to which the cells are exposed.  
 
(ii) IL-8 protein release upon co-culture with live versus dead biofilms. Live 
mixed biofilm induced similar IL-8 protein release with dead mixed biofilm (Figure 
4.10A). IL-8 protein release was higher following stimulation with live (12 h: 314 
pg/mL; 18 h: 204 pg/mL), but not dead P. gingivalis (12 h: 86 pg/mL; 18 h: 87 
pg/mL) nor dead S. mitis biofilm (12 h: 95 pg/mL; 18 h: 43 pg/mL). Elevated IL-8 
concentrations were observed with live S. mitis biofilm compared with dead Figure 
4.10B & C). To conclude, live bacterial biofilms induce marginally more IL-8 protein 
release than dead biofilms. 
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(iii) IL-8 protein release following co-culture with pathogenic or commensal 
biofilms. The protein release of IL-8 was investigated to evaluate differences in the 
epithelial cell response to pathogenic (multi-species and P. gingivalis) or 
commensal (S. mitis) biofilms. The pathogenic dead mixed species biofilms elicited 
more IL-8 protein release than the dead pathogenic monospecies biofilm and 
commensal biofilm (Figure 4.10). This demonstrates that pathogens differentially 
regulate IL-8 protein release in epithelial cells, and this depends on the type of 
pathogenic biofilm.  
 
IL-8 ELISA on the cell culture supernatants was useful in determining that the 
epithelial cells were releasing proteins upon co-culture with bacterial biofilms. This 
also showed that the protein release occurred in a time-dependant manner, and 
also showed the live versus dead and pathogen versus commensal variability.  
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(A) Mixed 
(B) P. gingivalis 
(C) S. mitis 
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Figure 4.10: Protein release of IL-8 in OKF6-TERT2 epithelial cells challenged 
with live and methanol-fixed (dead) bacterial biofilms. OKF6-TERT2 epithelial 
cells were challenged with (A) multi-species biofilm (P. gingivalis, F. nucleatum, A. 
actinomycetemcomitans and S. mitis), (B) P. gingivalis biofilm and (C) S. mitis 
biofilm for 1, 2, 4, 6, 8, 12, 18, 24, 48 and 72 h. Protein concentrations of IL-8 in 
the cell culture supernatants were measured by ELISA. Data shown are protein 
concentrations in pg/mL. Values are means ± SEM of duplicate measurements of 
two independent experiments.  
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4.4.8 Protein release in epithelial cells stimulated with bacterial biofilms on 
multiplex protein array. For a quick and easy evaluation of cytokines and 
chemokines in the cell culture supernatants of epithelial cells with bacterial 
biofilms, Proteome ProfilerTM antibody arrays (RnD systems, Inc, UK) were used. 
OKF6-TERT2 epithelial cells were challenged with medium, multi-species biofilm (P. 
gingivalis, F. nucleatum, A. actinomycetemcomitans and S. mitis) (Mix), P. 
gingivalis biofilm (Pg) and S. mitis biofilm (Sm) for 24 h. The cell culture 
supernatants were used in the human cytokine array. The cell culture supernatants 
were mixed with a cocktail of biotinylated detection antibodies, and then 
incubated with the human cytokine array. The array was then incubated with 
streptavidin-HRP followed by chemiluminescent detection. Light was emitted at 
each spot in proportion to the amount of cytokine bound. Array images shown are 
from 5 min exposures to X-ray film (Figure 4.12). The densitometry analysis was 
performed on X-ray film using the Quantity One® 1-D Analysis Software (Gel Doc™, 
BioRad) by calculating the adjusted volume of the spots from the pixel density after 
subtracting from the background (Supplementary Figure). Data was also 
represented as heat map of the protein concentration as fold change relative to 
medium control (Table 4.3). 
 
The chemokines, cytokines and acute phase proteins which were present in the cell 
culture supernatants of the epithelial cells co-cultured with the bacterial biofilms 
appeared as duplicate spots on the X-ray films. When densitometry analysis was 
performed on the X-ray films, the adjusted volume of the spots of IL-1α and IL-1β 
were observed more with live P. gingivalis compared with dead (Figure 4.11). 
Similar IL-1 ra volume was observed with live and dead mixed species and P. 
gingivalis biofilms. Only live S. mitis biofilms induced increased IL-1 ra volume 
compared with dead (Figure 4.11). IL-6 protein appeared on the X-ray films only in 
the supernatants of epithelial cells challenged with dead S. mitis biofilm (Figure 
4.11). Dead mixed species (3657 pixel intensity/mm2), P. gingivalis (559 pixel 
intensity/mm2) and S. mitis biofilms (3412 pixel intensity/mm2) induced more IL-8 
protein volume on the X-ray films compared with live mixed species (2039 pixel 
intensity/mm2), P. gingivalis (0 pixel intensity/mm2) and S. mitis (0 pixel 
intensity/mm2) biofilm (Figure 4.11). Marginally more sICAM1 and G-CSF protein 
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volumes were observed with live P. gingivalis biofilms compared with the dead 
biofilms, while dead mixed species biofilms induced more volume of the same 
proteins compared with live (Figure 4.11). Increase GM-CSF volumes were observed 
on the X-ray films with the dead mixed species, P. gingivalis and S. mitis biofilms 
compared with live (Figure 4.11). Serpin E1 and MIF volumes were higher with 
medium control compared with the bacterial biofilms (Figure 4.11).  
 
Data was also represented as heat map of the protein concentration as fold change 
relative to medium control (Table 4.3). The heat map summarises the chemokine 
and cytokine protein volumes in the cell culture supernatants from epithelial cells 
co-cultured with bacterial biofilms. More IL-8, G-CSF, GM-CSF and ICAM1 protein 
concentrations were observed with the dead mixed biofilm compared with the live. 
Dead P. gingivalis biofilms induced more IL-8 protein volume compared to the live 
biofilms.  IL-1 α, IL-6, IL-8 G-CSF and GM-CSF protein volumes were increased more 
with dead S. mitis compared to live. To conclude, dead bacterial biofilms induce 
more cytokine and chemokine release from the epithelial cells compared with live.  
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Figure 4.11: Human cytokine array of proteins from epithelial cells challenged 
with live and methanol-fixed (dead) bacterial biofilms. OKF6-TERT2 epithelial 
cells were challenged with media, multi-species biofilm (P. gingivalis, F. 
nucleatum, A. actinomycetemcomitans and S. mitis) (Mix), P. gingivalis biofilm (Pg) 
and S. mitis biofilm (Sm) for 24 h. The cell culture supernatants were mixed with a 
cocktail of biotinylated detection antibodies, and then incubated with the human 
cytokine array. The array was then incubated with streptavidin-HRP followed by 
chemiluminescent detection. Light was emitted at each spot in proportion to the 
amount of cytokine bound. Array images shown are from 5 min exposures to X-ray 
film.  
 
Media
Mix Live
Mix Dead
Pg Live
Pg Dead
Sm Live
Sm Dead
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Table 4.3: Densitometry analysis of human cytokine array of proteins from 
epithelial cells challenged with live and dead (methanol-fixed) bacterial 
biofilms. OKF6-TERT2 epithelial cells were challenged with media, muti-species 
biofilm (P. gingivalis, F. nucleatum, A. actinomycetemcomitans and S. mitis) (Mix), 
P. gingivalis biofilm (Pg) and S. mitis biofilm (Sm) for 24 h. The cell culture 
supernatants were mixed with a cocktail of biotinylated detection antibodies, and 
then incubated with the human cytokine array. The array was then incubated with 
streptavidin-HRP followed by chemiluminescent detection. Light was emitted at 
each spot in proportion to the amount of cytokine bound. Arrays were exposed to 
the X-ray film for 5 minutes. The densitometry analysis was performed on X-ray film 
using the Quantity One® 1-D Analysis Software (Gel Doc™, BioRad) by calculating the 
pixel density after subtracting from the background. Data is represented as heat 
map of the protein concentration as fold change relative to unstimulated control 
cells represented as 1.  
↓↓↓↓↓↓Serpin E1
↓↓↓↑↓↑MIF
↑↑↑sICAM-1
↓↓↓↓↓↓Gro α
↑↑↑↓GM-CSF
↑↑↑↑G-CSF
↑↓↑↓↑↑IL-8
↑IL-6
↓↓↑↑↑↑IL-1 ra
↑↑↑↑IL-1 β
↑↓↑↑↑↑IL-1 α
Sm 
Dead
Sm 
Live
Pg 
Dead
Pg  
Live
Mix 
Dead
Mix 
Live
Fold change
<0.5      0.5-1         1           1-2          2-3         >3
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4.4.9 Protein release of a panel of gingivitis-related proteins in epithelial cells 
with bacterial biofilms. Marked changes in IL-8 protein release were observed 
following stimulation with the different biofilms. To investigate the time-
dependant, live vs dead and pathogen vs commensal variability of protein release of 
the inflammatory cytokines (IL-1β, IL-6, G-CSF, GM-CSF, TNF–α) by the epithelial 
cells with bacterial biofilms, OKF6-TERT2 epithelial cells were co-cultured with live 
and methanol-fixed (dead) mixed species, P. gingivalis and S. mitis biofilms for 1, 
4, 6, 8, 12, 18 and 24 h. Protein release into the cell culture supernatants was 
assessed by Luminex. Bacterial biofilm co-culture with epithelial cells resulted in 
little measurable concentrations of IL-1β, GM-CSF and TNFα in the cell culture 
supernatants.  
 
(i) Time-dependent protein release. Time-dependent regulation of inflammatory 
cytokines was investigated in epithelial cells co-cultured with the bacterial 
biofilms. Similar to IL-8 release, there was time-dependent increase of protein 
concentration of IL-6 in the epithelial cells co-cultured with live and dead mixed 
species biofilms (Figure 4.12A; 4.13A & B; Table 4.4A). Dead mixed species and P. 
gingivalis biofilms induced regulation of IL-6 and G-CSF in a time-dependent 
manner only after 8 h of stimulation suggesting a later translational regulation of 
the proteins (Figure 4.12A & B; 4.13B & C; Table 4.4A & B). These data demonstrate 
that the proteins are regulated over time, and that this regulation varies depending 
on the nature of the biofilm to which the cells are exposed.  
 
(ii) Protein release upon stimulation with live versus dead biofilms. A greater 
increase in IL-8, IL-6 and G-CSF protein concentrations was observed following co-
culture with dead mixed species biofilm compared with live biofilms (Figure 4.12A; 
4.13A-C; Table 4.4A). For instance, after 24 h of stimulation with mixed species 
biofilm induced increased release of IL-8 with dead biofilms (6994 pg/mL) 
compared with live biofilms (602 pg/mL). There was higher IL-8 concentration with 
dead P. gingivalis and S. mitis biofilms compared with live only after 24 h (Figure 
4.12B & C; 4.13A; Table 4.4B & C). The concentration of G-CSF was elevated in 
epithelial cells co-cultured with dead P. gingivalis and S. mitis biofilm only after 24 
h (Figure 4.12B & C; 4.13C; Table 4.4B & C). Overall, the cytokine and chemokine 
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release was increased more with the dead biofilms compared with live in the 
epithelial cells. 
 
(iii) Protein release following co-culture with pathogenic or commensal biofilms. 
The protein release of inflammatory cytokines was investigated to evaluate 
differences in the epithelial cell response to pathogenic (multi-species and P. 
gingivalis) or commensal (S. mitis) biofilms. Increased protein release of IL-8, IL-6 
and G-CSF was observed following co-culture with the pathogenic biofilms 
compared with the commensal biofilms. Furthermore, pathogenic mixed species 
biofilm induced greater cytokine release than the mono-species P. gingivalis biofilm 
(Figure 4.12 & 4.13; Table 4.4). Overall, pathogenic biofilms show a greater 
tendency to increase protein release of the cytokines than commensal biofilms. 
To summarize, the data demonstrated that the chemokine and cytokine protein 
regulation occurred in a time-dependent manner depending on the nature of the 
biofilm. Interestingly, the protein release was increased more with the dead 
biofilms compared with the live biofilms in the epithelial cells. The pathogenic 
biofilms also show a greater propensity to increase protein release than the 
commensal biofilms. 
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(A) Mixed species biofilm 
Cytokine IL-8 IL-1β IL-6 GM-CSF G-CSF 
BIOFILM 
TIME 
L D L D L D L D L D 
1 h 55.99 138.81 0.77 0.77 18.31 58.08 14.26 14.26 32.10 50.92 
4 h 777.91 1896.46 19.11 16.48 275.25 609.16 15.44 41.23 99.15 361.53 
6 h 407.57 568.32 4.74 10.67 113.21 471.12 14.26 36.85 108.48 320.42 
8 h 459.92 1001.44 2.56 10.99 56.79 219.26 14.26 14.26 93.30 208.33 
12 h 661.23 1854.72 2.18 21.56 57.17 498.09 14.26 21.39 129.39 446.57 
18 h 992.20 5750.75 8.37 34.25 135.27 1087.33 14.26 118.42 158.90 1072.69 
24 h 602.52 6994.63 3.73 24.23 194.74 972.22 4.75 87.03 54.68 1543.09 
 
  
  154
 (B) P. gingivalis biofilm 
Cytokine IL-8 IL-1β IL-6 GM-CSF G-CSF 
BIOFILM 
TIME 
L D L D L D L D L D 
1 h 42.49 72.67 0.77 0.77 12.16 29.48 14.26 14.26 32.10 32.10 
4 h 812.62 777.58 5.06 4.56 152.53 211.03 7.14 7.14 85.48 127.39 
6 h 517.10 305.15 11.27 7.92 62.28 181.89 14.26 14.26 197.31 114.68 
8 h 1152.38 307.81 8.78 3.42 148.24 106.92 14.26 14.26 492.67 32.10 
12 h 1013.65 276.99 11.63 3.81 87.57 108.23 21.39 14.26 218.71 83.67 
18 h 600.84 361.10 13.50 6.52 48.80 146.37 14.26 14.26 274.41 124.76 
24 h 310.96 2095.94 5.54 6.75 236.93 265.89 15.44 31.49 277.81 436.45 
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(C) S. mitis biofilm 
Cytokine IL-8 IL-1β IL-6 GM-CSF G-CSF 
BIOFILM 
TIME 
L D L D L D L D L D 
1 h 61.45 82.22 0.77 0.77 19.91 39.36 14.26 14.26 13.27 32.10 
4 h 224.16 372.94 0.36 0.36 67.84 63.19 4.75 4.75 15.75 49.94 
6 h 993.30 254.63 18.87 11.50 586.22 229.76 53.76 14.26 225.38 94.63 
8 h 849.03 306.31 11.93 3.81 337.12 125.93 43.98 14.26 158.90 114.68 
12 h 727.50 486.49 16.38 8.32 473.32 165.20 53.76 14.26 249.39 119.50 
18 h 551.71 230.79 21.89 5.22 574.70 143.47 59.44 14.26 222.36 76.59 
24 h 577.38 1457.35 2.37 0.54 143.62 112.71 4.75 7.14 75.25 150.20 
 
Table 4.4: Protein release in OKF6-TERT2 epithelial cells challenged with live and methanol-fixed (dead) bacterial 
biofilms. OKF6-TERT2 epithelial cells were challenged with (A) mixed biofilm (P. gingivalis, F. nucleatum, A. 
actinomycetemcomitans and S. mitis), (B) P. gingivalis biofilm, (C) S. mitis biofilm for 1, 4, 6, 8, 12, 18 and 24 h. Protein 
concentrations in the cell culture supernatants were measured by Luminex for inflammatory cytokine panel of genes (IL-8, IL-
1 β, IL-6, G-CSF, GM-CSF and TNF-α). Data shown are protein concentrations in pg/mL. Values are means of duplicate 
measurements of two independent experiments. 
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(A) Mixed species biofilm 
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(B) P. gingivalis biofilm 
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(C) S. mitis biofilm 
 
 
Figure 4.12: Protein release in OKF6-TERT2 epithelial cells challenged with 
live and methanol-fixed (dead) bacterial biofilms. OKF6-TERT2 epithelial cells 
were challenged with (A) mixed biofilm (P. gingivalis, F. nucleatum, A. 
actinomycetemcomitans and S. mitis), (B) P. gingivalis biofilm, (C) S. mitis 
biofilm for 4, 12 and 24 h. Protein concentrations in the cell culture 
supernatants were measured by Luminex for inflammatory cytokine panel of 
genes (IL-8, IL-1 β, IL-6, G-CSF, GM-CSF and TNF-α). Data shown are protein 
concentrations in pg/mL. Values are means ± SEM of duplicate measurements of 
two independent experiments. These graphs show a global view of the data 
which includes all the inflammatory cytokine proteins released by the epithelial 
cells after co-culture with the different biofilm conditions at the time points 
tested. 
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 (A) IL-8 
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(B) IL-6 
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(C) G-CSF 
 
 
Figure 4.13: Protein release in OKF6-TERT2 epithelial cells challenged with 
live and methanol-fixed (dead) bacterial biofilms. OKF6-TERT2 epithelial cells 
were challenged with media, multi-species biofilm (P. gingivalis, F. nucleatum, 
A. actinomycetemcomitans and S. mitis), P. gingivalis biofilm and S. mitis 
biofilm for 1, 4, 6, 8, 12, 18 and 24h. Protein concentrations in the cell culture 
supernatants were measured by Luminex for inflammatory cytokine panel of 
genes (A) IL-8, (B) IL-6 and (C) G-CSF. Values are means ± SEM of duplicate 
measurements of two independent experiments. These graphs represent the 
same data as in Figure 4.13, but based on individual proteins. 
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4.5 DISCUSSION 
The current study investigated interactions between oral bacteria and the 
epithelium, aiming to further understand the aetiology and pathogenesis of 
periodontal disease. The epithelial-bacterial biofilm co-culture model created in 
earlier chapters 2 and 3 makes strides in part to successfully recapitulate the 
inflammatory changes in the host (epithelial cells) upon challenge with bacteria 
responsible for periodontal disease. Overall, the current study demonstrated: (i) 
the inflammatory response of the epithelium was different after stimulation 
with pathogenic or commensal bacterial biofilms, (ii) variability in the response 
of the epithelium when stimulated with bacteria in planktonic state compared 
with stimulation with biofilms, and (iii) stimulation of the epithelial cells with 
live or dead bacterial biofilms yielded differential inflammatory response from 
the epithelial cells. 
 
In this study the chemokines, including CXCL1, CXCL3, CXCL5, CXCL10, CXCL11 
and IL-8 were expressed more in the epithelial cells stimulated with pathogenic 
biofilms compared with commensal biofilms. These chemokines are responsible 
for the recruitment of immune cells responsible for innate (neutrophils) and 
adaptive (T cells) immune response to the site of inflammation. For example, IL-
8 acts as a neutrophil chemoattractant aiding in the migration and extravasation 
of neutrophils into the sites of inflammation (Tonetti et al., 1994). Furthermore, 
greater levels of expression of the inflammatory cytokines including IL-1α, IL-1β, 
IL-6, TNF-α, CSF2 (GM-CSF) and CSF3 (G-CSF) was observed when epithelial cells 
were stimulated with pathogenic biofilms compared with commensal biofilms. 
The increased activities of these chemokines and cytokines by the pathogenic 
mixed species and P. gingivalis biofilm compared with the commensal biofilms in 
this model agrees with what other investigators observed (Guggenheim et al., 
2009, Peyyala et al., 2012, Peyyala et al., 2011a). Therefore, the current model 
may have a role to play in studies to understand the effects of host response to 
pathogens and commensals.  
 
Pathogens (mixed species, P. gingivalis) were shown to induce greater 
inflammatory response in the epithelial cells compared with the commensals (S. 
mitis) at the mRNA and protein level, which was time dependant. In the current 
study lower levels of IL-8 production were observed from epithelial cells 
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stimulated by commensal bacteria compared with the pathogens, whereas P. 
gingivalis induced high levels of IL-8. Previous studies have also concluded that 
different dental plaque bacteria induce different host response profiles 
depending on their pathogenic or commensal status (Eberhard et al., 2009, 
Hasegawa et al., 2007, Krisanaprakornkit et al., 2000, Stathopoulou et al., 2010, 
Sliepen et al., 2009). In the study performed by Eberhard et al (2009), IL-8 
mRNA expression was higher when the GECs were stimulated with S. mutans and 
naturally formed multi-species biofilms compared with S. mitis biofilm. Similar 
results were observed for this study where the pathogenic multi-species and 
mono-species biofilms induced greater gene expression in the epithelial cells 
compared with the commensal S. mitis biofilm. It was also shown that 
planktonic S. mitis, S. salivarius and S. sanguinis induced production of IL-8 from 
the epithelial cells and fibroblasts at a similar level to uninfected cells, whereas 
A. actinomycetemcomitans and F. nucleatum induction was significantly higher 
(Sliepen et al., 2009). Moreover, Hasegawa and co-workers (2007) showed that 
S. gordonii, which is a commensal in the oral cavity, induced significantly less 
gingival epithelial cell transcriptome compared with the pathogenic P. gingivalis 
and A. actinomycetemcomitans (Hasegawa et al, 2007). The study also showed 
IL-6 and IL-8 production was induced more by F. nucleatum compared with S. 
gordonii, a stereotypical commensal. In summary, these studies have 
demonstrated that inflammatory mediators produced by the host, depends on 
the pathogenic properties of the bacteria involved.  
 
Biofilm formation is a key pathogenic characteristic of bacteria, particularly 
amongst those residing within the oral cavity (Ramage et al., 2010). It has been 
demonstrated from these studies that the putative periodontal pathogen P. 
gingivalis induces a greater IL-8 response in the epithelium at the mRNA and 
protein level in its biofilm state compared with planktonic bacteria. Previous 
studies have demonstrated differences in the host response to biofilms and 
planktonic bacteria (Daep et al., 2008, Oscarsson et al., 2008, Ramsey and 
Whiteley, 2009, Peyyala et al., 2011a). Oscarsson et al (2008) showed that there 
was enhanced IL-8 production from biofilms compared with planktonic A. 
actinomycetemcomitans. Using a biofilm rather than planktonic bacteria to 
study host-pathogen interaction is more representative with the in vivo situation 
because the periodontal bacteria in the dental plaque exist as complex microbial 
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consortia (Kolenbrander, 2000, Rosan and Lamont, 2000). Lo et al (2009) 
demonstrated that bacterial biofilms, which are dominant within the oral cavity, 
behave in a different manner to planktonic bacteria, as a comparative 
transcriptomic analysis of the P. gingivalis biofilm and planktonic cells revealed 
a difference in the genomic expression between the biofilms and planktonic 
bacteria (Lo et al., 2009). It was shown that several of the putative virulence 
determinants, sialidase (extracellular protease) and ADP-heptose-LPS 
heptosyltransferase (thiol protease), were up-regulated in biofilms compared to 
planktonic bacterial cells. Also, the transcriptomic profiling indicated a biofilm 
phenotype of slow growth rate and reduced metabolic activity. The altered gene 
expression profiles observed herein and elsewhere reflect the adaptive response 
of P. gingivalis to survive in a mature biofilm.  
 
Studying host-pathogen interaction using bacterial biofilms instead of planktonic 
bacteria is more representative to the in vivo situation. At initiation of this 
thesis work no published studies existed that specifically investigated the host-
pathogen interaction using a multi-species biofilm model at an orally relevant 
interface. However, subsequently several studies have appeared in the literature 
(Guggenheim et al., 2009, Guggenheim et al., 2001b, Peyyala et al., 2011a, 
Peyyala et al., 2012). These groups independently reported the creation of 
multi-species biofilm systems specifically created to model the oral epithelial 
inflammatory response. Peyyala and colleagues (2012) reported the use of 
planktonic, mono- and multi-species (3) biofilms containing Streptococcus 
sanguinis, Streptococcus oralis, Streptococcus gordonii, Actinomyces naeslundii, 
Fusobacterium nucleatum, and Porphyromonas gingivalis on rigid gas-permeable 
contact lenses. Challenge of OKF4 epithelial cells for up to 24h from planktonic 
or biofilm forms of these species induced Gro-1α, IL1α, IL-6, IL-8, TGFα, 
Fractalkine, MIP-1α, and IP-10. Interestingly, in agreement with this study herein 
P. gingivalis biofilms significantly inhibited the production of inflammatory 
mediators. Moreover, oral streptococcal species in both biofilms and planktonic 
forms showed poor stimulation, as did our study. This study did not however 
appear to monitor cell survival or bacterial parameters within the biofilm, and it 
was limited to only 3-species within the biofilm. Guggenheim and colleagues also 
produced a model was based on the Zurich biofilm model (Guggenheim et al., 
2004). This 9-species sub-gingival biofilm model was shown to invoke apoptosis 
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of cells, and trigger the release of pro-inflammatory mediators, whilst degrading 
cytokines through biofilm-specifically generated enzymes. Whilst this group 
undertook a detailed systematic approach to evaluating the effect of the biofilm 
on primary gingival epithelial cells, they did not provide a direct comparison to 
planktonic and mono-species biofilms, thus limiting the interpretation of the 
role of each bacteria within the biofilm.  
 
The selection of bacterial species within the biofilm plays a key role in defining 
the immune response. Interestingly, the dead bacterial biofilms induced greater 
chemokine and cytokine release from the epithelial cells compared with the live 
biofilms. Conversely, live bacterial biofilms induced greater chemokine and 
cytokine mRNA expression in epithelial cells compared with dead biofilms. 
Therefore, transcription and translation of inflammatory mediators was not 
consistent. This study and other studies have shown that periodontal pathogen 
bacteria, especially P. gingivalis, induce transcriptional up-regulation of 
chemokine and cytokine expression in the epithelial cells, but often 
inflammatory mediators are modulated downstream (Guo et al., 2008). P. 
gingivalis has been shown to inhibit IL-8 accumulation at two levels: (i) IL-8 
degradation by proteinases and (ii) IL-8 regulation by unidentified factors 
(Darveau et al., 1998, Mikolajczyk-Pawlinska et al., 1998, Huang et al., 2001, 
Zhang et al., 1999). P. gingivalis gingipains may play a vital role in the evasion 
of host defenses by disrupting cytokine signalling networks (Andrian et al., 
2006). Gingipains cleave and degrade most pro-inflammatory cytokines, 
including IL-1 β (Fletcher et al., 1997), IL-6 (Banbula et al., 1999), TNF-α 
(Calkins et al., 1998), and IL-8 (Mikolajczyk-Pawlinska et al., 1998, Zhang et al., 
1999). Killing P. gingivalis by methanol-fixation would have essentially 
immobilized the gingipains rendering it inactive to degrade the cytokines and 
chemokines. Another question that arises is if the chemokine or cytokine 
transcription actually translates into protein production? Sandros et al (2000) 
investigated whether cytokine transcription was translated into protein 
production by performing immunohistochemistry (IHC) on epithelial cells with 
biotinylated α-human IL-1β, IL-2, IL-6, IL-8 and TNF-α to visualise intracellular 
cytokines (Sandros et al., 2000). All the infected samples showed positive 
reactions in 80-90% of the cells, while no apparent differences were observed 
among the 4 tested cytokines, suggesting that any effect of inflammatory 
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mediators was result of direct effect against the mature protein. This suggests 
that the changes in cytokine and chemokine expression within the different 
parameters may have been the result of live periodontal pathogens, including P. 
gingivalis due to the degrading properties of gingipains. However, we cannot 
discount entirely the potential for technical problems. 
 
In summary, the current study showed differential immune responses to the 
pathogenic and commensal biofilms in epithelial cells. Even though both the 
pathogens and commensals had effects on the chemokine and cytokine 
expression and release, the pathogens induced more expression and release by 
the epithelial cells. Epithelial cells stimulated with mono-species biofilms does 
not reflect the immune responses demonstrated by a multi-species biofilm but it 
is useful in characterizing each individual bacterial species, which serves as a 
useful comparison in order to delineate complex inflammatory responses 
induced by multispecies biofilms. The current study was performed on 
monolayer of immortalized human oral keratinocytes but in the oral cavity, the 
bacterial biofilms come into contact with gingival tissue, which consists of 
multilayer of epithelial cells and connective tissue. The present study was 
performed in vitro and the conclusions drawn from these results must be 
interpreted with caution. Further studies are required to understand the 
workings of the host with regards to the bacterial biofilms and vice versa. The 
current study has established an in vitro model system, which allows to clearly 
differentiate, in vitro, the different response to commensals versus pathogens. 
This is a critical step to understanding both periodontal and other diseases. The 
hope for the future is to unravel the details of the mechanisms involved and 
thereby identify novel therapeutic targets for inflammatory and infectious 
disease.  
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CHAPTER 5:  
ROLE OF INTERLEUKIN-17A 
IN PERIODONTAL DISEASE  
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5.1 INTRODUCTION 
The previous chapter investigated a panel of cytokines and chemokines that 
were shown to be associated with experimental gingivitis, in particular those 
mediators produced by epithelial cells, which are central to orchestrating the 
immune response. These molecules were released from epithelial cells as a 
means of alerting the immune system that periodontal biofilms were present. 
Recent data indicates that early cell migration to the gingivae in periodontitis is, 
surprisingly, strongly mediated by a cytokine associated more with the adaptive 
response, IL-17A (Yu et al., 2007), which is key molecule to inducing and 
mediating numerous pro-inflammatory responses (Aggarwal and Gurney, 2002).  
 
Interleukin-17A (IL-17A) was initially identified in T cells (Liang et al., 2010), 
although subsequent studies identified numerous other cellular sources of IL-
17A, including γδ T cells, NK cells, neutrophils, eosinophils, LTi CD4 cells 
(Kimizuka et al., 2012) and mast cells (Hueber et al., 2010). IL-17A induces 
cytokine and growth factor production predominantly via signalling through the 
IL-17RA and IL-17RC heterodimer. IL-17RA is ubiquitously expressed, especially 
within hematopoietic tissues, and also by epithelial cells, endothelium, and 
fibroblasts (Gaffen, 2009). A protective role for IL-17 in bacterial and fungal 
infections emerged through studies in IL-17/IL-17RA deficient animals, which are 
susceptible to mucosal candidiasis (Takahashi et al., 2005), Klebsiella 
pneumoniae (Conti et al., 2009), Legionella pneumonia (Allam et al., 2011) and 
Porphyromonas gingivalis (Yu et al., 2007). In the latter model investigating IL-
17R deficient animals, IL-17 conferred protection by promoting neutrophil 
migration to the gingival tissues. The absence of IL-17R signalling significantly 
compromised the antimicrobial effects of infiltrating neutrophils, rendering the 
animals more susceptible to periodontal disease.  
 
IL-17A has been implicated in the pathogenesis of many chronic inflammatory 
diseases, such as Rheumatoid Arthritis, Psoriasis, Crohn’s Disease and Multiple 
Sclerosis (Korn et al., 2009). Numerous studies of models of arthritis, a diseases 
process with notable parallels to periodontal disease, demonstrate IL-17 may 
contribute to initiation and perpetuation of chronic, destructive inflammation 
(Miossec et al., 2009). Neutralising IL-17A is therapeutically beneficial, and a 
neutralising anti-IL17A monoclonal antibody has demonstrated promise as a 
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treatment for Rheumatoid Arthritis in human trials (Genovese et al., 2010). 
Therefore, IL-17 plays a potentially double-edged role in periodontal disease 
(PD), with the ability to both protect against infection and perpetuate 
inflammation.  
 
This conundrum is highlighted by findings in aged mice, which, in contrast to the 
findings in IL-17RA deficient animals, demonstrate increased periodontal bone 
loss, with associated substantial elevation of local IL-17A mRNA (Duarte et al., 
2010). In human studies, IL-17A mRNA expression is elevated in the gingival 
crevicular fluid and tissues of individuals with chronic periodontitis, compared 
with healthy controls (Vernal et al., 2005, Beklen et al., 2009). Systemically 
elevated serum IL-17A has been documented in patients with aggressive 
periodontitis (Schenkein et al., 2010). Further highlighting the association of IL-
17A with infection and inflammation, successful periodontal therapy results in a 
reduction in IL-17 expression (Cua and Tato, 2010). However, further studies 
have suggested that periodontitis may associate with reduced IL-17 in saliva 
(Zhao et al., 2011) and reduced concentration of IL-17 in the GCF of patients 
with GAP (Dutzan et al., 2011). Therefore, it may seem that in certain patients, 
at certain stages, IL-17 may mediate conflicting roles of both promoting 
protective neutrophil recruitment and perpetuating destructive inflammation. 
IL-17 is an attractive target for modulating bone destructive diseases including 
periodontitis. We sought to investigate alternative cellular sources of IL-17A, 
establish if it might be released from the tissue, and investigate potential 
effects of IL-17A on local epithelium.  
 
5.2 AIMS 
The aim of this study was to determine whether IL-17A is expressed within and 
released from periodontal tissues and to investigate its role in the regulation 
epithelial cell cytokine and chemokine production.  
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5.3 MATERIALS AND METHODS 
5.3.1 Human periodontal tissues 
Gingival tissues (n = 34) were obtained from patients with written consent, 
undergoing open flap debridement in the Unit of Periodontics at Glasgow Dental 
Hospital. Ethical review and approval was provided by the West of Scotland 
Research Ethics Committee. Patients undergoing open flap debridement had 
probing pocket depths of ≥ 6.0 mm, with clinical attachment loss of ≥ 4.0 mm, 
which persisted after non-surgical treatment. Patient age ranged from 38-64 
years with a mean age of 47 years. Healthy control tissues were obtained from 
patients with clinically healthy periodontal tissues undergoing surgical crown-
lengthening procedures.  
 
5.3.2 mRNA and protein detection  
Tissue samples were stored in RNA Later (Ambion) at -80°C prior to RNA 
extraction using RNeasy Fibrous Tissue Kit (Qiagen), as section 4.3.1, but with 
addition of a proteinase-K digest step. Cultured cells were processed as in 
Section 4.3.1. Reverse transcription, and Real time PCR was carried as in section 
4.3.1, with primers as in table 4.2 and additionally for IL-17A: Forward primer – 
GGAATCTCCACCGCAATGAG, Reverse primer – ACACCAGTATCTTCTCCAGCC. Data 
were analyzed Proteins in cell culture supernatants were detected by either 
EILSA (IL-6, IL-8 – both eBiosource, Invitrogen) or Luminex™ (G-CSF and GM-CSF – 
both Invitrogen) according to the manufacturer’s instructions and as described in 
section 4.3.2.  
 
5.3.3 Fluorescent microscopy and immunohistochemistry 
Five μm sections paraffin embedded periodontal tissues were deparaffinized and 
rehydrated. The 0.5% hydrogen peroxidase/methanol incubation and heat 
retrieval in 0.5 M citrate buffer (pH 6) was followed by incubation in 2.5% 
species/2.5% human serum with Avidin D (Vector Laboratories, Petersborough, 
U.K.). Staining for 1 h with mouse anti-mast cell tryptase [MCT] [0.43 mg/ml; 
Dako UK], was followed by 30 min incubation with biotinylated Abs (1:200; 
Vector Laboratories) with subsequent staining with streptavidin QDot605 (1:250; 
Invitrogen, Paisley, U.K.) for 45 min. Goat anti–IL-17 (5 mg/ml; R&D Systems, 
Abingdon, U.K.) was added overnight at 4oC, then incubated with a biotinylated 
Ab for 30 min, and stained with Avidin FITC (1:500; Vector Laboratories) for 45 
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min. Slides were mounted with Vectashield containing DAPI (Vector Labo- 
ratories) and analyzed on a fluorescent imaging microscope (BX50; Olympus, 
Essex, U.K.). Images were captured using Apple Open laboratory software. For 
immunhistochemistry, prepared periodontal tissue sections were incubated with 
goat anti–IL-17 overnight, incubated with ImmPRESS reagent anti-goat Ig for 30 
min (Vector Laboratories), and signal-developed using the peroxidase sub- strate 
nickel diaminobenzidine tetrahydrochloride (Vector Laboratories). 
 
5.3.4 Cell culture  
OKF6-TERT oral epithelial cells (kind gift of Rheinwald laboratory, Brigham and 
Woman’s Hospital, Boston) were grown at 37°C, with 5% CO2 in 75 cm2 cell 
culture flask (Corning NY, USA) in KSFM (Invitrogen). The cells were replated and 
grown to confluence in defined KSFM (Invitrogen) then stimulated as indicated in 
the figure legends. Cells were used were between passage 13 and 15. 
Periodontal tissue was transferred immediately after collection to chilled RPMI 
(Invitrogen), then a single cell suspension prepared using Liberase™ (Invitrogen) 
according to the manufacturer’s instructions. Cells were cultured at 2x106/ml in 
conditions indicated in the figure legends.  
 
5.3.5 Statistical analysis 
Microsoft Excel and GraphPad Prism were used to process raw data and 
implement statistical analysis in conjunction with graphical design.  Differences 
in mRNA abundance in healthy and periodontitis tissue biopsies as assessed by 
real-time PCR analysis were analysed by the Mann-Whitney U-test. Mann-
Whitney U-test is a non-parametric statistical hypothesis test for assessing 
whether one of two samples of independent observations tends to have larger 
values than the other. This test can be used when the data is not normally 
distributed; if the variances for the two conditions are noticeably different or if 
the data are measurements on an ordinal scale (allowing for rank order) 
(Kruskal, 1957). Differences between the mean cytokine protein levels between 
stimulated and control samples were analysed by one-way ANOVA the Levene’s 
test to test for the equality of variances in the samples and a post hoc Dunnett 
t-Test. Levene’s test is used to test if different samples have equal variances. 
Statistical tests like ANOVA assume that variances are equal across groups or 
samples and Levene test can be used to verify that assumption (Levene, 1960). 
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Dunnett’s test compares group means where all the groups are compared against 
one control group. The goal of this test is to identify groups whose means of the 
distributions are significantly different from the mean of the control group 
(Dunnett, 1964). Correlations between the cytokine levels were assessed using a 
bivariate Pearson correlation analysis. The bivariate Pearson correlation analysis 
is used to test the correlation between variables. Results are between -1 and 1. 
A result of -1 means that there is a perfect negative correlation between the 
two values, while a result of 1 means that there is a positive correlation 
between the two variables (Rodgers and Nicewander, 1988). 
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5.4 RESULTS 
5.4.1 Expression of IL-17A in human periodontal tissues. IL-17A gene 
expression was significantly elevated in diseased compared with healthy human 
periodontal tissues (Figure 5.1). Protein expression was confirmed by 
immunohistochemistry (Figure 5.2). There was considerable variability in the 
number of IL-17 positive cells within the diseased tissue samples, ranging from 
between 2 and 4 positive cells per field of view to over 20 positive cells per field 
of view. The healthy tissue did not demonstrate any IL-17A positive cells (data 
not shown). In order to identify the cellular source of the IL-17A protein, 
samples were initially investigated for CD3 and variable numbers of CD3 positive 
cells were found infiltrating the diseased tissue. When assessed by 
immunoflouresence, the CD3 positive cells did not account for all the IL-17 
present, therefore, as previous studies document high expression of IL-17 by 
mast cells in inflamed tissues (Hueber et al., 2010), therefore, IL-17 expression 
by mast cells was investigated. A composite overlay (Figure 5.3) demonstrates 
that the mast cells were predominantly IL-17A positive. 
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Figure 5.1: Expression of IL-17A in human periodontal tissue. IL-17 mRNA 
expression in gingival tissue obtained from patients with chronic periodontitis (n 
= 9) or healthy controls (n = 6). Each dot represents an individual patient 
sample. The difference in the IL-17A mRNA expression between the diseased and 
healthy tissue samples were assessed by Mann Whitney U test (* p < 0.005). 
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Figure 5.2: Expression of IL-17A in human periodontal tissue by 
immunohistochemistry. Sections of paraffin embedded periodontal tissue, from 
patients with chronic periodontitis, demonstrating IL-17A positive cells stained 
brown (inset box shows isotype control) at 100 X (A) and 400 X (B). 
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Figure 5.3: Expression of IL-17A in human periodontal tissue by Immunofluorescence. Immunofluorescence demonstrating IL-17A in 
green (A), mast cells in red (B), and composite overlay showing co-localization of IL-17A to mast cells (C). 
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5.4.2 Release of IL-17A from periodontal tissue. Single cell suspensions 
obtained from diseased human periodontal tissues were stimulated with 
PMA/ionomycin for 48 h. Only following stimulation, IL-17A was detectable by 
ELISA in the cell culture supernatants of 9 out of 10 patients’ samples. There 
was an apparent dichotomy: cultures from 50% of the patients releasing 
considerably more IL-17A than the other samples. There was no correlation 
between these patients’ clinical condition (probing pocket depths at surgical site 
or age) and the concentration of IL-17A released. Interestingly, IL-17 release was 
not stimulated by LPS (either P. gingivalis or E. coli, data not shown). Next, the 
release of other inflammatory cytokines into the cell culture supernatants was 
investigated to establish if the IL-17 release reflected a different inflammatory 
profile overall. Considerable IFN was released only upon cell stimulation, 
(Figure 5.4B). TNFα was found in high concentrations in both the unstimulated 
and the stimulated cell culture samples (Figure 5.4C). IL-1β release was highly 
variable amongst the unstimulated and stimulated samples (Figure 5.4D). IL-6 
concentrations decreased upon stimulation compared with the unstimulated 
samples (Figure 6.4E). High concentrations of IL-10 were released from both the 
unstimulated and stimulated samples (Figure 5.4F). There was a possibility of a 
link between the baseline concentration of IL-6 and the final concentration of IL-
17A, however this was not statistically significant. Due to the small number of 
patient samples no link or correlation between the different cytokines could be 
inferred with certainty. Nevertheless, it was noted in baseline samples that IL-
1β, IL-6 and IL-10 concentrations were all correlated (all > 0.730, p < 0.025). 
These apparent relationships were lost on stimulation, where after IL-6 
correlated with IFNγ (0. 733, p=0.024). No correlation between IL-17A 
concentrations and the other cytokines could be found, therefore there was no 
apparent ‘profile’ or cassette of cytokines associated with particular patient 
samples. 
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Figure 5.4: Cytokine release from tissues obtained from patients with chronic 
periodontitis. Diseased periodontal tissue samples (n=10) were enzymatically 
digested to single cell suspensions and then stimulated with PMA/Ionomycin for 
48 hours. Cytokine release was assessed by Luminex™ of cell culture 
supernatants. Each point represents an individual patient sample. Data shown 
are cytokine concentrations of (A) IL-17A, (B) IFNγ, (C) TNFα, (D) IL-1β, (E) IL-6 
and (F) IL-10 in pg/mL in the stimulated and unstimulated samples. Differences 
between pre- and post-stimulation levels of cytokines secreted by periodontal 
tissue cells were assessed by paired sample Wilcoxan signed ranks test. (* p < 
0.05; **p < 0.005). 
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5.4.3 Effect of IL-17A on OKF6 oral epithelial cells. It was hypothesised that 
IL-17 released in the periodontium likely acts locally on epithelial cells and this 
was first investigated by confirming expression of the IL-17 Receptor (IL-17R) 
subunits on the oral epithelial cell line, OKF6, by PCR (data not shown). Culture 
with IL-17A for 4 and 24 h resulted a dose and time dependent upregulation of a 
number of chemokine and cytokine genes (Figure 5.5), including CXCL-1, -3 -5, 
IL-8, CCL5, IL-1α, IL-1β, GMCSF and GCSF. Protein release was investigated by 
ELISA and Luminex™ of cell culture supernatants. OKF6 cells demonstrated a 
dose response to IL-17A, which resulted in a statistically significant release of IL-
8, IL-6, G-CSF and GM-CSF after 4 h stimulation (p = 0.037, p = 0.0040, p = 0.037 
and p = 0.0012, respectively) and after 24 h for all but the GM-CSF (p = 0.0023, p 
= 0.0040, p = 0.035 and p = 0.060 respectively) (Figure 5.6). IL-1α and TNFα 
were also analysed, however, no protein product was detected in the culture 
fluids (data not shown). Thus, IL-17A appeared to have potent effects on 
epithelial cells, inducing a dose and time dependent upregulation of numerous 
chemokines and cytokines by oral epithelial cells. 
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Figure 5 .5: Gene expression changes in epithelial cells stimulated with IL-17. 
OKF6 cells were stimulated with 100 ng/ml IL-17A for 4 h (A) and 24 h (B). Gene 
expression was analysed by TaqMan Low Density Array (TLDA) allowing multiple 
genes to be analysed simultaneously. Graphs demonstrate fold change in gene 
expression following IL-17A stimulation. Data are mean fold change +/- SEM of 
duplicate measurements from two independent experiments. 
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Figure 5.6: Cytokine and chemokine release from epithelial cells stimulated 
with IL-17A. OKF6 cells were stimulated with 1, 10 or 100 ng/ml IL-17A for 4 h 
or 24 h, after which the cell culture supernatants were analysed by 
ELISA/Luminex™. Data are mean +/- SEM of triplicate measurements of two or 
more independent experiments. The difference in dose response of the IL-17A 
with respect to IL-8, IL-6, G-CSF and GM-CSF release from the epithelial cells 
were assessed by Jonckheere-Terpstra Test (*p < 0.05, **p < 0.005). 
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5.5 DISCUSSION 
IL-17A expression was significantly increased in diseased, chronically inflamed 
periodontal tissues, compared with healthy tissues, and a considerable 
proportion of this IL-17 localised to mast cells. Moreover, IL-17 could be released 
in response to calcium and protein kinase C agonists. IL-17A may locally activate 
a number of cells including oral epithelial cells resulting in increased chemokine 
and cytokine expression. This study is, to the best of our knowledge, the first to 
document the expression of IL-17 in mast cells in periodontal disease. Previous 
studies have documented elevated IL-17A mRNA expression in chronically 
inflamed periodontal tissues compared with gingivitis models and healthy 
controls (Vernal et al., 2005, Takahashi et al., 2011, Beklen et al., 2009), and 
elevated IL-17A protein in GCF (Vernal et al., 2005). These data confirm these 
findings and imply that the IL-17 detected in GCF is likely to be predominantly 
derived from local cells rather than the serum, although elevated serum IL-17A 
has been reported in patients with aggressive periodontitis (Schenkein et al., 
2010).  
 
Following periodontal treatment both local and systemic effects on IL-17 
expression have been documented (Perregaux and Gabel, 1998, Cua and Tato, 
2010), suggesting that the elevated IL-17 expression is driven either directly by 
the pathogenic plaque biofilm or secondarily to mediators induced by the 
biofilm. Cardoso et al elegantly demonstrate the presence of Th17 cells in the 
periodontitis lesion (Cardoso et al., 2009), and the current study suggests that 
these cells, and mast cells, are likely to both provide sources of IL-17 in these 
tissues. Recent data suggests that at different stages of disease, periods of 
disease intensity and even at different locations within lesions adjacent to the 
same tooth, there may be variable expression of IL-17 as the cellular 
composition of the lesion changes (Liang et al., 2006). The role of the mast cell 
in periodontal disease although intriguing, remains relatively poorly understood 
(Berglundh and Donati, 2005, Gemmell et al., 2004). Both mucosal (Mu) and 
connective tissue (CT) mast cells are consistently identified in both health and 
inflammatory disease in the oral cavity (Gemmell et al., 2004, Steinsvoll et al., 
2004). The density of mast cells is increased in chronic periodontitis and, as 
would be expected the Mu mast cells appear to dominate the oral mucosa 
(Gemmell et al., 2004). Mast cells produce numerous cytokines (Galli and Tsai, 
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2010) implicated in periodontal pathogenesis, including IL-1 and TNF, and the 
current study described their capacity to produce IL-17. It could be argued that 
in the context of bacterial infection, the protective roles of IL-17 at mucosal 
surfaces may dominate the pathogenic. Clearly, the timing of such cytokine 
release is likely to be critical to its ultimate role. Mast cells are positioned to 
rapidly release numerous mediators capable of promoting neutrophil 
recruitment, which is essential to early bacterial control, but likely contributes 
to later stages of chronic inflammation. Thus, perhaps mast cell derived 
cytokines and other mediators offer potential novel therapeutic targets.   
 
Here it was also documented that IL-17 exerts a broad range of functions in oral 
epithelial cells, which extends previous studies investigating IL-17 augmentation 
of TLR mediated IL-1β and TNFα release from gingival epithelial cells (Beklen et 
al., 2009). Given the previously reported synergism between both IL-17A and IL-
17F and IL-22 (Liang et al., 2006, Kolls et al., 2008) this was investigated in the 
current study system; however, no additional effect above that of IL-17 was 
observed. The lack of release from the epithelial cells of IL-1α and TNFα is 
somewhat surprising, given their apparent gene regulation, however, this may 
reflect the requirement for processing prior to release (Perregaux and Gabel, 
1998). Similarly, TNFα requires processing by TACE ADAM17 (Pradines-Figueres 
and Raetz, 1992). 
 
From this data, it appears that IL-17A plays an important role in the protective 
periodontal immune response to bacterial pathogens. The upregulation of acute 
inflammatory mediators (such as IL-8) will promote neutrophil recruitment and 
potentiate the removal of any invading microbial threat. Therefore it is 
important to understand the benefits of this cytokine, before systemic 
therapeutic agents are used to antagonise its actions. The previous chapter 
discussed the potential roles that the innate inflammatory mediators play in the 
pathogenesis of periodontal disease. Some demonstrated protective roles and 
some destructive. IL-17 seems to play a role in the protective periodontal 
immune response by the release of IL-8 to counter the bacterial pathogens. It 
would be interesting to investigate the IL-17 expression using the epithelial cell-
biofilm co-culture model used in the previous chapters to understand the effects 
of the bacterial biofilms in the IL-17 expression.   
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CHAPTER 6:  
DISCUSSION 
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6.1 INTRODUCTION 
6.1 Summary 
Periodontal disease involves a complex network of interactions between 
bacterial (biofilm and planktonic) and cellular responses. This series of 
investigations has demonstrated this phenomenon through a reductionist 
approach, i.e. the successful development of an epithelial-bacterial biofilm co-
culture model system, which recapitulates the inflammatory changes in host 
epithelial cells upon challenge with bacteria associated with periodontal 
disease. In summary, this model has demonstrated clear differences between (i) 
planktonic and bacterial biofilms, (ii) pathogens and commensals and (iii) live 
and dead bacterial challenge. These observations and the utility of the model 
will provide a platform to investigate key questions relating to pathogen and 
host within the oral cavity and beyond.  
 
6.2 In vivo studies of periodontal disease 
In vivo study models have been used extensively to investigate the pathogenesis 
of periodontal disease. These models include human and various animal models. 
The quest for understanding the pathogenesis of periodontal disease is rooted in 
an important human experimental gingivitis study almost half a century ago (Löe 
et al., 1965). This study significantly impacted on periodontal research because 
of the simple and instructive demonstration of the causal role of plaque bacteria 
in gingivitis. Similar studies latterly showed that cell-mediated immune response 
played an important role in the process (Smith et al., 1978). Recently, 
Offenbacher’s group evaluated the inflammatory mediators in the GCF during 
the induction and resolution of experimental plaque-induced gingivitis in humans 
(Offenbacher et al., 2010, Offenbacher et al., 2009). Ultimately, these studies 
showed that the destructive inflammatory mediators produced in response to 
the bacterial plaque are reversed once the causative factor (bacterial plaque) is 
removed. Even though these studies were instrumental in understanding 
periodontal disease, prospective studies to investigate the mechanisms 
underlying the progression of periodontal disease cannot be answered by in vivo 
studies of humans alone due to important ethical considerations (Williams et al., 
2012). This is especially true given the growing body of literature showing an 
association between periodontal disease and systemic health (Offenbacher et 
al., 2010, Offenbacher et al., 2009, Lockhart et al., 2012).  
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To overcome these ethical limitations animal models have been used extensively 
to study host-bacterial interactions and have assisted in elucidating the 
pathogenesis of periodontal disease (Graves et al., 2012). These studies have 
helped demonstrate the clinical progression of periodontitis as subclinical 
gingivitis, clinical gingivitis and periodontal breakdown. However, as in human 
models there are limitations, including species differences and diverse 
microflora, they only provide a ‘snapshot’ of the disease process, and of course 
the ethical implications of animal use (Gruber and Hartung, 2004). To illustrate 
this point, a murine Calvarian model was used to investigate host-bacterial 
interactions with P. gingivalis (Boyce et al., 1989, Graves et al., 2001, Leone et 
al., 2006). This model was not performed within an oral environment and also 
provides no information relating to the interactions with the epithelial tissues, 
therefore its validity must be questioned. Moreover, an oral gavage model using 
human periodontal pathogens to study the consequent impact on periodontium 
has been used extensively (Baker et al., 1999, Chang et al., 1988, Garlet et al., 
2005, Klausen et al., 1991, Lalla et al., 1998, Sharma et al., 2005). These key 
pathogens are not indigenous mouse oral microflora, so prior antibiotic 
treatment is required to reduce the resident microflora, so the impact on the 
host and its translation to human oral disease is questionable. Similar arguments 
can be made about tissue cage, chamber models and airpouch models (Edwards 
et al., 1981, Pouliot et al., 2000, Genco et al., 1991, Genco et al., 1992). 
Ultimately, the main drawback of these animal models is that they do not 
accurately recapitulate human periodontal disease, creating more questions 
than answers. Moreover, P. gingivalis from Socransky’s red complex is touted as 
the alpha-periodontal pathogen (Socransky et al., 1998), and is therefore 
subject to the majority of studies (Hajishengallis et al., 2012). Yet, increasing 
evidence from recent studies indicate that bacteria such as Filifactor alocis 
appear to play a significant role in periodontal disease (Schlafer et al., 2010). 
Moreover, the contribution of uncultivable bacteria and multispecies consortia 
should not be discounted (Peters et al., 2012). Modelling a large number of 
experimental parameters in animal models is therefore problematic, so in vitro 
studies provide an opportunity to refine and reduce these parameters.  
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6.3 In vitro modelling of periodontal disease 
Modelling biofilms associated with periodontal disease has been subject to 
numerous studies over the years (Hope et al., 2012, Marsh, 2006, Periasamy and 
Kolenbrander, 2009b, Peyyala et al., 2011b, Pratten, 2007). Defined and 
undefined biofilm consortia have been evaluated to provide insight into how oral 
bacteria interact with one another (Lamont and Jenkinson, 1998). However, 
recent studies have evolved this concept to include mammalian cells in an 
attempt to understand how these interact with the host (Dickinson et al., 2011, 
Belibasakis et al., 2011b, Belibasakis et al., 2011a, Guggenheim and Meier, 2011, 
Peyyala et al., 2011a, Peyyala et al., 2012). These have a number of advantages 
over in vivo periodontal disease models, the most obvious being the ethical 
argument. These controlled and reproducible systems enable evaluation of 
periodontal biofilms in ‘real-time’, allowing for the analysis of both biofilm 
consortia and cellular responses and how they modulate one another. The 
control of the system is of critical importance particularly when dissecting 
immune pathways. Guggenheim’s group pioneered the use of in vitro host-
pathogen interactions using a multi-species biofilm-epithelial cell co-culture 
model to investigate the cellular response to oral biofilms (Belibasakis et al., 
2011b, Belibasakis et al., 2011a, Guggenheim and Meier, 2011), an innovative 
approach that has been recently emulated (Peyyala et al., 2011a, Peyyala et al., 
2012). These studies have independently shown differences in cytokine and 
chemokine response to the different bacterial biofilms and planktonic cells.  
 
The aim of the work presented herein was to develop a simple in vitro 
periodontal biofilm model to study host-pathogen interactions with respect to 
pathogen versus commensal, and biofilms versus planktonic cells. Ultimately, 
the study was aimed at creating a model that could be used to evaluate the 
effects of various bioactive molecules associated with oral health. To this end a 
simple in vitro 4-species biofilm model was successfully produced. This 
minimalist approach was employed because models, which use pooled saliva or 
pooled plaque samples are associated with problems of reproducibility (Hope et 
al., 2012). The current model delivered mono-species and multi-species biofilms 
grown on hydroxyapatite in artificial saliva through the sequential addition of 
the bacteria. The advantage to this approach was reproducibility, growth on a 
biologically relevant substrate and in a biologically relevant media, and 
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development of a biofilm in a manner similar to plaque. However, the limited 
number of bacterial species involved can be construed as a flaw to the model. 
However, in this scenario this was used as an advantage because the limited 
parameters enabled careful dissection of their contribution to inflammatory 
mediators. Therefore, this model can be used for high throughput analysis of 
host-pathogen interactions without worrying about ethical approvals for using 
human biological samples.  
 
Specifically, the model showed that the individual bacteria preferentially survive 
when grown as multi-species biofilms compared with mono-species biofilms in 
cell culture conditions, and was successfully used to investigate host-pathogen 
interactions. This is in agreement with previous multi-species biofilm models, 
demonstrating mutualistic behaviour (Periasamy and Kolenbrander, 2009b). The 
current study also showed differential immune responses of various cytokines 
and chemokines to the pathogens and commensals. Even though both the 
pathogens and commensals affected the expression and release of inflammatory 
mediators, the pathogens preferentially induced expression and release by the 
epithelial cells as illustrated by the defined array patterns. Moreover, there is a 
high level of confidence in the data generated as IL-8 gene expression was 
observed following P. gingivalis biofilm challenge, whereas the release of IL-8 
did not correlate with the gene expression. This is explained by gingipain 
release, a key immunomodulatory component of P. gingivalis (Mikolajczyk-
Pawlinska et al., 1998). Therefore, the hypothesis that this model system could 
differentiate clearly between commensal and pathogenic, and planktonic and 
biofilms, was satisfactorily demonstrated. This offers improvements on others 
studies that investigated protein release without gene expression (Peyyala, 2012 
#360), or focussed predominantly only on pathogenic biofilms (Guggenheim et 
al., 2009).  
 
In summary, a novel in vitro model has been developed which successfully 
recapitulates the inflammatory changes in the host (epithelial cells) upon 
challenge with bacteria responsible for health and disease in periodontal 
disease. 
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6.4 Pathogens, commensals and the immune system 
There have been several studies pertaining to the gut or intestinal epithelium 
(Pott and Hornef, 2012, Brandtzaeg, 2011, Brandtzaeg, 2010). These studies 
discuss how immune homeostasis in the gut environment is modulated by 
adaptive and innate immune responses and coordinated by antigen-presenting 
cells. Immune homeostasis in the oral cavity could also be explained in a similar 
manner. The oral cavity also consists of a range of commensals and pathogens 
that are in a state of homeostasis with the epithelium. This may be due to the 
fact that the innate immune system is highly active in the healthy tissues 
(Darveau, 2010). An imbalance of this system can contribute to the destruction 
of the periodontal tissue (Page and Kornman, 1997). Also, the recognition that 
both the commensals and pathogens can initiate innate immune responses 
through TLRs, which recognise microbes (Beutler et al., 2003). The current study 
demonstrated clear differences in the epithelial cell responses after challenge 
with commensals and pathogens. This was in agreement with a study showing 
similar epithelial cell responses to pathogenic P. gingivalis and commensal S. 
gordonii. This group investigated the gingival epithelial responses to pathogens 
and commensals in vitro using a co-culture model (Dickinson et al., 2011, 
Hasegawa et al., 2007). The oral commensal S. gordonii and opportunistic 
commensal F. nucleatum were shown to induce the gingival epithelial cell 
transcriptome less significantly compared with the oral pathogens P. gingivalis 
and A. actinomycetemcomitans. The limitation of this study was that the 
bacteria were in suspension when cultured with the epithelial cells. The study 
by Jeff Ebersole’s group also investigated the differential epithelial cell 
response to commensal and pathogen biofilms with respect to protein release of 
various cytokines and chemokines (Peyyala et al., 2012). The current study 
showed similar protein profile with IL-8 and IL-1α where there was lower 
production of these proteins with P. gingivalis and Streptococcus species 
stimulation. In summary, all these studies show that pathogens and commensals 
behave differently when they come in contact with the epithelial cells. The 
exact mechanisms have not been fully understood. 
 
It is not known how exactly the commensal S. mitis interacts with the innate 
immune system. It has been shown that S. mitis is remarkably tolerant to human 
β-defensin 2 (hBD-2) and other antimicrobial peptides (Nishimura et al., 2004, 
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Ouhara et al., 2005). In addition to this, S. mitis can also modulate the 
expression of the pro-inflammatory chemokine IL-8 by not promoting the IL-8 
expression (Eberhard et al., 2009). Taken together, these data indicate that S. 
mitis, as a beneficial commensal, can supplement host immunity by maintaining 
tissue homeostasis. On the other hand, the pathogenic mixed species and P. 
gingivalis biofilms boasts of a huge array of virulence factors, which can induce 
the innate immune response. The putative periodontal pathogen P. gingivalis 
attaches to the epithelial cells using fimbriae and gingipains and invades the 
cells {Weinberg, 1997 #231; Guo, 2010 #60}. The lipopolysaccharide (LPS) with 
its lipid A component in P. gingivalis induces a strong response from the host 
immune systems as it binds the toll-like receptor complex which promotes the 
secretion of pro-inflammatory cytokines in the epithelial cells including many 
other cell types (Loppnow et al., 1990). P. gingivalis uses gingipains to disrupt 
the cytokines and cytokine receptor networks of the host, including IL-1 beta 
(Sharp et al., 1998), interleukin-6 (IL-6), interleukin-8 (IL-8) (Mikolajczyk-
Pawlinska et al., 1998), interferon-gamma (Yun et al., 1999) and TNF-alpha 
(Calkins et al., 1998). This could explain why protein release of these cytokines 
and chemokines does not correlate with the gene expression. All these factors 
prove the pathogenic potential of P. gingivalis. The host immune system does 
not rely totally on epithelial cells to act as defense against pathogenic plaque. A 
mixture of cells and other inflammatory mediators play a role in maintaining 
homeostasis within the gingival crevicular space.  
 
6.5 IL-17 A – Important protection against pathogens 
A protective role for IL-17 in oral microbial infections emerged through studies 
in IL-17/IL-17R deficient animals, which are susceptible to mucosal candidiasis 
(Takahashi et al., 2005) and P. gingivalis (Yu et al., 2007). The study by Yu et al 
demonstrated increased periodontal disease susceptibility in IL-17R deficient 
animals and elucidates to a protective role of IL-17 against P. gingivalis induced 
periodontal disease by promoting the migration of neutrophils to the site of 
infection to combat the pathogenic threat. However, a recent study by Eskan et 
al using an ageing mouse model of periodontal disease demonstrated that 
elevated IL-17 levels are associated with excessive neutrophil infiltration 
through the inhibition of development endothelial locus 1 (Del1) and the 
promotion of lymphocyte function associated antigen 1 (LFA-1) dependant 
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recruitment of neutrophils (Eskan et al., 2012). Therefore, these contrasting 
studies suggest that although IL-17 is required to protect mucosal surfaces of the 
periodontium from potential pathogens an over excessive IL-17 response may 
promote the pathogenesis of periodontal disease. Indeed, clinical studies have 
shown elevated levels of IL-17 mRNA in gingival tissue of periodontal disease 
patients (Vernal et al., 2005, Takahashi et al., 2011, Beklen et al., 2009) and 
elevated IL-17A protein levels in GCF (Vernal et al., 2005), serum and saliva of 
patients with periodontal disease (Ozcaka et al., 2011, Schenkein et al., 2010). 
Furthermore, IL-17 levels in serum and saliva have been demonstrated to 
correlate with clinical parameter of periodontal disease and IL-17 levels have 
been shown to fall after periodontal therapy (Duarte et al., 2010, Schenkein et 
al., 2010). 
 
The current study confirmed that elevated levels of IL-17 mRNA in gingival tissue 
are associated with periodontal disease. This also suggests that levels of IL-17 
detected in GCF by other groups are likely to be primarily derived from local 
cells rather than serum. In this study we demonstrated that mast cells may be a 
key source of IL-17 in the periodontium and although oral epithelial cells 
themselves do not express IL-17 they can respond to exogenous IL-17 by 
upregulating the expression of a range of pro-inflammatory mediators including 
IL-8, IL-6, TNF-α, IL-1 α and the colony stimulating factors. The upregulated 
expression of these mediators by oral keratinocytes maybe a key mechanism by 
which IL-17 protects mucosal surfaces from pathogens. For example, increased 
expression of CXCL8 (IL-8) expression will promote neutrophil recruitment to the 
site of infection and potentiate the removal of any microbial threat. However, 
studies of models of arthritis, a diseases process with notable parallels to 
periodontal disease, demonstrate IL-17 may contribute to initiation and 
perpetuation of chronic, destructive inflammation (Miossec et al., 2009). 
Furthermore, mast cells have also been demonstrated to be one of the key IL-17 
producing cells in the synovium of patients with arthritis (Hueber et al., 2010). 
Therefore, it is interesting to speculate that mast cells through the expression of 
IL-17 may play a key role in the regulation of the periodontal immune response 
and contribute to the pathogeneisis of periodontal disease.  
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6.6 Future studies 
These studies have developed a simple co-culture model to investigate host-
pathogen interactions in the context of oral disease. This provides the 
opportunity to evaluate how small molecules of anti-microbial or immuno-
modulatory capacity interact with biofilms and host cells. These would prove 
useful for the development of novel oral healthcare products. From a basic 
scientific standpoint this system would be useful to evaluate the role of 
virulence factors, such as gingipains, through the use of defined mutants. It 
would be particularly interesting to supplement the biofilm with other oral 
pathogens and to evaluate the contribution these make through analogous 
studies described herein. Finally, and potentially the most interesting, would be 
to investigate the immunity in more detail. Given the interesting IL-17 data 
generated and the role of the mast cells, it would be useful to introduce new 
mammalian cells types either singly or as a 3-D cell culture model. This would 
provide the opportunity to evaluate the individual component that these cells 
types play in oral health whilst concomitantly evaluating their impact on plaque 
biofilms.  
 
6.7 Conclusion 
In summary, the current study has shown differential immune responses to the 
pathogenic and commensal biofilms in epithelial cells. Even though both the 
pathogens and commensals had effects on the chemokine and cytokine 
expression and release, the pathogens induced more expression and release by 
the epithelial cells. Epithelial cells stimulated with mono-species biofilms does 
not reflect the immune responses demonstrated by a multi-species biofilm but it 
is useful in characterizing each individual bacterial species. The current study 
was performed on monolayer of immortalized human oral keratinocytes, but in 
the oral cavity bacterial biofilms come into contact with gingival tissue, which 
consists of multilayer of epithelial cells and connective tissue. The present study 
was performed in vitro and the conclusions drawn from these results must be 
interpreted with caution. Further studies are required to understand the 
workings of the host with regards to the bacterial biofilms and vice versa. The 
current study has established an in vitro model system, which allows to clearly 
differentiate, in vitro, the different response to commensals versus pathogens. 
This is a critical step to understanding both periodontal and other diseases. This 
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study also investigated a novel cytokine IL-17, which has been shown to have a 
protective role against the influx of the periodontal pathogens. The hope for the 
future is to unravel the details of the mechanisms involved and thereby identify 
more novel therapeutic targets for inflammatory and infectious disease.  
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